Processing 00000000.tx.1: Wortmannin-Sensitive Pathway Is Required for Insulin-Stimulated Phosphorylation of Inhibitor B Sanjay K. 

Phrase: "Wortmannin-Sensitive Pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "Is"

Phrase: "Required for Insulin-Stimulated Phosphorylation of Inhibitor B Sanjay K."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   757   C0021643:insulin inhibitor [Pharmacologic Substance]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C1514873:Required [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1708601:K' [Quantitative Concept]
   739   C1948023:Stimulated [Natural Phenomenon or Process]
   739   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.2: Pandey, Hua-Jun He, Alan Chesley, Magdalena Juhaszova, Michael T. 

Phrase: "Pandey,"

Phrase: "Hua-Jun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "He,"

Phrase: "Alan Chesley,"

Phrase: "Magdalena Juhaszova,"

Phrase: "Michael T."
Processing 00000000.tx.3: Crow and Michel Bernier Diabetes Section, Laboratory of Clinical Investigation (S.K.P., H.-J.H., M.B.), Laboratory of Cardiovascular Science (A.C., M.T.C.), and Research Resource Branch (M.J.), National Institute on Aging, NIH, Baltimore, Maryland 21224-6825 Address all correspondence and requests for reprints to: Michel Bernier, Ph.D., Diabetes Section, Laboratory of Clinical Investigation, National Institute on Aging, NIH, 5600 Nathan Shock Drive, Baltimore, Maryland 21224. 

Phrase: "Crow"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0326391:Crow [Bird]
  1000   C1551958:Crow [Language]
  1000   C1555179:Crow [Population Group]

Phrase: "and"

Phrase: "Michel Bernier Diabetes Section,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "Laboratory of Clinical Investigation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "("

Phrase: "S."

Phrase: "K.P.,"

Phrase: "H.-J.H.,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "Laboratory of Cardiovascular Science"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "(A.C., M.T."

Phrase: "C."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Research Resource Branch"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1253959:Branch [Body Part, Organ, or Organ Component]
   827   C1881507:Branch [Chemical Viewed Structurally]
   827   C2700383:Branch [Plant]
   827   C2826234:BRANCH [Intellectual Product]
   734   C0035201:Research Resource [Idea or Concept]

Phrase: "("

Phrase: "M."

Phrase: "J."

Phrase: ")"

Phrase: ","

Phrase: "National Institute on Aging,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1955974:National Institute on Aging [Health Care Related Organization]
   812   C0001811:Ageing [Organism Function]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]
   812   C3245503:national [Intellectual Product]
   779 E C0001779:Age [Organism Attribute]

Phrase: "NIH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027468:NIH [Health Care Related Organization]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "Maryland 21224-6825"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024858:Maryland [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Michel Bernier,"

Phrase: "Ph.D.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1512022:Ph.D. [Intellectual Product]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Diabetes Section,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]

Phrase: "Laboratory of Clinical Investigation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "National Institute on Aging,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1955974:National Institute on Aging [Health Care Related Organization]
   812   C0001811:Ageing [Organism Function]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]
   812   C3245503:national [Intellectual Product]
   779 E C0001779:Age [Organism Attribute]

Phrase: "NIH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027468:NIH [Health Care Related Organization]

Phrase: "5600 Nathan Shock Drive,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013126:Drive [Mental Process]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "Maryland 21224."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024858:Maryland [Geographic Area]
Processing 00000000.tx.4: E-mail: bernierm{at}vax.grc.nia.nih.gov  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  The aim of this study was to examine the signaling pathways by which insulin promotes activation of nuclear factor B (NFB) through the regulation of inhibitor B (IB). 

Phrase: "E-mail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0024492:Mail [Manufactured Object]
   827   C1538057:MAIL [Gene or Genome]
   827   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "bernierm{at}vax.grc.nia.nih.gov  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The aim of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the signaling pathways by which insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   809   C1512804:Insulin Signaling Pathway [Molecular Function]
   809   C2984300:Insulin signaling pathway [Molecular Function]
   783   C0037080:pathways signaling [Molecular Function]
   773 E C0037083:signaling pathway [Cell Function]
   773 E C0086982:Signaling Pathway [Molecular Function]
   767   C2984427:Insulin Pathway [Functional Concept]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "activation of nuclear factor B (NFB)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "through the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of inhibitor B (IB)."
Processing 00000000.tx.5: We show here that although insulin increased B-dependent reporter gene expression and augmented nuclear translocation of the p65/RelA subunit of NFB and its DNA binding, it was able to induce a time-dependent accumulation of phosphorylated and ubiquitinated IB without its proteolytic degradation. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that"

Phrase: "although"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "B-dependent reporter gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0017262:Gene Expression [Genetic Function]
   840   C0206414:Reporter Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "augmented nuclear translocation of the p65/RelA subunit of NFB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1518440:Nuclear Translocation [Molecular Function]
   736   C0040715:Translocation [Cell or Molecular Dysfunction]
   736   C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "its DNA binding,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148673:DNA Binding [Genetic Function]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "it"

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a time-dependent accumulation of phosphorylated"

Phrase: "and"

Phrase: "ubiquitinated IB without its proteolytic degradation."
Processing 00000000.tx.6: In contrast, cell stimulation with the cytokine TNF allowed activation of NFB through phosphorylation, ubiquitination, and subsequent degradation of IB. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "cell stimulation with the cytokine TNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "activation of NFB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "through phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "ubiquitination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "subsequent degradation of IB."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.7: Immunofluorescence studies revealed the presence of a large pool of phosphorylated IB in the nucleus of unstimulated and insulin-treated cells. 

Phrase: "Immunofluorescence studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of a large pool of phosphorylated IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "of unstimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439819:Unstimulated [Qualitative Concept]

Phrase: "and"

Phrase: "insulin-treated cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.8: IB kinase and , central players in the phosphorylation of IB, were rapidly induced following exposure to TNF but not insulin. 

Phrase: "IB kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: ","

Phrase: "central players in the phosphorylation of IB,"

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "exposure to TNF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "but"

Phrase: "not insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.9: Furthermore, insulin-stimulated IB phosphorylation did not depend on activation of the Ras/ERK cascade. 

Phrase: "Furthermore,"

Phrase: "insulin-stimulated IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "depend on activation of the Ras/ERK cascade."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C2611095:ERK cascade [Molecular Function]
   744   C0034678:RAS [Gene or Genome]
   744   C0725813:depend [Medical Device]
   744   C1707310:Cascade [Manufactured Object]
   744   C1879547:Activation [Activity]
Processing 00000000.tx.10: Expression of a dominant-negative mutant of Akt1 or class I PI3K inhibited the insulin stimulation of PI3K/Akt1 signaling without affecting phosphorylation of IB. 

Phrase: "Expression of a dominant-negative mutant of Akt1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "class I PI3K"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2936824:PI-3K [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0441885:Class I [Classification]
   734   C2698967:Class I [Finding]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the insulin stimulation of PI3K/Akt1 signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "without affecting phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "of IB."
Processing 00000000.tx.11: Interestingly, the PI3K inhibitors wortmannin and LY294002 blocked insulin-stimulated class I PI3K-dependent events at much lower doses than that required to inhibit phosphorylation of IB. 

Phrase: "Interestingly,"

Phrase: "the PI3K inhibitors wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "LY294002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "insulin-stimulated class I PI3K-dependent events at much lower doses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0441471:Events [Event]
   738   C3541888:Events [Classification]

Phrase: "than that"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "phosphorylation of IB."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.12: These data demonstrate that insulin regulates IB function through a distinct low-affinity wortmannin-sensitive pathway.  

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "IB function through a distinct low-affinity wortmannin-sensitive pathway."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0031843:function [Physiologic Function]
   738   C0542341:Function [Functional Concept]
   738   C0700205:FUNCTION [Classification]
   738   C1705273:Function [Intellectual Product]
Processing 00000000.tx.13: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  THE NUMBER OF cells in tissues is determined by the homeostatic balance between proliferation of new cells and death of senescent or damaged cells. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "THE NUMBER OF cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "determined by the homeostatic balance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014653:Balance [Organism Function]
   760   C0019868:homeostatic [Biologic Function]
   760   C0205415:Balance [Functional Concept]
   760   C0560184:Balance [Finding]

Phrase: "between proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "of new cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "death of senescent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011065:Death [Organism Function]
   790   C1306577:Death, NOS [Finding]

Phrase: "or"

Phrase: "damaged cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.14: Apoptosis, also termed programmed cell death, is an active, genetically controlled process that has been identified as a key phenomenon is the pathogenesis of a wide variety of diseases, including diabetes (1). 

Phrase: "Apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "also"

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "programmed cell death,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:Programmed Cell Death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "an active, genetically controlled process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1184743:Process [Body Part, Organ, or Organ Component]
   812   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "identified as a key phenomenon"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "is"

Phrase: "the pathogenesis of a wide variety of diseases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0543483:pathogenesis [Functional Concept]
   744   C0699748:Pathogenesis [Pathologic Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Although the biochemical and genetic events leading to apoptotic death have been the subject of intense investigation, some studies reported that insulin, through its binding to the insulin receptor (IR), confers protection against apoptosis mediated by the removal of serum and growth factors from the culture medium in a number of cell types, which include IR-expressing Chinese hamster ovary (CHO) cells (2, 3, 4, 5). 

Phrase: "Although"

Phrase: "the biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "genetic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "leading to apoptotic death"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0011065:Death [Organism Function]
   770   C0332152:Leading [Temporal Concept]
   770   C1306577:Death, NOS [Finding]
   770   C1516044:Apoptotic [Qualitative Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "the subject of intense investigation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: "some studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "through its binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to the insulin receptor (IR),"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "confers"

Phrase: "protection against apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "mediated by the removal of serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0229671:Serum [Body Substance]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "growth factors from the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]
   748   C0871911:cultural factors [Idea or Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "in a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of cell types,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "which"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "IR-"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "expressing"

Phrase: "Chinese hamster ovary (CHO) cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.16: A recent report established that the survival function of insulin can occur by means of activation of nuclear factor B (NFB) through Raf-1 activation (6). 

Phrase: "A recent report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that"

Phrase: "the survival function of insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "can"

Phrase: "occur by means of activation of nuclear factor B (NFB)"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   753   C1824728:FACTOR B [Gene or Genome]
   736   C0521447:Nuclear [Spatial Concept]
   736   C1521761:Factor [Functional Concept]
   736   C1704970:Means [Conceptual Entity]
   736   C1709305:Occur [Activity]
   736   C1879547:Activation [Activity]
   736   C2745955:OCCUR [Temporal Concept]
   736   C2827422:Factor [Conceptual Entity]
   703 E C0444504:Mean [Quantitative Concept]
   703 E C2347634:Mean [Quantitative Concept]
   703 E C2348143:Mean [Quantitative Concept]

Phrase: "through Raf-1 activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1879547:Activation [Activity]
   734   C0812215:Raf-1 [Gene or Genome]
   734   C1706586:RAF-1 [Gene or Genome]
   734   C2746015:Raf-1 [Molecular Function]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.17: The transcription factor NFB, a p50/p65 heterodimer, is maintained in an inactive form in the cytoplasm by association with the inhibitory protein inhibitor B (IB) (7). 

Phrase: "The transcription factor NFB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   875   C1824728:FACTOR B [Gene or Genome]

Phrase: "a p50/p65 heterodimer,"

Phrase: "is"

Phrase: "maintained in an inactive form"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205254:Inactive [Qualitative Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1314677:Maintained [Functional Concept]
   760   C1522492:Form [Functional Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "in the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "by association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with the inhibitory protein inhibitor B (IB) (7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   829   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1999216:Inhibitor [Qualitative Concept]
   795   C3463820:Inhibitory [Activity]

Phrase: ")."
Processing 00000000.tx.18: IB possesses both a nuclear localization signal and a nuclear export sequence that allows it to shuttle between the cytoplasm and the nucleus (8). 

Phrase: "IB"

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "both a nuclear localization signal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0525021:Nuclear Localization Signal [Amino Acid Sequence]
   827   C0475264:Localisation [Functional Concept]
   827   C0521447:Nuclear [Spatial Concept]
   827   C1710082:Signal [Phenomenon or Process]
   827   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "a nuclear export sequence"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0887840:Nuclear Export [Cell Function]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0521447:Nuclear [Spatial Concept]
   827   C0699789:Export [Phenomenon or Process]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "that"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "shuttle between the cytoplasm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010834:Cytoplasm [Cell Component]

Phrase: "and"

Phrase: "the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.19: As recently shown, the nuclear export property of IB contributes to the largely cytoplasmic localization of inactive NFB/IB complexes, thus allowing efficient NFB activation by extracellular signals. 

Phrase: "As"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "the nuclear export property of IB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0871161:Property [Qualitative Concept]
   748   C1882134:Property [Conceptual Entity]
   748   C2347695:Property [Entity]

Phrase: "contributes to the largely cytoplasmic localization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0010834:Cytoplasmic [Cell Component]
   753   C0475264:Localisation [Functional Concept]
   753   C0521449:Cytoplasmic [Body Location or Region]
   753   C1744691:localisation [Biologic Function]
   753   C1880177:Contribute [Activity]

Phrase: "of inactive NFB/IB complexes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C1704241:Complexes [Chemical Viewed Structurally]
   762 E C0439855:Complex [Qualitative Concept]

Phrase: "thus"

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "efficient NFB activation by extracellular signals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]
Processing 00000000.tx.20: On cell stimulation with the cytokine TNF as well as a broad range of stimuli, IB is rapidly phosphorylated on two serine residues (Ser-32 and Ser-36) by the two main IB kinase (IKK) activities, which then marks IB for ubiquitin-mediated proteolysis by the 26S proteasome complex (9). 

Phrase: "On cell stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with the cytokine TNF"

Phrase: "as well as"

Phrase: "a broad range of stimuli,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "IB is rapidly"

Phrase: "phosphorylated on two serine residues"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205448:Two [Quantitative Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(Ser-32"

Phrase: "and"

Phrase: "Ser-36"

Phrase: ")"

Phrase: "by the two main IB kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: ")"

Phrase: "activities,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "which then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "marks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "IB for ubiquitin-mediated proteolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1313661:Ubiquitin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1421262:UBIQUITIN B [Gene or Genome]

Phrase: "by the 26S proteasome complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   734   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1166804:26S proteasome [Cell Component]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.21: As a result of IB degradation, the released NFB heterodimer is then free to translocate to the nucleus, in which it activates transcription of target genes including IB. 

Phrase: "As a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of IB degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "the released NFB heterodimer"

Phrase: "is"

Phrase: "then free to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1883708:Then [Temporal Concept]
   827   C1996904:Free [Qualitative Concept]

Phrase: "translocate to the nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "in which"

Phrase: "it"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "transcription of target genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "IB."
Processing 00000000.tx.22: There is evidence, however, for the existence of alternative NFB activation pathways. 

Phrase: "There"

Phrase: "is"

Phrase: "evidence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "however,"

Phrase: "for the existence"

Phrase: "of alternative NFB activation pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1704259:Pathways [Molecular Function]
   799   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.23: Stimulus-induced tyrosine phosphorylation of IB allows its association with PI3K, thus causing dissociation of the inhibitory protein from NFB (10), and intranuclear proteolysis of incoming IB avoids termination of nuclear NFB activity during cell activation (11). 

Phrase: "Stimulus-induced tyrosine phosphorylation of IB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1519726:Tyrosine Phosphorylation [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "its association with PI3K,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "thus"

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "dissociation of the inhibitory protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "from NFB (10"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   861   C1824728:FACTOR B [Gene or Genome]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "intranuclear proteolysis of incoming IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597304:Proteolysis [Molecular Function]

Phrase: "avoids"

Phrase: "termination of nuclear NFB activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0599944:termination factor [Biologically Active Substance]
   748   C1549081:Termination [Intellectual Product]
   748   C1692758:termination [Idea or Concept]

Phrase: "during cell activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1326120:cell activation [Cell Function]
   861   C1879547:Activation [Activity]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.24: Remarkably, little is known about the mode of regulation of NFB in response to insulin. 

Phrase: "Remarkably,"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the mode of regulation of NFB"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   760   C1824728:FACTOR B [Gene or Genome]
   739   C0205309:Known [Qualitative Concept]
   739   C0521447:Nuclear [Spatial Concept]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]
   739   C1513371:Mode [Functional Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1705738:Mode [Quantitative Concept]
   739   C2347637:Mode [Quantitative Concept]
   739   C2348146:Mode [Quantitative Concept]
   739   C2827422:Factor [Conceptual Entity]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.25: Therefore, we undertook a study to examine the role of insulin on phosphorylation and degradation of IB, the primary regulator of signal-induced activation of NFB, and to compare this effect with that of the cytokine TNF, a prototypical NFB activator. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "undertook"

Phrase: "a study to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "examine"

Phrase: "the role of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "on phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "degradation of IB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "the primary regulator of signal-induced activation of NFB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0182953:REGULATOR [Medical Device]
   738   C1704734:Regulator [Medical Device]
   738   C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "this effect with that of the cytokine TNF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "a prototypical NFB activator."
Processing 00000000.tx.26: During the course of the study, it was observed that insulin stimulated phosphorylation of IB without promoting its proteolytic degradation in a way that TNF did. 

Phrase: "During the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of the study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "it"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "phosphorylation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "without promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "its proteolytic degradation in a way"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "that TNF"

Phrase: "did."
Processing 00000000.tx.27: It was therefore decided to extend this observation through an analysis of the insulin-signaling pathways that may be contributing to the regulation of IB function. 

Phrase: "It"

Phrase: "was"

Phrase: "therefore"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "this observation through an analysis of the insulin-signaling pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0302523:Observation [Research Activity]
   739   C0700325:observation [Health Care Activity]
   739   C1964257:Observation [Diagnostic Procedure]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "contributing to the regulation of IB function."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   744   C1705273:Function [Intellectual Product]
   744   C1880177:Contributing [Activity]
   744   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.28: In this study, a number of methods were employed, including the use of pharmacological inhibitors, indirect immunofluorescence, expression of active and inactive proteins, and Western blots using various phospho-specific antibodies.  

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "a number of methods"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the use of pharmacological inhibitors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "indirect immunofluorescence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0282646:Indirect Immunofluorescence [Laboratory Procedure]
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0439852:Indirect [Qualitative Concept]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "expression of active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "inactive proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "various phospho-specific antibodies."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   844   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0205369:Specific [Qualitative Concept]
   812   C1552740:specific [Intellectual Product]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.29: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Materials PD98059, LY294002, wortmannin, and insulin were purchased from Calbiochem (La Jolla, CA); 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials PD98059,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0298346:PD98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "LY294002,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "wortmannin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Calbiochem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)"

Phrase: ";"
Processing 00000000.tx.30: U0129 from Promega Corp. 

Phrase: "U0129 from Promega Corp."
Processing 00000000.tx.31: (Madison, WI); 

Phrase: "(Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.32: cycloheximide from Sigma Chemical Co. 

Phrase: "cycloheximide from Sigma Chemical Co."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   704 E C0947670:Actidione [Antibiotic,Organic Chemical]
Processing 00000000.tx.33: (St. Louis, MO); 

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.34: and TNF from R\|[amp ]\|D Systems (Minneapolis, MN). 

Phrase: "and"

Phrase: "TNF from R\\|[amp ]\\|D Systems"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1363984:TNF-R [Gene or Genome]
   783   C1706001:TNF-R [Gene or Genome]

Phrase: "(Minneapolis,"

Phrase: "MN"

Phrase: ")."
Processing 00000000.tx.35: Protein G-Plus/protein A- agarose was obtained from Oncogene Science, Inc. 

Phrase: "Protein G-Plus/protein A- agarose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0036681:Agarose [Carbohydrate]
   709   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "obtained from Oncogene Science,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0029016:Oncogene [Gene or Genome]
   770   C0036397:Science [Occupation or Discipline]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "Inc."
Processing 00000000.tx.36: (Manhasset, NY); 

Phrase: "(Manhasset,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.37: electrophoresis reagents such as gels, Tris-glycine SDS running buffer, and polyvinylidene difluoride (PVDF) membrane were purchased from Novex Corp. 

Phrase: "electrophoresis reagents such as gels,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "Tris-glycine SDS running buffer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   897   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "polyvinylidene difluoride (PVDF) membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
   734   C0071710:polyvinylidene difluoride [Organic Chemical]

Phrase: "were"

Phrase: "purchased from Novex Corp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0683758:Corp. [Organization]
   770   C0869011:purchased [Activity]
Processing 00000000.tx.38: (San Diego, CA); 

Phrase: "(San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: ";"
Processing 00000000.tx.39: polyclonal antibodies to the phosphorylated forms of Akt (Ser-473) and IB (Ser-32) were purchased from New England Biolabs, Inc. 

Phrase: "polyclonal antibodies to the phosphorylated forms of Akt"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Ser-473"

Phrase: ")"

Phrase: "and"

Phrase: "IB (Ser-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "purchased from New England Biolabs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0027965:New England [Geographic Area]
   760   C0014282:England [Geographic Area]
   760   C0205314:New [Temporal Concept]
   760   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.40: (Beverly, MA). 

Phrase: "(Beverly,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.41: Glutathione S-transferase (GST)-IB, horseradish peroxidase-conjugated monoclonal antibody antiubiquitin antibody (clone P4D1), and rabbit polyclonal antibodies to c-Src and the phosphorylated form of PKC- (Thr-410) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA); 

Phrase: "Glutathione S-transferase (GST)-IB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   933   C0017831:Glutathione S-Transferase B [Amino Acid, Peptide, or Protein,Enzyme]
   722   C1512218:Glutathione Transferase Inhibitor [Pharmacologic Substance]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "horseradish peroxidase-conjugated monoclonal antibody antiubiquitin antibody"

Phrase: "(clone P4D1"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "rabbit polyclonal antibodies to c-Src"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   783   C0368815:antibodies c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "the phosphorylated form of PKC-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "(Thr-410"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "obtained from Santa Cruz Biotechnology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "(Santa Cruz,"

Phrase: "CA)"

Phrase: ";"
Processing 00000000.tx.42: rabbit polyclonal antibodies to the phosphorylated form of GSK-3 (Ser-9) was purchased from Cell Signaling Technology, Inc. 

Phrase: "rabbit polyclonal antibodies to the phosphorylated form of GSK-3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   736   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   734   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   719   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   703 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Ser-9"

Phrase: ")"

Phrase: "was"

Phrase: "purchased from Cell Signaling Technology,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0037083:Cell Signaling [Cell Function]
           Signaling
   760   C0007634:Cell [Cell]
   760   C0039421:Technology [Occupation or Discipline]
   760   C0869011:purchased [Activity]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "Inc."
Processing 00000000.tx.43: (Beverly, MA). 

Phrase: "(Beverly,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.44: Anti-Flag M2 monoclonal antibody affinity gel was purchased from Kodak Co. 

Phrase: "Anti-Flag M2 monoclonal antibody affinity gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0017243:Gel [Biomedical or Dental Material]
   795   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "purchased from Kodak Co."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0869011:purchased [Activity]
Processing 00000000.tx.45: (New Haven, CT) and Sigma; 

Phrase: "(New Haven,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205314:New [Temporal Concept]

Phrase: "CT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.46: rabbit polyclonal antibody to c-myc was from Upstate Biotechnology, Inc. 

Phrase: "rabbit polyclonal antibody to c-myc"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was from Upstate Biotechnology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]

Phrase: "Inc."
Processing 00000000.tx.47: (Lake Placid, NY). 

Phrase: "(Lake Placid, NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027976:NY [Geographic Area]
   827   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.48: The plasmids expressing myc epitope-tagged Akt1 were purchased from UBI, whereas the plasmid-encoding Flag-tagged IB was a kind gift from Dr. 

Phrase: "The plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "expressing"

Phrase: "myc epitope-tagged Akt1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0285558:AKT1 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0812228:AKT1 [Gene or Genome]

Phrase: "were"

Phrase: "purchased from UBI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "whereas"

Phrase: "the plasmid-encoding Flag-tagged IB"

Phrase: "was"

Phrase: "a kind gift from Dr."
Processing 00000000.tx.49: Albert S. 

Phrase: "Albert S."
Processing 00000000.tx.50: Baldwin (University of North Carolina). 

Phrase: "Baldwin"

Phrase: "(University of North Carolina"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028407:North Carolina [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1709269:North [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.51: The plasmid-encoding dominant- negative mutant form of the p85 subunit of class I PI3K(p85) was provided by Drs. 

Phrase: "The plasmid-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "dominant- negative mutant form of the p85 subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "of class I PI3K(p85"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C3541313:p85 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "provided by Drs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.52: W. 

Phrase: "W."
Processing 00000000.tx.53: Ogawa and Masato Kasuga (Kobe University, Japan). 

Phrase: "Ogawa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "and"

Phrase: "Masato Kasuga"

Phrase: "(Kobe University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.54: [-32P]ATP (3000 Ci/mmol) was purchased from Amersham Pharmacia Biotech (Arlington Heights, IL). 

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "(3000 Ci/mmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "was"

Phrase: "purchased from Amersham Pharmacia Biotech"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0331955:Pharmacia [Health Care Related Organization]
   760   C0869011:purchased [Activity]

Phrase: "(Arlington Heights,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:heights [Organism Attribute]
   777 E C0205250:High [Qualitative Concept]
   777 E C1299351:High [Qualitative Concept]
   777 E C1522410:Highest [Qualitative Concept]
   777 E C2700149:HIGH [Intellectual Product]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.55: Cell culture and transient transfection assays CHO cells expressing the wild-type (WT) human IR (CHO-IR) and CHO-IR/SOS cells that stably express a transdominant inhibitory mSOS1 mutant have been described elsewhere (12). 

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "transient transfection assays CHO cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   844   C0085080:Chinese Hamster Ovary Cell [Cell]
   818   C0018555:Chinese Hamster [Mammal]
   795   C0007634:Cells [Cell]
   795   C0008120:chinese [Language]
   795   C0018557:Hamster [Mammal]
   795   C0029939:Ovary [Body Part, Organ, or Organ Component]
   795   C0152035:Chinese [Population Group]
   795   C0227898:ovary [Body Part, Organ, or Organ Component]
   795   C1278992:Ovary [Body Part, Organ, or Organ Component]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the wild-type (WT) human IR"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   884   C1448132:insulin receptor, human [Amino Acid, Peptide, or Protein,Receptor]
   840   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C1334133:INSULIN RECEPTOR [Gene or Genome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0086418:Human [Human]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(CHO-IR"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   840   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C1334133:INSULIN RECEPTOR [Gene or Genome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "CHO-IR/SOS cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   894   C0085080:Chinese Hamster Ovary Cell [Cell]
   829   C0030281:Insulin Cell [Cell]
   813   C1514760:Receptor Cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "that stably"

Phrase: "express"

Phrase: "a transdominant inhibitory mSOS1 mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.56: Human HepG2 cells were purchased from ATCC (Manassas, VA). 

Phrase: "Human HepG2 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C2717940:HepG2 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "purchased from ATCC (Manassas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0598079:ATCC [Intellectual Product]
   770   C0869011:purchased [Activity]

Phrase: "VA)."
Processing 00000000.tx.57: Cells were cultured in Hams F-12 medium (CHO cells) or DMEM with high glucose (HepG2 cells) supplemented with 100 U/ml penicillin, 100 g/ml streptomycin, and 10% FBS (Gemini, Calabasas, CA), and maintained in a humidified atmosphere of 5% CO2 in air at 37 C. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in Hams F-12 medium"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0439133:(f) [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1553038:[f] [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "(CHO cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "DMEM with high glucose"

Phrase: "(HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "supplemented with 100 U/ml penicillin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0439340:U/ml [Quantitative Concept]
   790   C1880521:U/mL [Quantitative Concept]
   790   C2945590:U/mL [Quantitative Concept]
   753   C0030842:Penicillin [Antibiotic,Organic Chemical]
   753   C0220892:Penicillin [Antibiotic,Organic Chemical]
   753   C0439526:/mL [Quantitative Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "100 g/ml streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "10% FBS (Gemini,"

Phrase: "Calabasas,"

Phrase: "CA),"

Phrase: "and"

Phrase: "maintained in a humidified atmosphere of 5% CO2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0004178:Atmosphere [Natural Phenomenon or Process]
   744   C0678214:atmosphere [Quantitative Concept]
   744   C1314677:Maintained [Functional Concept]
   744   C2347816:Co2+ [Element, Ion, or Isotope]
   711 E C0024501:Maintain [Activity]

Phrase: "in air at 37 C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001861:Air [Substance]
   760   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.58: Transient cotransfection of CHO-IR cells was performed according to the manufacturers protocols for the use of TransFast reagent (Promega Corp.). 

Phrase: "Transient cotransfection of CHO-IR cells"

Phrase: "was"

Phrase: "performed according to the manufacturers protocols"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0442711:Protocols [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0884358:Performed [Functional Concept]
   719   C0947322:Manufacturer [Intellectual Product]
   719 E C1507394:Protocol [Intellectual Product]
   719 E C1522729:Protocol [Intellectual Product]
   719   C1705426:Manufacturer [Population Group]
   719 E C2348563:Protocol [Intellectual Product]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of TransFast reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Promega Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: ")."
Processing 00000000.tx.59: In some experiments, basal and stimulated NFB-mediated luciferase activity was analyzed according to the procedure of Bertrand et al. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "stimulated NFB-mediated luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C1151115:luciferase activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "analyzed according to the procedure of Bertrand et al."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   742   C0680240:according [Social Behavior]
   742   C0936012:Analyzed [Research Activity]
   742   C1948041:Procedure [Therapeutic or Preventive Procedure]
   742   C2700391:Procedure [Activity]
   742   C3274430:PROCEDURE [Health Care Activity]
   742   C3538935:Procedure [Idea or Concept]
   742   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.60: (6) with slight modification. 

Phrase: "(6"

Phrase: ")"

Phrase: "with slight modification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.61: Briefly, cells seeded into 35-mm dishes were transiently transfected in 800 l Hams F-12 medium supplemented with 0.3% FBS, 0.1 g pCMVSport -galactosidase (Life Technologies, Inc., Rockville, MD; as a monitor for transfection efficiency) and 0.5 g pNFB-TA-Luc (CLONTECH Laboratories, Inc., Palo Alto, CA), a reporter plasmid (pGL2) containing four tandem copies of the B consensus sequence (5'-GGGAATTTCC-3') (13) inserted upstream of a minimal thymidine kinase promoter driving a luciferase reporter gene. 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "seeded into 35-mm dishes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0020498:DISH [Disease or Syndrome]
   726   C0036563:Seed [Plant]
   726   C1705192:Seed [Laboratory Procedure]
   726   C1882540:{Seed} [Quantitative Concept]
   726   C2346495:Seed [Conceptual Entity]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected in 800 l Hams F-12 medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   744   C0009458:Medium [Intellectual Product]
   744   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   744   C0439133:(f) [Intellectual Product]
   744   C0439536:Medium [Quantitative Concept]
   744   C1553038:[f] [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 0.3% FBS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "0.1 g pCMVSport -galactosidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.,"

Phrase: "Rockville,"

Phrase: "MD"

Phrase: ";"

Phrase: "as"

Phrase: "a monitor for transfection efficiency"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030695:monitor [Health Care Activity]
   760   C0150369:monitor [Health Care Activity]
   760   C0181904:Monitor [Medical Device]
   760   C0596972:Monitor [Medical Device]
   760   C1521743:Monitor [Professional or Occupational Group]
   760   C1704646:Monitor [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "0.5 g pNFB-TA-Luc"

Phrase: "(CLONTECH Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Inc.,"

Phrase: "Palo Alto,"

Phrase: "CA),"

Phrase: "a reporter plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(pGL2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1866552:PGL2 [Disease or Syndrome]
  1000   C3273616:PGL2 [Gene or Genome]

Phrase: ")"

Phrase: "containing four tandem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]

Phrase: "copies of the B consensus sequence"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0079160:Consensus Sequence [Nucleotide Sequence]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0376298:Consensus [Social Behavior]
   753   C1519249:Sequence [Functional Concept]
   753   C1948062:Copies [Manufactured Object]

Phrase: "(5'-GGGAATTTCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "(13"

Phrase: ")"

Phrase: "inserted upstream of a minimal thymidine kinase promoter"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0040078:Thymidine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0441587:Inserted [Health Care Activity]
   744   C0522505:Upstream [Spatial Concept]
   744   C0547040:Minimal [Qualitative Concept]
   744   C1524031:MINIMAL [Qualitative Concept]
   744   C2945599:Minimal [Qualitative Concept]
   711 E C1743766:Insert [Medical Device]
   711 E C1883719:Insert [Functional Concept]

Phrase: "driving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004379:Driving [Daily or Recreational Activity]
   966 E C0013126:Drive [Mental Process]

Phrase: "a luciferase reporter gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1334435:Luciferase Gene [Gene or Genome]
   901   C0206414:Reporter Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.62: One hour later, 1.5 ml Hams F-12 medium containing 0.3% serum was added to each dish. 

Phrase: "One hour later,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439227:Hour [Temporal Concept]
   827   C0564385:/hour [Quantitative Concept]

Phrase: "1.5 ml Hams F-12 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0009458:Medium [Intellectual Product]
   795   C0439536:Medium [Quantitative Concept]
   795   C1705217:Medium [Substance]
   795   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.3% serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "added to each dish."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0020498:DISH [Disease or Syndrome]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.63: Twenty-four hours after transfection, cells were incubated in the absence or the presence of 10 nM insulin for 24 h or 20 ng/ml TNF for 7 h before assaying luciferase activity, which was normalized on the basis of -galactosidase expression. 

Phrase: "Twenty-four hours after transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "the presence of 10 nM insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "or"

Phrase: "20 ng/ml TNF for 7 h"

Phrase: "before assaying luciferase activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "was"

Phrase: "normalized on the basis of -galactosidase expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]
   748   C1882115:Normalized [Research Activity]
Processing 00000000.tx.64: Cell extract preparation as well as luciferase and -galactosidase assays were performed according to the manufacturers protocols (Promega Corp.). 

Phrase: "Cell extract preparation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0920433:cell preparation [Laboratory Procedure]
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "as well as"

Phrase: "luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and -"

Phrase: "galactosidase assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed according to the manufacturers protocols"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0442711:Protocols [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0884358:Performed [Functional Concept]
   719   C0947322:Manufacturer [Intellectual Product]
   719 E C1507394:Protocol [Intellectual Product]
   719 E C1522729:Protocol [Intellectual Product]
   719   C1705426:Manufacturer [Population Group]
   719 E C2348563:Protocol [Intellectual Product]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Promega Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: ")."
Processing 00000000.tx.65: In some experiments, cells were transfected with promoterless pGL2 plasmid. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with promoterless pGL2 plasmid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1866552:PGL2 [Disease or Syndrome]
   760   C3273616:PGL2 [Gene or Genome]
Processing 00000000.tx.66: Preparation of nuclear extracts and EMSA EMSA analysis of nuclear extracts prepared from untreated and insulin-treated cells was performed according to a recently described procedure (14). 

Phrase: "Preparation of nuclear extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "EMSA EMSA analysis of nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "prepared from untreated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332155:untreated [Finding]
   756   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "insulin-treated cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "performed according to a recently described procedure"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   774   C2985643:Performed Procedure [Research Activity]
   748   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   748   C0332185:Recently [Temporal Concept]
   748   C0680240:according [Social Behavior]
   748   C0884358:Performed [Functional Concept]
   748   C1552738:described [Idea or Concept]
   748   C1948041:Procedure [Therapeutic or Preventive Procedure]
   748   C2700391:Procedure [Activity]
   748   C3274430:PROCEDURE [Health Care Activity]
   748   C3538935:Procedure [Idea or Concept]
   748   C3539779:Procedure [Intellectual Product]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.67: Briefly, CHO-IR cells were grown to confluency in 100-mm dishes and incubated in serum-free medium (SFM) for 3 h before treatment. 

Phrase: "Briefly,"

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown to confluency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205200:Confluent [Qualitative Concept]

Phrase: "in 100-mm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0020498:DISH [Disease or Syndrome]

Phrase: "and"

Phrase: "incubated in serum-free medium (SFM)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0009458:Medium [Intellectual Product]
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1705217:Medium [Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   760   C3244283:medium [Intellectual Product]

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "before treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.68: Nuclear proteins were isolated 6 h after stimulation with 10 nM insulin by the method of Muller et al. 

Phrase: "Nuclear proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028589:Nuclear Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "6 h after stimulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0444953:H 6 [Intellectual Product]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "with 10 nM insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Muller et al."
Processing 00000000.tx.69: (15), with minor modifications. 

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "with minor modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.70: In some experiments, 20 ng/ml TNF- was added for 30 min. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "20 ng/ml TNF-"

Phrase: "was"

Phrase: "added for 30 min."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.71: Gel-purified double-stranded consensus NFB probe (5'-AGTTGAGGGGACTTTCCCAGG-3') (Promega Corp.) was end-labeled with [-32P]ATP. 

Phrase: "Gel-purified double-stranded consensus NFB probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   866   C0441087:Double probe [Medical Device]
   791   C0182400:Probe [Medical Device]
   791   C1704681:Probe [Gene or Genome]
   791   C2347609:Probe [Chemical Viewed Functionally]
   791   C3536729:Probe [Manufactured Object]

Phrase: "(5'-AGTTGAGGGGACTTTCCCAGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "(Promega Corp.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "was"

Phrase: "end-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP."
Processing 00000000.tx.72: Identical amounts of radioactive probe (12 x 105 cpm) were added to binding reactions containing 2 g nuclear extracts in a final volume of 10 l in DNA-binding buffer (Promega Corp.). 

Phrase: "Identical amounts of radioactive probe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "(12 x 105 cpm)"

Phrase: "were"

Phrase: "added to binding reactions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1524062:Added [Functional Concept]
   737   C0443286:Reaction [Functional Concept]
   737   C1114821:Reaction [Clinical Attribute]
   737 E C1883712:Add [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2 g nuclear extracts in a final volume of 10 l"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0521447:Nuclear [Spatial Concept]
   722   C1518434:Nuclear Extract [Biomedical or Dental Material]
   704   C2828366:Extract [Substance]

Phrase: "in DNA-binding buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   734   C1148673:DNA Binding [Genetic Function]

Phrase: "(Promega Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: ")."
Processing 00000000.tx.73: Specificity was determined by prior addition of 100-fold excess unlabeled consensus NFB or Oct-1 (TGTCGAATGCAAATCACTAGA) oligonucleotide. 

Phrase: "Specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "determined by prior addition of 100-fold excess unlabeled consensus NFB"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   750   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   750   C1824728:FACTOR B [Gene or Genome]
   735   C0332152:Prior [Temporal Concept]
   735   C0332462:Fold [Spatial Concept]
   735   C0376298:Consensus [Social Behavior]
   735   C0521447:Nuclear [Spatial Concept]
   735   C1521761:Factor [Functional Concept]
   735   C1880834:FOLD [Phenomenon or Process]
   735   C1883712:Addition [Functional Concept]
   735   C1979886:Excess [Qualitative Concept]
   735   C2826257:PRIOR [Event]
   735   C2827422:Factor [Conceptual Entity]

Phrase: "or"

Phrase: "Oct-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442824:OCT-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(TGTCGAATGCAAATCACTAGA"

Phrase: ")"

Phrase: "oligonucleotide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.74: Where used, 2 g of polyclonal rabbit NFB p65 antibody (Santa Cruz Biotechnology) was incubated with nuclear extracts for 20 min at room temperature before the start of the reaction. 

Phrase: "Where"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "2 g of polyclonal rabbit NFB p65 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0439267:g% [Quantitative Concept]

Phrase: "(Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "was"

Phrase: "incubated with nuclear extracts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1518434:Nuclear Extract [Biomedical or Dental Material]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   737   C2828366:Extract [Substance]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "before the start"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Start [Temporal Concept]

Phrase: "of the reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.75: Reaction mixtures were incubated for 20 min at 25 C before separating on nondenaturing 6% polycrylamide gels at room temperature and subjected to electrophoresis in 0.5x Tris-borate-EDTA buffer before vacuum drying and autoradiography. 

Phrase: "Reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "incubated for 20 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 25 C"

Phrase: "before separating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:separating [Spatial Concept]

Phrase: "on nondenaturing 6% polycrylamide gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "subjected to electrophoresis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "in 0.5x Tris-borate-EDTA buffer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0146923:Tris-borate-EDTA buffer [Organic Chemical]
   858   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   839   C0991799:BORATE BUFFER [Pharmacologic Substance]
   799   C0006007:Borate [Chemical Viewed Structurally]
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   799   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   799   C0814229:TRI [Intellectual Product]

Phrase: "before vacuum drying"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0011682:drying [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]
   827 E C1512080:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "autoradiography."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.76: Protein determination was performed using the BCA protein assay reagent from Pierce Chemical Co. 

Phrase: "Protein determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1148554:determination [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BCA protein assay reagent from Pierce Chemical Co."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.77: (Rockford, IL). 

Phrase: "(Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.78: It is important to note that the rationale for using different times of insulin exposure was based on the premises that phosphorylation of IB precedes its ubiquitination, a step required for NFB nuclear translocation. 

Phrase: "It"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the rationale for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0392360:Rationale [Idea or Concept]
   790   C2699007:Rationale [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different times of insulin exposure"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   781   C2348485:Exposure Time [Quantitative Concept]
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   745   C1442103:Time Difference [Temporal Concept]
   745   C1547049:*Time Difference [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "was"

Phrase: "based on the premises"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that phosphorylation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "precedes"

Phrase: "its ubiquitination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "a step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1261552:Step [Conceptual Entity]
  1000   C1704379:Step [Functional Concept]
  1000   C1705117:Step [Quantitative Concept]
  1000   C2825408:Step [Manufactured Object]

Phrase: "required for NFB nuclear translocation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   778   C1824728:FACTOR B [Gene or Genome]
   774   C1518440:Nuclear Translocation [Molecular Function]
   748   C0040715:Translocation [Cell or Molecular Dysfunction]
   748   C0521447:Nuclear [Spatial Concept]
   748   C1514873:Required [Functional Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C2987521:Translocation [Activity]
Processing 00000000.tx.79: Accordingly, the EMSA analysis is routinely performed using nuclear extracts prepared from untreated cells and cells treated with insulin for 6 h (14). 

Phrase: "Accordingly,"

Phrase: "the EMSA analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "routinely"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "prepared from untreated cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0332155:untreated [Finding]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 6 h (14"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.80: Similarly, a longer incubation period with insulin was used for the analysis of NFB-dependent gene expression because of the time required for the transcriptional and translational processes to be activated in the cell. 

Phrase: "Similarly,"

Phrase: "a longer incubation period with insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1320226:Incubation period [Finding]
   753   C0439531:/period [Temporal Concept]
   753   C1948053:Period [Temporal Concept]
   742   C0425943:period length [Finding]

Phrase: "was"

Phrase: "used for the analysis of NFB-dependent gene expression"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   772   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   756   C0017262:Gene Expression [Genetic Function]
   756   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   756   C1824728:FACTOR B [Gene or Genome]
   754   C0085801:Analysis, Factor [Quantitative Concept]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0017337:Gene [Gene or Genome]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0521447:Nuclear [Spatial Concept]
   738   C0851827:Dependent [Qualitative Concept]
   738   C0936012:Analysis [Research Activity]
   738   C1273517:used [Finding]
   738   C1521761:Factor [Functional Concept]
   738   C1524024:analysis [Functional Concept]
   738   C1701901:Dependent [Qualitative Concept]
   738   C2827422:Factor [Conceptual Entity]
   738   C3244310:dependent [Functional Concept]
   737   C1524063:Use of [Functional Concept]
   704 E C0042153:use [Functional Concept]
   704 E C0457083:Use [Functional Concept]
   704 E C1947944:Use [Intellectual Product]

Phrase: "because of the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "required for the transcriptional"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040649:Transcriptional [Genetic Function]
   770   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "translational processes to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   848   C1519614:Translation Process [Genetic Function]
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]

Phrase: "be"

Phrase: "activated in the cell."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1879547:Activated [Activity]
   770   C1948049:Cell [Spatial Concept]
   737 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.81: Immunofluorescence microscopy CHO-IR cells were seeded on glass coverslips and stained for indirect immunofluorescence. 

Phrase: "Immunofluorescence microscopy CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0085080:Chinese Hamster Ovary Cell [Cell]
   806   C0030281:Insulin Cell [Cell]
   795   C1514760:Receptor Cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded on glass coverslips"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0017596:Glass [Manufactured Object]
   770   C1947936:Glass [Medical Device]
   737   C0036563:Seed [Plant]
   737   C1705192:Seed [Laboratory Procedure]
   737   C1882540:{Seed} [Quantitative Concept]
   737   C2346495:Seed [Conceptual Entity]

Phrase: "and"

Phrase: "stained for indirect immunofluorescence."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0282646:Indirect Immunofluorescence [Laboratory Procedure]
   770   C0016318:Immunofluorescence [Laboratory Procedure]
   770   C0079603:Immunofluorescence [Laboratory Procedure]
   770   C0439852:Indirect [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   767   C0183489:Immunofluorescent stain [Indicator, Reagent, or Diagnostic Aid]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   715 E C0282648:Direct immunofluorescence [Laboratory Procedure]
Processing 00000000.tx.82: After fixing in fresh 4% paraformaldehyde in PBS supplemented with 200 nM okadaic acid (Calbiochem), cells were permeabilized in 0.1% (wt/vol) Triton X-100 in PBS for 10 min at room temperature, and then were incubated with blocking buffer (1% BSA in PBS) for 20 min. 

Phrase: "After fixing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0231441:Fix [Finding]

Phrase: "in fresh 4% paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "supplemented with 200 nM okadaic acid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0312860:NM [Cell Function]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "permeabilized in 0.1%"

Phrase: "(wt/vol) Triton X-100 in PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   748   C0242759:Triton [Geographic Area]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "were"

Phrase: "incubated with blocking buffer"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "(1% BSA in PBS)"

Phrase: "for 20 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.83: After a series of washes, cells were probed with 2 g/ml of rabbit anti-phospho IB or 4 g/ml of rabbit anti-IB for 16 h at 4 C. 

Phrase: "After a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of washes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0441648:Wash [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "probed with 2 g/ml of rabbit anti-phospho IB"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   756   C1300565:g/mL [Quantitative Concept]
   754   C0432618:Anti-B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754 E C1637390:mL/g [Quantitative Concept]
   738   C0034493:Rabbit [Mammal]
   738   C0439267:g% [Quantitative Concept]
   738   C0439526:/mL [Quantitative Concept]
   738   C1999216:Inhibitor [Qualitative Concept]
   704   C0182400:Probe [Medical Device]
   704   C1704681:Probe [Gene or Genome]
   704   C2347609:Probe [Chemical Viewed Functionally]
   704   C3536729:Probe [Manufactured Object]

Phrase: "or"

Phrase: "4 g/ml of rabbit anti-IB"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1300565:g/mL [Quantitative Concept]
   767 E C1637390:mL/g [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]

Phrase: "for 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.84: The primary antibodies were detected with AlexaFluor 488-conjugated antirabbit IgG (Molecular Probes, Eugene, OR). 

Phrase: "The primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "detected with AlexaFluor 488-conjugated antirabbit IgG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0442726:Detected [Finding]
   748   C0522529:Conjugated [Spatial Concept]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Eugene,"

Phrase: "OR"

Phrase: ")."
Processing 00000000.tx.85: Cells were observed with an LSM-410 inverted confocal microscope (Carl Zeiss, Thornwood, NY). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "observed with an LSM-410 inverted confocal microscope"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1626420:Confocal microscope [Medical Device]
   744   C0181839:Microscope [Medical Device]
   744   C0443241:Inverted [Qualitative Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1706379:Microscope [Medical Device]

Phrase: "(Carl Zeiss,"

Phrase: "Thornwood,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.86: The confocal pinhole was set to obtain spatial resolution of 0.4 m in the horizontal plane and 1 m in the axial dimension. 

Phrase: "The confocal pinhole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450042:Pinhole [Medical Device]

Phrase: "was"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "spatial resolution of 0.4 m"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514893:Resolution [Idea or Concept]
   753   C1706463:Resolution [Quantitative Concept]
   753   C2699488:Resolution [Conceptual Entity]

Phrase: "in the horizontal plane"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0446380:Horizontal plane [Spatial Concept]
   861   C0205126:Horizontal [Spatial Concept]
   861   C0444660:Plane [Spatial Concept]

Phrase: "and"

Phrase: "1 m in the axial dimension."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.87: In vitro IKK and IKK assay The protocol for the in vitro kinase assay was adapted from the method of Uhlik et al. 

Phrase: "In vitro IKK"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1150571:IKK [Molecular Function]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "The protocol for the in vitro kinase assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0442711:Protocol [Intellectual Product]
   744   C1507394:Protocol [Intellectual Product]
   744   C1522729:Protocol [Intellectual Product]
   744   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "adapted from the method of Uhlik et al."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0025663:Method [Intellectual Product]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]
   744   C2937289:adapted [Organic Chemical]
Processing 00000000.tx.88: (16). 

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.89: After the indicated treatments, cells were lysed on ice in a lysis buffer containing 20 mM HEPES, pH 7.6, 250 mM NaCl, 1% Nonidet P-40 (wt/vol), 20 mM -glycerophosphate, 1 mM EDTA, 20 mM p-nitrophenylphosphate, 0.1 mM sodium orthovanadate, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and 1/100 volume of 100x protease inhibitor cocktail (Calbiochem). 

Phrase: "After the indicated treatments,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C0024348:lysed [Pathologic Function]

Phrase: "in a lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "250 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Nonidet P-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "(wt/vol), 20 mM -glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "20 mM p-nitrophenylphosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0068854:nitrophenylphosphate [Organophosphorus Compound,Pharmacologic Substance]

Phrase: "0.1 mM sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0029366:Orthovanadate [Inorganic Chemical]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "1 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1/100 volume of 100x protease inhibitor cocktail"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0449468:*Volume [Quantitative Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]

Phrase: "(Calbiochem"

Phrase: ")."
Processing 00000000.tx.90: After 20 min on ice, lysates were clarified by centrifugation at 12,000 x g for 20 min at 4 C. 

Phrase: "After 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "on ice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "clarified by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C2986669:Clarified [Activity]

Phrase: "at 12,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.91: The supernatants were used for immunoprecipitation of IKK and IKK with 2 g/sample of rabbit polyclonal antihuman IKK and IKK (Santa Cruz Biotechnology) that were preadsorbed for 1 h with 100 l of protein A/protein G-Sepharose slurry (50%). 

Phrase: "The supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "used for immunoprecipitation of IKK"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   781   C1524063:Use of [Functional Concept]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1150571:IKK [Molecular Function]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "IKK with 2 g/sample of rabbit polyclonal antihuman IKK"

Phrase: "and"

Phrase: "IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "(Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "that"

Phrase: "were"

Phrase: "preadsorbed for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "with 100 l"

Phrase: "of protein A/protein G-Sepharose slurry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1883043:Slurry [Substance]
   719   C0075172:protein A-sepharose [Carbohydrate]

Phrase: "(50%"

Phrase: ")."
Processing 00000000.tx.92: After a 3-h incubation at 4 C, the immunocomplexes were washed three times with lysis buffer, once with lysis buffer containing 1 M urea, and twice with the kinase reaction buffer (20 mM HEPES, pH 7.6, 20 mM MgCl2, 20 mM -glycerophosphate, 1 mM EDTA, 20 M ATP, and 2 mM dithiothreitol). 

Phrase: "After a 3-h incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0041119:3 H [Element, Ion, or Isotope]

Phrase: "at 4 C,"

Phrase: "the immunocomplexes"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with lysis buffer,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "once with lysis buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]
   770   C1720092:Once [Intellectual Product]
   770   C1948045:Once [Temporal Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 M urea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   771 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "twice with the kinase reaction buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]

Phrase: "(20 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "20 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20 mM -glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "20 M ATP,"

Phrase: "and"

Phrase: "2 mM dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.93: The kinase reaction was started by adding 30 l of the kinase reaction buffer in the presence of 5 Ci of [-32P]ATP and 1 g of GST-IB (1317) fusion protein per assay and incubating for 30 min at 30 C. 

Phrase: "The kinase reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "started by adding 30 l of the kinase reaction buffer"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0443286:Reaction [Functional Concept]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1272689:Started [Qualitative Concept]
   706 E C0439659:Start [Temporal Concept]
   706   C1883712:Add [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5 Ci of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "and"

Phrase: "1 g of GST-IB (1317"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   762   C2827790:g/s [Quantitative Concept]
   742   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "fusion protein per assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332466:Fusion [Functional Concept]
   770   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "incubating for 30 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:incubating [Laboratory Procedure]

Phrase: "at 30 C."
Processing 00000000.tx.94: The reactions were stopped by adding 13.5 l of 3x Laemmli sample buffer. 

Phrase: "The reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "stopped by adding 13.5 l of 3x Laemmli sample buffer."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   754   C0258024:Laemmli buffer [Organic Chemical]
   738   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   738   C0370003:Sample [Substance]
   738   C1272691:stopped [Qualitative Concept]
   738   C2347026:Sample [Conceptual Entity]
   704   C1883712:Add [Functional Concept]
   704 E C1947925:Stop [Activity]
   704 E C2746065:Stop [Temporal Concept]
Processing 00000000.tx.95: In vitro c-Raf-1 kinase assay The manufacturers protocols for the use of the c-Raf-1-coupled kinase assay kit was followed (Upstate Biotechnology, Inc.). 

Phrase: "In vitro c-Raf-1 kinase assay"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   900   C1515653:In Vitro Assay [Research Activity]
   845   C0139030:raf-1 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0005507:Assay [Laboratory Procedure]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0243073:assay [Qualitative Concept]
   795   C1510438:Assay [Laboratory Procedure]
   788   C1449849:raf Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "The manufacturers protocols for the use"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0442711:Protocols [Intellectual Product]
   719 E C1507394:Protocol [Intellectual Product]
   719 E C1522729:Protocol [Intellectual Product]
   719 E C2348563:Protocol [Intellectual Product]

Phrase: "of the c-Raf-1-coupled kinase assay kit"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   893   C0072470:c kit [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   795   C0812225:KIT [Medical Device]
   795   C1150635:KIT [Molecular Function]
   795   C1705212:Kit [Medical Device]
   795   C1705213:KIT [Medical Device]
   795   C3273202:Kit [Manufactured Object]

Phrase: "was"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "(Upstate Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.96: Briefly, cells were lysed, and the clarified lysates were subjected to immunoprecipitation using 5 g/assay of c-Raf-1 antibody preadsorbed to protein A/protein G-Sepharose. 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "the clarified lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "5 g/assay of c-Raf-1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0005507:Assay [Laboratory Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]

Phrase: "preadsorbed to protein A/protein G-Sepharose."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0075172:protein A-sepharose [Carbohydrate]
   778   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   774   C0060916:protein g [Amino Acid, Peptide, or Protein]
   774   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036681:Sepharose [Carbohydrate]
   748   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.97: After a 2-h incubation at 4 C, the immunocomplexes were washed with lysis buffer and then incubated with 0.4 g/assay of inactive ERK kinase (MEK)1 and 1 g/assay of inactive ERK for 30 min at 30 C. 

Phrase: "After a 2-h incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "at 4 C,"

Phrase: "the immunocomplexes"

Phrase: "were"

Phrase: "washed with lysis buffer"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with 0.4 g/assay of inactive ERK kinase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   757   C0010536:G-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0532059:ERK-4 [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0005507:Assay [Laboratory Procedure]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205254:Inactive [Qualitative Concept]
   739   C0243073:assay [Qualitative Concept]
   739   C0439267:g% [Quantitative Concept]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1510438:Assay [Laboratory Procedure]

Phrase: "(MEK)1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1434639:MEK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0752313:mek [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "1 g/assay of inactive ERK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 30 C."
Processing 00000000.tx.98: The kinase reaction was started by adding 5 Ci of [-32P]ATP and 10 l of myelin basic protein (MBP) (2 mg/ml) per assay and incubating for 10 min at 30 C. 

Phrase: "The kinase reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "started by adding 5 Ci of [-32P"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C1272689:Started [Qualitative Concept]
   748   C1553631:32p [Medical Device]
   714 E C0439659:Start [Temporal Concept]
   714   C1883712:Add [Functional Concept]

Phrase: "]ATP"

Phrase: "and"

Phrase: "10 l of myelin basic protein (MBP)"

Phrase: "(2 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml) per assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "incubating for 10 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:incubating [Laboratory Procedure]

Phrase: "at 30 C."
Processing 00000000.tx.99: The reactions were stopped by spotting samples onto p81 paper, which was then washed three times with 0.75% phosphoric acid and once with acetone before the determination of incorporated radioactivity by liquid scintillation counting. 

Phrase: "The reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "stopped by spotting samples"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C0025874:Spotting [Pathologic Function]
   770   C0312414:Spotting [Sign or Symptom]
   770   C1272691:stopped [Qualitative Concept]
   770   C1704255:Spotting [Functional Concept]
   737 E C0329155:Spot [Fish]
   737   C0370003:Sample [Substance]
   737 E C1427618:SPOT [Gene or Genome]
   737 E C1705203:Spot [Conceptual Entity]
   737 E C1947925:Stop [Activity]
   737   C2347026:Sample [Conceptual Entity]
   737 E C2746065:Stop [Temporal Concept]

Phrase: "onto p81 paper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030351:Paper [Manufactured Object]
   861   C1547566:Paper [Idea or Concept]

Phrase: "which"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with 0.75% phosphoric acid"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "once with acetone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]
   790   C1720092:Once [Intellectual Product]
   790   C1948045:Once [Temporal Concept]

Phrase: "before the determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1148554:determination [Laboratory Procedure]

Phrase: "of incorporated radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "by liquid scintillation counting."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0036406:Scintillation Counting [Laboratory Procedure]
   827   C0302908:Liquid [Substance]
   827   C0678573:scintillation [Natural Phenomenon or Process]
   827   C1304698:Liquid [Finding]
   827   C1546699:Liquid NOS [Intellectual Product]
   827   C1561501:Liquid NOS [Substance]
   793   C0750480:Count [Activity]
   793   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.100: In vitro Akt kinase assay The manufacturers protocol for the use of the Akt kinase assay kit was followed (Cell Signaling Technologies). 

Phrase: "In vitro Akt kinase assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   911   C1515653:In Vitro Assay [Research Activity]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]

Phrase: "The manufacturers protocol for the use of the Akt kinase assay kit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0442711:Protocol [Intellectual Product]
   736   C1507394:Protocol [Intellectual Product]
   736   C1522729:Protocol [Intellectual Product]
   736   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "(Cell Signaling Technologies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039421:technologies [Occupation or Discipline]
   734   C0037083:Cell Signaling [Cell Function]

Phrase: ")."
Processing 00000000.tx.101: Briefly, CHO-IR cells were transiently transfected with an empty expression vector alone or with plasmids encoding WT or dominant negative mutant of myc-tagged Akt1. 

Phrase: "Briefly,"

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with an empty expression vector"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C1880497:Empty [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "dominant negative mutant of myc-tagged Akt1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.102: After a 3-h serum starvation, cells were left untreated or treated with 10 nM insulin for 2 h. 

Phrase: "After a 3-h serum starvation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038187:Starvation [Finding]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "or"

Phrase: "treated with 10 nM insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1522326:Treated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.103: Cells were lysed and the Akt kinase assay was performed on c-myc immunoprecipitates in the presence 200 M ATP and 1 g GSK-3 fusion protein for 30 min at 30 C. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "the Akt kinase assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed on c-myc"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "immunoprecipitates in the presence 200 M ATP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0301871:Immunoprecipitate [Immunologic Factor]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "1 g GSK-3 fusion protein for 30 min"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0010536:Protein Kinase G [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1333582:Fusion 1 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   754   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   754   C0060916:protein g [Amino Acid, Peptide, or Protein]
   754   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0332466:Fusion [Functional Concept]
   738   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "at 30 C."
Processing 00000000.tx.104: The kinase reaction was stopped by the addition of Laemmli sample buffer. 

Phrase: "The kinase reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by the addition of Laemmli sample buffer."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   767   C0258024:Laemmli buffer [Organic Chemical]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0370003:Sample [Substance]
   744   C1272691:stopped [Qualitative Concept]
   744   C1883712:Addition [Functional Concept]
   744   C2347026:Sample [Conceptual Entity]
   711 E C1947925:Stop [Activity]
   711 E C2746065:Stop [Temporal Concept]
Processing 00000000.tx.105: The detection of phosphorylated GSK-3 was carried out by immunoblotting technique using phospho-specific antibodies. 

Phrase: "The detection of phosphorylated GSK-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by immunoblotting technique"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020985:Immunoblotting [Laboratory Procedure]
   770   C0439787:Out [Spatial Concept]
   770   C0449851:Technique [Functional Concept]
   770   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "phospho-specific antibodies."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.106: Gel electrophoresis and Western blot analysis Unless otherwise indicated, cells were lysed directly in Laemmli sample buffer containing 5% 2-mercaptoethanol and 1 mM vanadate. 

Phrase: "Gel electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596607:Gel Electrophoresis [Laboratory Procedure]
   861   C0013855:Electrophoresis [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "Unless"

Phrase: "otherwise"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "directly in Laemmli sample buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0258024:Laemmli buffer [Organic Chemical]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C1947931:Directly [Qualitative Concept]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% 2-mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and"

Phrase: "1 mM vanadate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0042305:Vanadate [Inorganic Chemical]
Processing 00000000.tx.107: After heating at 70 C for 10 min, proteins were separated by SDS-PAGE on 412% polyacrylamide gradient gel along with prestained protein markers, and electrotransfer onto PVDF membrane. 

Phrase: "After heating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018851:Heating [Environmental Effect of Humans]

Phrase: "at 70 C"

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "on 412% polyacrylamide gradient gel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C1382104:Gel [Substance]

Phrase: "along with prestained protein markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "electrotransfer onto PVDF membrane."
Processing 00000000.tx.108: The membrane was incubated with blocking buffer (5% [wt/vol] nonfat dried milk in Tris-buffered saline 0.1% [wt/vol] Tween-20) for 1 h at room temperature and then probed with various antibodies for 1 h at room temperature or overnight at 4 C. 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "incubated with blocking buffer"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "(5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[wt/vol] nonfat dried milk"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   840   C0452721:Dried milk [Food]
   804   C0026131:Milk [Body Substance]
   804   C0349374:Milk [Food]
   804   C0444318:Milk [Substance]
   804   C1512080:Dried [Qualitative Concept]
   804   C2825079:Milk [Food]
   804   C2827485:Dried [Body Substance]
   771 E C0011682:Dry [Natural Phenomenon or Process]
   771 E C0205222:Dry [Qualitative Concept]
   748 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   748 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   733 E C0443260:Milky [Finding]

Phrase: "in Tris-buffered saline 0.1%"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0036082:Saline [Substance]
   804   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   804   C0814229:TRI [Intellectual Product]

Phrase: "[wt/vol] Tween-20"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   812   C0449468:VOL [Quantitative Concept]
   812   C0560268:vol% [Quantitative Concept]
   812   C1690016:% vol [Qualitative Concept]
   812   C2700323:WT [Fish]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "probed with various antibodies"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "or"

Phrase: "overnight at 4 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.109: After a series of washes, positive signals were visualized by chemiluminescence in combination with Hyperfilm-ECL (Amersham Pharmacia Biotech). 

Phrase: "After a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of washes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0441648:Wash [Activity]

Phrase: "positive signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "visualized by chemiluminescence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   790   C0234621:Visualized [Functional Concept]
   790   C1450278:Chemiluminescence [Natural Phenomenon or Process]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with Hyperfilm-ECL (Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.110: The same membranes were then reprobed if needed. 

Phrase: "The same membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "reprobed"

Phrase: "if"

Phrase: "needed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]
Processing 00000000.tx.111: When justified, autoradiography of the membrane was performed to detect 32P-incorporation into substrates. 

Phrase: "When"

Phrase: "justified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1552821:justify [Functional Concept]

Phrase: ","

Phrase: "autoradiography of the membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004400:Autoradiography [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "32P-incorporation into substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]
Processing 00000000.tx.112: Band intensities were quantitated by laser densitometry using the ImageQuant software (Molecular Dynamics, Inc., Sunnyvale, CA). 

Phrase: "Band intensities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:intensities [Qualitative Concept]

Phrase: "were"

Phrase: "quantitated by laser densitometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0011321:Densitometry [Laboratory Procedure]
   770   C0023089:Laser [Manufactured Object]
   770   C0458142:Laser [Phenomenon or Process]
   770   C1023865:Laser [Plant]
   770   C1706315:Laser [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ImageQuant software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Molecular Dynamics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: "Inc.,"

Phrase: "Sunnyvale,"

Phrase: "CA)."
Processing 00000000.tx.113: The linearity of the signals on the blots was assessed as follows: Varying amounts of cell lysates were immunoblotted with a panel of antibodies and the ECL signal generated was then plotted. 

Phrase: "The linearity of the signals"

Phrase: "on the blots"

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "Varying amounts of cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "immunoblotted with a panel of antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0441833:Panel [Idea or Concept]
   753   C1999270:Panel [Intellectual Product]
   753   C3537156:Panel [Manufactured Object]
   719   C0020985:Immunoblot [Laboratory Procedure]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "the ECL signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "plotted."
Processing 00000000.tx.114: All experimental values felt within the linear portion of the curve.  

Phrase: "All experimental values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "felt within the linear portion of the curve."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205132:Linear [Spatial Concept]
   744   C0205134:Curve [Spatial Concept]
   744   C0449719:Portion [Spatial Concept]
   711   C0013987:feel [Mental Process]
Processing 00000000.tx.115: Results Top Abstract Introduction Materials and Methods Results Discussion References  Modulation of NFB nuclear translocation, DNA binding, and B-dependent transcription A luciferase reporter gene assay was used to investigate whether the prosurvival function of insulin (2) was correlated with induction of B-dependent transcription in CHO-IR cells. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Modulation of NFB nuclear translocation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443264:Modulation [Spatial Concept]

Phrase: "DNA binding,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148673:DNA Binding [Genetic Function]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "B-dependent transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040649:Transcription [Genetic Function]

Phrase: "A luciferase reporter gene assay"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   875   C1334435:Luciferase Gene [Gene or Genome]
   861   C0206414:Reporter Gene [Gene or Genome]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0017337:Gene [Gene or Genome]
   812   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C0335038:Reporter [Professional or Occupational Group]
   812   C1510438:Assay [Laboratory Procedure]
   812   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   812   C1705915:Reporter [Conceptual Entity]
   812   C1709908:Reporter [Group]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "the prosurvival function of insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "correlated with induction of B-dependent transcription"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0040649:Transcription [Genetic Function]
   748   C0205263:Induction [Functional Concept]
   748   C0851827:Dependent [Qualitative Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
   748   C1701901:Dependent [Qualitative Concept]
   748   C1707520:Correlated [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "in CHO-IR cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.116: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.117: 1A, addition of insulin to SFM-treated cells for 24 h resulted in a 3.1  0.5-fold increase in B promoter activity (P < 0.001). 

Phrase: "1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "addition of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "to SFM-treated cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C1183428:Free cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "resulted in a 3.1  0.5-fold increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0444499:0/5 [Quantitative Concept]
   742   C0332462:Fold [Spatial Concept]
   742   C0442805:Increase [Functional Concept]
   742   C1880834:FOLD [Phenomenon or Process]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "in B promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.118: A similar increase in B-dependent transcription (3.6  0.3-fold; P < 0.001) was observed on stimulation with TNF (20 ng/ml). 

Phrase: "A similar increase in B-dependent transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "(3.6  0.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "; P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "was"

Phrase: "observed on stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1441672:Observed [Functional Concept]
   790   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with TNF (20 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.119: Control expression of the promoterless luciferase gene remained unchanged by the various treatments (data not shown). 

Phrase: "Control expression of the promoterless luciferase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0017262:Gene Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "remained"

Phrase: "unchanged by the various treatments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442739:Unchanged [Finding]
   760   C2346711:Unchanged [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.120: View larger version (34K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.121: Modulation of NF-B activity in CHO-IR cells. 

Phrase: "Modulation of NF-B activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "in CHO-IR cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.122: A, Cells transiently cotransfected with 4x-B-Luc reporter plasmid and pCMVSport -galactosidase expression plasmid were maintained for 24 h in Hams F-12 medium containing 0.3% FBS and then in SFM in the absence or the presence of insulin (10 nM) or TNF (20 ng/ml) for an additional 24 h. 

Phrase: "A,"

Phrase: "Cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cotransfected with 4x-B-Luc reporter plasmid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0335038:Reporter [Professional or Occupational Group]
   748   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   748   C1705915:Reporter [Conceptual Entity]
   748   C1709908:Reporter [Group]

Phrase: "and"

Phrase: "pCMVSport -galactosidase expression plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "maintained for 24 h"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]

Phrase: "in Hams F-12 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0009458:Medium [Intellectual Product]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.3% FBS"

Phrase: "and"

Phrase: "then in SFM"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0009458:Medium [Intellectual Product]
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1705217:Medium [Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1883708:Then [Temporal Concept]
   760   C1996904:Free [Qualitative Concept]
   760   C3244283:medium [Intellectual Product]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "the presence of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(10 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "or"

Phrase: "TNF (20 ng/ml) for an additional 24 h."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   784   C0439446:mL/24.h [Quantitative Concept]
   784   C1533072:ng/mL/h [Quantitative Concept]
   784   C2827809:h*ng/mL [Quantitative Concept]
   781 E C2827838:mL/h/ng [Quantitative Concept]
   764   C0439275:ng/mL [Quantitative Concept]
   762   C0439391:mL/h [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.123: Cell extracts were analyzed for luciferase activity and normalized for -gal as described under Materials and Methods. 

Phrase: "Cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "analyzed for luciferase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1151115:luciferase activity [Molecular Function]
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "normalized for -gal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882115:Normalized [Research Activity]

Phrase: "as"

Phrase: "described under Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.124: Results are the means  SD of two experiments performed in duplicate dishes (n = 4). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the means  SD of two experiments"

Phrase: "performed in duplicate dishes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205173:Duplicate [Functional Concept]
   770   C0884358:Performed [Functional Concept]
   770   C3539942:Duplicate [Intellectual Product]
   737   C0020498:DISH [Disease or Syndrome]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.125: ***, P < 0.001 when compared with control. 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.126: B, EMSA analysis in nuclear extracts from CHO-IR cells stimulated with insulin or TNF for 6 h. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "EMSA analysis in nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "from CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "stimulated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "TNF for 6 h."
Processing 00000000.tx.127: C, Immunoblotting of the same nuclear extracts. 

Phrase: "C,"

Phrase: "Immunoblotting of the same nuclear extracts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.128: Accumulation of p65 protein was detected using specific antibodies. 

Phrase: "Accumulation of p65 protein"

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.129: Data are representative of three (panel B) or two (panel C) independent experiments.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882932:Representative [Activity]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "(panel C) independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.130: To examine further the effect of these agents, DNA-binding EMSA and NFB nuclear translocation analysis were performed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the effect of these agents,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "DNA-binding EMSA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596608:EMSA [Diagnostic Procedure]
   827   C0949632:EMSA [Laboratory Procedure]
   734   C1148673:DNA Binding [Genetic Function]

Phrase: "and"

Phrase: "NFB nuclear translocation analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0085801:Analysis, Factor [Quantitative Concept]
   827   C1294199:Translocation analysis [Laboratory Procedure]
   799   C0002778:Analysis [Laboratory Procedure]
   799   C0936012:Analysis [Research Activity]
   799   C1524024:analysis [Functional Concept]
   709   C1518440:Nuclear Translocation [Molecular Function]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.131: Consistent with the luciferase activity, a 6-h incubation with insulin induced a 5.3  0.6-fold increase in NFB DNA binding when compared with control unstimulated cells (Fig. 1B, left panel). 

Phrase: "Consistent with the luciferase activity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "a 6-h incubation with insulin"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a 5.3  0.6-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0442805:Increase [Functional Concept]

Phrase: "in NFB DNA binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1148673:DNA Binding [Genetic Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   708   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "when"

Phrase: "compared with control unstimulated cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0007634:Cells [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C0439819:Unstimulated [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.132: The specificity of the complex was shown by competing out the signal with a 100-fold excess of unlabeled oligonucleotide containing the binding site for NFB but not that of the unrelated Oct-1 sequence (data not shown). 

Phrase: "The specificity of the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "was"

Phrase: "shown by competing out"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "the signal with a 100-fold excess of unlabeled oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1710082:Signal [Phenomenon or Process]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the binding site for NFB"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0005456:Binding Site [Receptor]
   778   C0682969:Binding Site [Amino Acid Sequence]
   748   C0205145:Site [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "that of the unrelated Oct-1 sequence"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1442824:OCT-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0445356:Unrelated [Finding]
   748   C1519249:Sequence [Functional Concept]
   748   C1704623:Unrelated [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.133: Incubation of nuclear extracts from insulin-treated cells with anti-p65 antibody markedly reduced the intensity of the radioactive band (Fig. 1B, right panel). 

Phrase: "Incubation of nuclear extracts"

Phrase: "from insulin-treated cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "with anti-p65 antibody markedly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the intensity of the radioactive band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0522510:Intensity [Qualitative Concept]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.134: The latter finding suggests the presence of p65 in this DNA-protein complex. 

Phrase: "The latter finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of p65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in this DNA-protein complex."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2246376:DNA-protein complex [Cell Component]
   901   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1523872:protein complex [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.135: Immunoblot analysis of nuclear proteins from CHO-IR cells treated in the presence of insulin or TNF revealed an accumulation of the p65 protein in this fraction (Fig. 1C). 

Phrase: "Immunoblot analysis of nuclear proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   781   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "from CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "treated in the presence of insulin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1522326:Treated [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "TNF"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "an accumulation of the p65 protein"

Phrase: "in this fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.136: Having demonstrated the ability of insulin to stimulate NFB, the subsequent studies were focused on the effects of insulin toward the regulation of IB phosphorylation and stability. 

Phrase: "Having"

Phrase: "demonstrated"

Phrase: "the ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "stimulate"

Phrase: "NFB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   901   C1824728:FACTOR B [Gene or Genome]

Phrase: "the subsequent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "focused on the effects of insulin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205234:Focused [Spatial Concept]
   753   C1280500:effects [Qualitative Concept]
   753   C1285542:focused [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "toward the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "stability."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]
Processing 00000000.tx.137: Insulin-induced IB phosphorylation without subsequent degradation To study the effects of insulin on the phosphorylation of IB, we measured the accumulation of IB phosphorylated at Ser-32 by Western blot analysis of total cell lysates with a phospho-specific antibody. 

Phrase: "Insulin-induced IB phosphorylation without subsequent degradation To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of IB,"

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the accumulation of IB"

Phrase: "phosphorylated at Ser-32"

Phrase: "by Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "of total cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "with a phospho-specific antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]
Processing 00000000.tx.138: Treatment of CHO-IR cells with 10 nM insulin resulted in a time-dependent increase in IB phosphorylation that reached a maximum after 2 h stimulation and subsequent decline thereafter (Fig. 2A). 

Phrase: "Treatment of CHO-IR cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "with 10 nM insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "resulted in a time-dependent increase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0040223:Time [Temporal Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   753   C3541383:Time [Temporal Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "in IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "that"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "a maximum after 2 h stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2946875:Maximum-H [Pharmacologic Substance]
   753   C0806909:Maximum [Quantitative Concept]
   753   C1552615:maximum [Quantitative Concept]
   753   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "and"

Phrase: "subsequent decline thereafter"

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.139: The gradual decrease in phospho-IB signals observed following the 6-h time point is unlikely the result of a proteolytic degradation of endogenous pools of IB protein. 

Phrase: "The gradual decrease in phospho-IB signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the 6-h time point"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C2348792:Time Point [Temporal Concept]
   812   C0040223:Time [Temporal Concept]
   812   C1552961:Point [Quantitative Concept]
   812   C2347617:point [Quantitative Concept]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "the result of a proteolytic degradation of endogenous pools of IB protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   735   C1274040:Result [Functional Concept]
   735   C1546471:Result [Idea or Concept]
   735   C2825142:Result [Finding]
Processing 00000000.tx.140: A small but reproducible increase in the phosphorylation of IB was observed following cell stimulation for 10 min (Fig. 2B, right panel). 

Phrase: "A small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "but"

Phrase: "reproducible increase in the phosphorylation of IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "cell stimulation for 10 min (Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.141: The inhibition of protein synthesis with cycloheximide did not block phosphorylation and stability of IB in response to a 1-h or 3-h stimulation with insulin (Fig. 2C). 

Phrase: "The inhibition of protein synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C1519619:Protein Synthesis Inhibition [Genetic Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "with cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "stability of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205360:Stability [Qualitative Concept]
   770   C2347098:Stability [Qualitative Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to a 1-h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "or"

Phrase: "3-h stimulation with insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.142: Next, we evaluated whether TNF would display similar kinetics of phosphorylation in our system. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "whether"

Phrase: "TNF"

Phrase: "would"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "similar kinetics of phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022702:Kinetics [Natural Phenomenon or Process]
   770   C0220865:kinetics [Functional Concept]
   770   C2825046:Kinetics [Occupation or Discipline]

Phrase: "in our system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.143: In cells treated with TNF, the induction of IB phosphorylation occurred at a much faster rate, with maximum effect seen after 10 min and subsequent decline in IB protein to near undetectable levels (Fig. 2B, left panel). 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with TNF,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "the induction of IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "occurred at a much faster rate,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]
   753   C1709305:Occurred [Activity]
   719   C0015663:Fast [Finding]
   719   C0456962:Fast [Qualitative Concept]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: "with maximum effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "seen after 10 min"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0205397:Seen [Qualitative Concept]
   770   C0702093:/min [Temporal Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "and"

Phrase: "subsequent decline in IB protein"

Phrase: "to near undetectable levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.144: Longer exposure to TNF (23 h) restored the levels of IB protein but was completely abolished when cells were pretreated with cycloheximide (Fig. 2D). 

Phrase: "Longer exposure to TNF (23 h)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "restored"

Phrase: "the levels of IB protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolished"

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   734 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.145: Similar studies were carried out in a second insulin-responsive cell type. 

Phrase: "Similar studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a second insulin-responsive cell type."
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   770   C0007634:Cell Type [Cell]
           Cell
   770   C0449475:cell type [Intellectual Product]
   767   C0030281:Insulin Cell [Cell]
   767   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0205342:Responsive [Functional Concept]
   744   C0205436:Second [Quantitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0439787:Out [Spatial Concept]
   744   C0457385:Second [Temporal Concept]
   744   C0565930:/second [Quantitative Concept]
   744   C0849355:Out [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1547052:*Type [Quantitative Concept]
   744   C1561503:second [Idea or Concept]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1704653:Cell [Medical Device]
   744   C1705190:Second [Qualitative Concept]
   744   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.146: Like CHO-IR cells, the phosphorylation rate of IB in response to insulin was slower than with TNF in HepG2 cells (Fig. 2E). 

Phrase: "Like CHO-IR cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "the phosphorylation rate of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "slower than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439834:Slow [Qualitative Concept]

Phrase: "with TNF"

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2E"

Phrase: ")."
Processing 00000000.tx.147: The levels of IB protein were reduced after a 30-min stimulation with TNF, whereas the IB content was intact in cells treated with insulin for periods up to 2 h. 

Phrase: "The levels of IB protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "reduced after a 30-min stimulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with TNF,"

Phrase: "whereas"

Phrase: "the IB content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "intact in cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   841   C0682538:intact cell [Cell]
   790   C0205266:Intact [Qualitative Concept]
   790   C1554187:Intact [Idea or Concept]

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   966   C0439531:/period [Temporal Concept]
   966   C1948053:Period [Temporal Concept]
   916 E C0332182:Periodic [Temporal Concept]
   916 E C1706381:PERIODIC [Intellectual Product]
   893 E C0031084:Periodicities [Temporal Concept]

Phrase: "up to 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.148: Reprobing the membrane with anti-ERK1/2 antibodies indicated equal loading of proteins in each lane. 

Phrase: "Reprobing"

Phrase: "the membrane with anti-ERK1/2 antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025255:Membrane [Tissue]
   748   C0596901:Membrane [Cell Component]
   748   C1706182:Membrane [Manufactured Object]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "equal loading of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1708715:Loading [Activity]

Phrase: "in each lane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.149: View larger version (52K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(52K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.150: Signal-induced phosphorylation and expression of IB. 

Phrase: "Signal-induced phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "expression of IB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.151: A, SFM-treated CHO-IR cells were incubated in the presence of insulin (10 nM) for the times indicated. 

Phrase: "A,"

Phrase: "SFM-treated CHO-IR cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   863   C1183428:Free cell [Cell]
   838   C0085080:Chinese Hamster Ovary Cell [Cell]
   796   C0030281:Insulin Cell [Cell]
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   787   C1514760:Receptor Cell [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   702   C0428357:Serum insulin [Laboratory Procedure]
   702   C1261415:serum insulin [Laboratory or Test Result]

Phrase: "were"

Phrase: "incubated in the presence of insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(10 nM) for the times"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.152: B, Shorter kinetics were performed in response to TNF (10 ng/ml) or insulin (10 nM). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Shorter kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022702:Kinetics [Natural Phenomenon or Process]
   861   C0220865:kinetics [Functional Concept]
   861   C2825046:Kinetics [Occupation or Discipline]

Phrase: "were"

Phrase: "performed in response"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0871261:Response [Organism Attribute]
   790   C0884358:Performed [Functional Concept]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to TNF (10 ng/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10 nM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.153: C, SFM-treated cells were preincubated with cycloheximide (10 g/ml) for 30 min and then stimulated with insulin for 1 and 3 h. 

Phrase: "C,"

Phrase: "SFM-treated cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C1183428:Free cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated with cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   734 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(10 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) for 30 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0439445:mL/min [Quantitative Concept]
   770   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stimulated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "3 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.154: D, Following a 30-min preincubation with cycloheximide, CHO-IR cells were treated with TNF (20 ng/ml) for 03 h. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a 30-min preincubation with cycloheximide,"

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with TNF (20 ng/ml)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0439275:ng/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 03 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.155: E, HepG2 cells were left untreated or were treated with insulin (10 nM) or TNF (10 ng/ml) for the indicated times. 

Phrase: "E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "or"

Phrase: "were"

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "or"

Phrase: "TNF (10 ng/ml) for the indicated times."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439275:ng/mL [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.156: In all instances, cell lysates were resolved by SDS-PAGE and analyzed for IB phosphorylation by Western blotting using phospho-specific antibodies to this protein. 

Phrase: "In all instances,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550608:Instance [Idea or Concept]

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "resolved by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "analyzed for IB phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0936012:Analyzed [Research Activity]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "phospho-specific antibodies to this protein."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   809   C1445860:Antibody to protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Protein antibody
   773   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.157: The membrane was then reprobed with an antibody against the total IB protein. 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "reprobed with an antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against the total IB protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0555903:Total protein [Laboratory Procedure]
   902   C1261360:total protein [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.158: Either c-Src (C and D) or ERK1/2 (E) protein levels were determined by immunoblotting with specific antibodies, as a loading control. 

Phrase: "Either c-Src (C"

Phrase: "and"

Phrase: "D)"

Phrase: "or"

Phrase: "ERK1/2 (E) protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "with specific antibodies,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "a loading control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.159: Data in each panel are representative of three to four independent experiments.  

Phrase: "Data in each panel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three to four independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1882932:Representative [Activity]
Processing 00000000.tx.160: The presence of phosphorylated IB in the absence of proteolytic degradation in insulin-treated cells is distinct from the mechanism of action of TNF. 

Phrase: "The presence of phosphorylated IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of proteolytic degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "in insulin-treated cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "distinct from the mechanism of action of TNF."
Processing 00000000.tx.161: The accumulation of phospho-IB promoted by insulin could be explained by the inhibition of ubiquitination, which is a prerequisite for its subsequent degradation by the proteasome. 

Phrase: "The accumulation of phospho-IB"

Phrase: "promoted by insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756   C0033414:Promote [Activity]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "explained by the inhibition of ubiquitination,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1519751:Ubiquitination [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "which"

Phrase: "is"

Phrase: "a prerequisite for its subsequent degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679209:prerequisite [Idea or Concept]

Phrase: "by the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.162: Alternatively, insulin may block proteasome-dependent protein degradation. 

Phrase: "Alternatively,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "proteasome-dependent protein degradation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
Processing 00000000.tx.163: To allow further study of IB, CHO-IR cells were pretreated with the peptide proteasomal inhibitor (PSI) that causes the accumulation of ubiquitinated proteins (17) and blocks activation of NFB (18). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "further study of IB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with the peptide proteasomal inhibitor (PSI)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   754   C2266856:Proteasome Inhibitor [Molecular Function]
   754   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "that"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the accumulation of ubiquitinated proteins"

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "activation of NFB (18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: ")."
Processing 00000000.tx.164: Our control experiment showed that TNF rapidly induced IB phosphorylation as assessed either with anti-(pSer32) IB antibody (Fig. 3A, middle panel, lane 2) or the detection of the slowly migrating form of IB characteristic of the Ser32-Ser36-phosphorylated species (Fig. 3A, bottom panel, lane 2). 

Phrase: "Our control experiment"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0243148:control [Qualitative Concept]
   861   C0681814:Experiment [Research Activity]
   861   C1550141:Control [Substance]
   861   C1706386:Experiment [Conceptual Entity]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that TNF rapidly induced IB phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]
   709   C0024320:TNF-b [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "as"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "either with anti-"

Phrase: "(pSer32"

Phrase: ")"

Phrase: "IB antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 3A,"

Phrase: "middle panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "the detection of the slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "migrating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrating [Functional Concept]

Phrase: "form of IB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "characteristic of the Ser32-Ser36-phosphorylated species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521970:Characteristic [Qualitative Concept]

Phrase: "(Fig. 3A,"

Phrase: "bottom panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.165: Concomitantly, there is accumulation of immunoreactive phosphorylated IB protein that migrated as high-molecular-weight species (Fig. 3A, top panel, lane 2). 

Phrase: "Concomitantly,"

Phrase: "there"

Phrase: "is"

Phrase: "accumulation of immunoreactive phosphorylated IB protein"

Phrase: "that"

Phrase: "migrated as high-molecular-weight species"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C1979900:High molecular weight [Qualitative Concept]
   790   C0026385:Molecular Weight [Quantitative Concept]
   783   C0948775:high weight [Sign or Symptom]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C0205250:High [Qualitative Concept]
   753   C0232902:Migrated [Functional Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]
   753   C1705920:Species [Conceptual Entity]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "(Fig. 3A,"

Phrase: "top panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.166: As expected, TNF exerted a time-dependent destabilization of phosphorylated IB (Fig. 3A, bottom panel, lanes 35). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "TNF"

Phrase: "exerted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Exerted [Organism Function]

Phrase: "a time-dependent destabilization of phosphorylated IB (Fig. 3A,"

Phrase: "bottom panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.167: However, pretreatment of the cells with PSI maintained the levels of phospho-IB protein despite stimulation with TNF for periods up to 2 h (Fig. 3A, bottom panel, lanes 810). 

Phrase: "However,"

Phrase: "pretreatment of the cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "with PSI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   865   C2266856:Proteasome Inhibitor [Molecular Function]
   865   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "the levels of phospho-IB protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "despite stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with TNF"

Phrase: "for periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   966   C0439531:/period [Temporal Concept]
   966   C1948053:Period [Temporal Concept]
   916 E C0332182:Periodic [Temporal Concept]
   916 E C1706381:PERIODIC [Intellectual Product]
   893 E C0031084:Periodicities [Temporal Concept]

Phrase: "up to 2 h (Fig. 3A,"

Phrase: "bottom panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 810"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.168: Moreover, a significant increase in the pool of high-molecular-weight IB species was observed in PSI-treated cells in response to TNF (Fig. 3A, top panel, lanes 810). 

Phrase: "Moreover,"

Phrase: "a significant increase in the pool"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "of high-molecular-weight IB species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1705920:Species [Conceptual Entity]

Phrase: "was"

Phrase: "observed in PSI-treated cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   748   C0007634:Cells [Cell]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0332293:treated [Therapeutic or Preventive Procedure]
   748   C1441672:Observed [Functional Concept]
   748   C1522326:Treated [Functional Concept]
   748   C1999216:Inhibitor [Qualitative Concept]
   748   C3282337:Cells [Cell]
   743   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   743   C2266856:Proteasome Inhibitor [Molecular Function]
   743   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   714 E C1269647:Cell [Cell]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to TNF (Fig. 3A,"

Phrase: "top panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 810"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.169: The presence of polyubiquitinated forms of IB was confirmed by immunoprecipitation (Fig. 3C). 

Phrase: "The presence of polyubiquitinated forms of IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "confirmed by immunoprecipitation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.170: However, it should be noted that the stabilization and accumulation of phosphorylated IB on TNF stimulation was paralleled by a reduction of the unmodified pool of the protein (Fig. 3A, lower panel, lanes 810). 

Phrase: "However,"

Phrase: "it"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the stabilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293130:Stabilisation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "accumulation of phosphorylated IB"

Phrase: "on TNF stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "paralleled by a reduction of the unmodified pool of the protein"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   754   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0301630:Reduction [Natural Phenomenon or Process]
   738   C0337051:Pool [Geographic Area]
   738   C0392756:Reduction [Qualitative Concept]
   738   C0441610:Reduction [Therapeutic or Preventive Procedure]
   738   C1509144:pool [Clinical Attribute]
   738   C2349200:Pool [Functional Concept]
   704   C2348042:Parallel [Qualitative Concept]
   704   C2826345:PARALLEL [Research Activity]

Phrase: "(Fig. 3A,"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "lanes 810"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.171: View larger version (46K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.172: PSI increases phosphorylation and stabilization of ubiquitinated IB. 

Phrase: "PSI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   865   C2266856:Proteasome Inhibitor [Molecular Function]
   865   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "stabilization of ubiquitinated IB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.173: CHO-IR cells were pretreated in the absence (lanes 15) or the presence (lanes 610) of 50 M PSI for 1 h followed by the addition of 10 ng/ml TNF (A) or 10 nM insulin (B) for the indicated times (0120 min). 

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(lanes 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(lanes 610"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "of 50 M PSI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]
   804   C2266856:Proteasome Inhibitor [Molecular Function]
   804   C3537238:Proteasome Inhibitor [Pharmacologic Substance]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "followed by the addition of 10 ng/ml TNF ("
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   764   C0332283:Followed by [Temporal Concept]
           followed
   764   C0439275:ng/mL [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C1883712:Addition [Functional Concept]
   708 E C1719822:Follow [Intellectual Product]

Phrase: "A)"

Phrase: "or"

Phrase: "10 nM insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(B) for the indicated times"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347469:/B [Quantitative Concept]

Phrase: "(0120 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.174: Total cell lysates were immunoblotted with anti-phospho-IB antibody (upper panels, long exposure; middle panels, short exposure). 

Phrase: "Total cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "immunoblotted with anti-phospho-IB antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0301850:Anti-B antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0178481:antibody inhibitor [Immunologic Factor]
   774   C0432618:Anti-B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]
   714   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(upper panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "long exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "; middle panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "short exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.175: Comparable aliquots were probed with the anti-IB, followed by anti-c-Src to show comparable protein load in each lane. 

Phrase: "Comparable aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "probed with the anti-IB,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0432618:Anti-B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1999216:Inhibitor [Qualitative Concept]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "followed by anti-c-Src to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332283:Followed by [Temporal Concept]
           followed
   790   C0432624:Anti C [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0432626:Anti c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "comparable protein load in each lane."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1550025:Load [Idea or Concept]
   753   C1704782:Load [Manufactured Object]
   753   C1708715:Load [Activity]
Processing 00000000.tx.176: The IB protein levels were quantitated and expressed as fold stimulation over control cells (time = 0). 

Phrase: "The IB protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "quantitated"

Phrase: "and"

Phrase: "expressed as fold stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332462:Fold [Spatial Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1880834:FOLD [Phenomenon or Process]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "over control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "= 0"

Phrase: ")."
Processing 00000000.tx.177: All blots and quantitative analysis are representative of two independent experiments. 

Phrase: "All blots"

Phrase: "and"

Phrase: "quantitative analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0392762:Quantitative [Quantitative Concept]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "are"

Phrase: "representative of two independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.178: An asterisk denotes high-molecular-weight phosphorylated IB. 

Phrase: "An asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "denotes"

Phrase: "high-molecular-weight"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1979900:High molecular weight [Qualitative Concept]
   913   C0948775:high weight [Sign or Symptom]
   901   C0026385:Molecular Weight [Quantitative Concept]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1521991:Molecular [Qualitative Concept]
   827   C1705104:Weight [Idea or Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0567416:Molecule [Substance]

Phrase: "phosphorylated"

Phrase: "IB."
Processing 00000000.tx.179: C, CHO-IR cells were transiently transfected with an expression plasmid encoding Flag-tagged IB, serum-starved, and left untreated (-) or treated (+) with 50 M PSI for 1 h before the addition of TNF (10 ng/ml) or insulin (10 nM) for the indicated times. 

Phrase: "C,"

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with an expression plasmid encoding Flag-tagged IB,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   739   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   739   C1547699:Encoding [Idea or Concept]
   739   C1708067:Flag [Functional Concept]
   739   C1708632:Tagged [Qualitative Concept]
   739   C1999216:Inhibitor [Qualitative Concept]
   739   C2700640:Encoding [Activity]
   706 E C0037293:Tag [Neoplastic Process]
   706 E C0181496:Tag [Manufactured Object]
   706 E C1710492:TAG [Gene or Genome]

Phrase: "serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "starved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348531:Starve [Activity]

Phrase: ","

Phrase: "and"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "(-"

Phrase: ")"

Phrase: "or"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "with 50 M PSI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]
   804   C2266856:Proteasome Inhibitor [Molecular Function]
   804   C3537238:Proteasome Inhibitor [Pharmacologic Substance]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "before the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of TNF (10 ng/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10 nM) for the indicated times."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0312860:NM [Cell Function]
Processing 00000000.tx.180: Ubiquitination of IB was detected by immunoprecipitation with anti-Flag antibody, followed by immunoblotting with the anti-ubiquitin antibody. 

Phrase: "Ubiquitination of IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519751:Ubiquitination [Molecular Function]

Phrase: "was"

Phrase: "detected by immunoprecipitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with anti-Flag antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with the anti-ubiquitin antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.181: The data are representative of two independent experiments.  

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of two independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.182: In the presence of PSI, the amount of phosphorylated and polyubiquitinated IB increased with insulin in a time-dependent fashion (Fig. 3B, lanes 610) at a rate that was slower than that induced by TNF. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of PSI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   865   C2266856:Proteasome Inhibitor [Molecular Function]
   865   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "the amount of phosphorylated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "polyubiquitinated IB"

Phrase: "increased with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   858   C0020459:increased insulin [Disease or Syndrome]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   718 E C1517378:Gain [Quantitative Concept]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in a time-dependent fashion"

Phrase: "(Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "lanes 610"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "at a rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "slower than that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0439834:Slow [Qualitative Concept]

Phrase: "induced by TNF."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]
Processing 00000000.tx.183: We could not detect significant reduction of the pool of IB after insulin treatment (Fig. 3B, bottom panel). 

Phrase: "We"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "significant reduction of the pool of IB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "after insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.184: It should be noted that PSI markedly increased the extent of IB phosphorylation without its degradation (Fig. 3, A and B, lane 1 vs. 6); 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that PSI markedly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   825   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   825   C2266856:Proteasome Inhibitor [Molecular Function]
   825   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the extent of IB phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439792:Extent [Spatial Concept]

Phrase: "without its degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "vs. 6"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.185: interestingly, very little accumulation of polyubiquitinated forms of IB was observed. 

Phrase: "interestingly,"

Phrase: "very little accumulation of polyubiquitinated forms of IB"

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.186: This would argue that phosphorylation alone is not sufficient to cause ubiquitination of IB. 

Phrase: "This"

Phrase: "would"

Phrase: "argue"

Phrase: "that phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "ubiquitination of IB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519751:Ubiquitination [Molecular Function]
Processing 00000000.tx.187: Taken together, these experiments suggest that the phosphorylation and ubiquitination of IB occur normally in response to insulin. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "ubiquitination of IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519751:Ubiquitination [Molecular Function]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "normally in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.188: Immunofluorescence studies To examine whether insulin and TNF affect the localization of IB, indirect immunofluorescence microscopy was performed. 

Phrase: "Immunofluorescence studies To"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0016318:Immunofluorescence [Laboratory Procedure]
   827   C0079603:Immunofluorescence [Laboratory Procedure]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   771 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   755 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "examine"

Phrase: "whether"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "TNF"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the localization of IB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "indirect immunofluorescence microscopy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]
   827   C0026018:Microscopy [Laboratory Procedure]
   755 E C0205288:Microscopic [Qualitative Concept]
   734   C0282646:Indirect Immunofluorescence [Laboratory Procedure]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.189: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.190: 4A, phosphorylated IB demonstrated prominent nuclear staining in the presence or absence of stimulation by insulin under conditions in which unmodified IB was predominantly detected in the cytoplasm. 

Phrase: "4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "phosphorylated IB"

Phrase: "demonstrated"

Phrase: "prominent nuclear staining in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "or"

Phrase: "absence of stimulation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "in which unmodified IB"

Phrase: "was"

Phrase: "predominantly"

Phrase: "detected in the cytoplasm."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010834:Cytoplasm [Cell Component]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.191: Interestingly, a 2.2- and 3-fold increase in phospho-IB staining was observed in the cytosol of PSI- and TNF-treated cells, respectively (Fig. 4B). 

Phrase: "Interestingly,"

Phrase: "a 2.2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3-fold increase in phospho-IB staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed in the cytosol of PSI-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C1383501:Cytosol [Cell Component]
   744   C1441672:Observed [Functional Concept]
   744   C1999216:Inhibitor [Qualitative Concept]
   735   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   735   C2266856:Proteasome Inhibitor [Molecular Function]
   735   C3537238:Proteasome Inhibitor [Pharmacologic Substance]

Phrase: "and"

Phrase: "TNF-treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "respectively"

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.192: When the same cells were further analyzed, the nuclear content of phosphorylated IB went up about 1.8-fold following a 5-min treatment with TNF. 

Phrase: "When"

Phrase: "the same cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: ","

Phrase: "the nuclear content of phosphorylated IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "went up about 1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332462:Fold [Spatial Concept]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a 5-min treatment with TNF."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.193: View larger version (94K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(94K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.194: Cellular distribution of IB by indirect immunofluorescence. 

Phrase: "Cellular distribution of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "by indirect immunofluorescence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0282646:Indirect Immunofluorescence [Laboratory Procedure]
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0439852:Indirect [Qualitative Concept]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.195: A, CHO-IR cells were left untreated (a, c) or treated with 10 nM insulin (b, d) for 4 h. 

Phrase: "A,"

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "("

Phrase: "a,"

Phrase: "c)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "treated with 10 nM insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1522326:Treated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "d) for 4 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.196: Staining with anti-phospho-IB (upper panels) and anti-IB (lower panels) was performed on fixed cells as described in Materials and Methods. 

Phrase: "Staining with anti-phospho-IB (upper panels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "anti-IB (lower panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0441833:Panel [Idea or Concept]
   804   C1999270:Panel [Intellectual Product]
   804   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "performed on fixed cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   816   C1253961:Fixed cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C2827483:Fixed [Body Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.197: Similar results were obtained with HepG2 cells (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with HepG2 cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C2717940:HepG2 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.198: B, CHO-IR cells were incubated in the absence or the presence of 50 M PSI for 1 h or 20 ng/ml TNF for 5 min. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "the presence of 50 M PSI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "or"

Phrase: "20 ng/ml TNF for 5 min."
Processing 00000000.tx.199: Staining with anti-phospho-IB was then performed. 

Phrase: "Staining with anti-phospho-IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.200: Bars, 15 m. 

Phrase: "Bars,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "15 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.201: The cells shown are representative of more than 100 cells. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882932:Representative [Activity]

Phrase: "than 100 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1441340:100 cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.202: The data in each panel are representative of three independent experiments.  

Phrase: "The data in each panel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.203: Effect of insulin on the activation of IKK and IKK Because the IB kinases (IKK and ) constitute the key regulatory enzymes in phosphorylating the IB protein both at Ser-32 and Ser-36, it is plausible that the insulin-induced increase in IB phosphorylation might occur via a rise in IKK activity. 

Phrase: "Effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "and"

Phrase: "IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "Because"

Phrase: "the IB kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "and )"

Phrase: "constitute"

Phrase: "the key regulatory enzymes in phosphorylating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0014442:Enzymes [Enzyme,Organic Chemical]
   753   C0014445:enzymes [Functional Concept]

Phrase: "the IB protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "both at Ser-32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "Ser-36,"

Phrase: "it"

Phrase: "is"

Phrase: "plausible"

Phrase: "that"

Phrase: "the insulin-induced increase in IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0020459:INSULIN INCREASE [Disease or Syndrome]
   744   C0442805:Increase [Functional Concept]

Phrase: "might"

Phrase: "occur via a rise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "in IKK activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.204: To our surprise, using an immunoprecipitation-based kinase assay with GST-IB (1317) fusion protein as the substrate, it was found that treatment of CHO-IR cells with insulin (2 h) failed to induce IKK activities, compared with control unstimulated cells (Fig. 5). 

Phrase: "To our surprise,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an immunoprecipitation-based kinase assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "with GST-IB (1317"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0017831:Glutathione S-Transferase B [Amino Acid, Peptide, or Protein,Enzyme]
   867   C1512218:Glutathione Transferase Inhibitor [Pharmacologic Substance]
   861   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C1532411:Transferase inhibitor [Pharmacologic Substance]
   827   C1658753:transferase inhibitor [Molecular Function]
   799   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "fusion protein as the substrate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332466:Fusion [Functional Concept]
   760   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "it"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that treatment of CHO-IR cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   742   C0039798:treatment [Functional Concept]
   742   C0087111:Treatment [Therapeutic or Preventive Procedure]
   742   C1522326:Treatment [Functional Concept]
   742   C1533734:Treatment [Therapeutic or Preventive Procedure]
   742   C1705169:Treatment [Conceptual Entity]
   742   C3538994:TREATMENT [Research Activity]

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2 h)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "IKK activities,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "compared with control unstimulated cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0007634:Cells [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C0439819:Unstimulated [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.205: In contrast, exposure to TNF resulted in IKK activation. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "exposure to TNF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "resulted in IKK activation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1150571:IKK [Molecular Function]
   770   C1879547:Activation [Activity]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]
Processing 00000000.tx.206: Thus, it is likely that the insulin-stimulated phosphorylation at Ser-32 of IB may result from the activation of additional enzyme(s) present in the insulin signaling pathways. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the insulin-stimulated phosphorylation at Ser-32 of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]

Phrase: "may"

Phrase: "result from the activation of additional enzyme"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0014429:Enzyme Activation [Molecular Function]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C1274040:Result [Functional Concept]
   748   C1524062:Additional [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1879547:Activation [Activity]
   748   C2825142:Result [Finding]

Phrase: "("

Phrase: "s)"

Phrase: "present in the insulin signaling pathways."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   822   C1512804:Insulin Signaling Pathway [Molecular Function]
   822   C2984300:Insulin signaling pathway [Molecular Function]
   783   C0037080:pathways signaling [Molecular Function]
   773 E C0037083:signaling pathway [Cell Function]
           Signaling
   773 E C0086982:Signaling Pathway [Molecular Function]
   767   C2984427:Insulin Pathway [Functional Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
   753   C3537152:signaling [Biologic Function]
   719 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.207: View larger version (23K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.208: Differential effect of insulin and TNF on IKK activation. 

Phrase: "Differential effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "TNF on IKK activation."
Processing 00000000.tx.209: CHO-IR cells were treated in the absence or the presence of insulin (10 nM) or TNF (20 ng/ml) for 2 h. 

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated in the absence"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0332197:absence [Quantitative Concept]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C1522326:Treated [Functional Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "the presence of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(10 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "or"

Phrase: "TNF (20 ng/ml) for 2 h."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C1533072:ng/mL/h [Quantitative Concept]
   804   C2827809:h*ng/mL [Quantitative Concept]
   800 E C2827838:mL/h/ng [Quantitative Concept]
   778   C0439275:ng/mL [Quantitative Concept]
   774   C0439391:mL/h [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.210: Following incubation, IKK and IKK immunoprecipitates were prepared and then resuspended in a kinase reaction buffer containing 20 M [-32P]ATP and 1 g GST-IB for 30 min at 30 C. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation,"

Phrase: "IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "and"

Phrase: "IKK immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resuspended in a kinase reaction buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20"

Phrase: "M [-"

Phrase: "32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "and"

Phrase: "1 g GST-IB for 30 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017831:Glutathione S-Transferase B [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "at 30 C."
Processing 00000000.tx.211: After quenching the phosphorylation reaction, radiolabeled samples were resolved by SDS-PAGE, transferred onto PVDF membranes, and analyzed by autoradiography. 

Phrase: "After"

Phrase: "quenching"

Phrase: "the phosphorylation reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "radiolabeled samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "resolved by SDS-PAGE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "transferred onto PVDF membranes,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C0596901:Membrane [Cell Component]
   726 E C1705822:Transfer [Activity]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "analyzed by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.212: Data are representative of three experiments.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]
Processing 00000000.tx.213: Role of the Ras-ERK pathway in IB phosphorylation Because Raf-1 is a key regulatory enzyme of the Ras/Raf-1/MEK/ERK cascade and has been shown to be involved in NFB activation on insulin treatment (14), we examined whether expression of a transdominant negative mutant of the guanine nucleotide exchange factor, SOS1 protein, would ultimately have an effect on insulin-dependent IB phosphorylation in CHO-IR cells. 

Phrase: "Role of the Ras-ERK pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "Because"

Phrase: "Raf-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812215:Raf-1 [Gene or Genome]
  1000   C1706586:RAF-1 [Gene or Genome]
           RAF
  1000   C2746015:Raf-1 [Molecular Function]
   861   C1425569:RAF [Gene or Genome]

Phrase: "is"

Phrase: "a key regulatory enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "of the Ras/Raf-1/MEK/ERK cascade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2611095:ERK cascade [Molecular Function]
   799   C1707310:Cascade [Manufactured Object]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in NFB activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   790   C1824728:FACTOR B [Gene or Genome]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1314939:Involved [Functional Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1879547:Activation [Activity]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "on insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "expression of a transdominant negative mutant of the guanine nucleotide exchange factor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "SOS1 protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0217396:SOS1 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "would"

Phrase: "ultimately"

Phrase: "have"

Phrase: "an effect on insulin-dependent IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "in CHO-IR cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.214: To address this question, we first evaluated the activation of Raf-1 in a standard immunoprecipitation-based kinase assay in which CHO-IR/SOS cells were incubated in the absence or the presence of insulin for 5 min. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the activation of Raf-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "in a standard immunoprecipitation-based kinase assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]

Phrase: "in which CHO-IR/SOS cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   894   C0085080:Chinese Hamster Ovary Cell [Cell]
   829   C0030281:Insulin Cell [Cell]
   813   C1514760:Receptor Cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "the presence of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.215: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.216: 6A, insulin-stimulated c-Raf-1 activity was totally absent in these cells. 

Phrase: "6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553638:6a [Medical Device]

Phrase: "insulin-stimulated c-Raf-1 activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C1145751:insulin activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "totally absent in these cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]
Processing 00000000.tx.217: However, despite the lack of Ras-Raf-1 activation, phosphorylation without degradation of IB occurred in response to insulin (Fig. 6B). 

Phrase: "However,"

Phrase: "despite the lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "of Ras-Raf-1 activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "phosphorylation without degradation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "occurred in response"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C1709305:Occurred [Activity]
   790   C2911692:Response [Mental Process]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.218: Pharmacological inhibition of MEK-1 with PD98059 (25 M) or U0126 (1 M) did not alter insulins ability to induce IB phosphorylation (data not shown). 

Phrase: "Pharmacological inhibition of MEK-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "with PD98059"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "(25"

Phrase: "M)"

Phrase: "or"

Phrase: "U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M)"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "insulins ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.219: Of importance, insulin (110 nM) suppresses apoptosis mediated by the removal of serum and growth factors in CHO-IR/SOS cells (15). 

Phrase: "Of importance,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(110 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "mediated by the removal of serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0229671:Serum [Body Substance]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "growth factors in CHO-IR/SOS cells"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   761   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0007595:cells growth [Cell Function]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0220844:growth [Physiologic Function]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C2911660:Growth [Activity]
   706   C1521761:Factor [Functional Concept]
   706   C2827422:Factor [Conceptual Entity]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.220: Therefore, it would appear that signaling through the Ras/Raf-1/MEK/ERK pathway has little if any role in mediating insulin-dependent regulation of IB and antiapoptotic function. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "would"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that signaling through the Ras/Raf-1/MEK/ERK pathway"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C1514731:Ras Signaling Pathway [Molecular Function]
   757   C0037080:pathway signaling [Molecular Function]
   757   C0037083:signaling pathway [Cell Function]
           Signaling
   757   C0086982:Signaling Pathway [Molecular Function]
   739   C3537152:signaling [Biologic Function]

Phrase: "has"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "if"

Phrase: "any role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "insulin-dependent regulation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "antiapoptotic function."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   861   C2986514:antiapoptotic [Chemical Viewed Functionally]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.221: View larger version (25K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.222: Raf-1-independent modulation of IB phosphorylation by insulin. 

Phrase: "Raf-1-independent modulation of IB phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443264:Modulation [Spatial Concept]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.223: A, c-Raf-1 immunoprecipitates from control and insulin-treated CHO-IR cells and CHO-IR/SOS cells were resuspended in kinase reaction buffer containing 5 Ci radiolabeled ATP, inactive MEK-1, inactive ERK1/ERK2, and 20 g MBP. 

Phrase: "A,"

Phrase: "c-Raf-1 immunoprecipitates from control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "insulin-treated CHO-IR cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   875   C0030281:Insulin Cell [Cell]
   861   C0085080:Chinese Hamster Ovary Cell [Cell]
   795   C1514760:Receptor Cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]
   711   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   711   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "CHO-IR/SOS cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   894   C0085080:Chinese Hamster Ovary Cell [Cell]
   829   C0030281:Insulin Cell [Cell]
   813   C1514760:Receptor Cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in kinase reaction buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 Ci"

Phrase: "radiolabeled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527121:Radiolabeled [Qualitative Concept]
   966 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "ATP,"

Phrase: "inactive MEK-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1434639:MEK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0205254:Inactive [Qualitative Concept]
   827   C0752313:mek [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "inactive ERK1/ERK2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1150579:ERK2 [Molecular Function]

Phrase: "and"

Phrase: "20 g MBP."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   884   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   875   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026969:Myelin [Tissue]
   804   C0026973:Myelin [Cell Component]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1527178:Basic [Functional Concept]
   733 E C0920750:basicity [Quantitative Concept]
Processing 00000000.tx.224: Bars represent densitometry of phosphorylated MBP. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "densitometry of phosphorylated MBP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0011321:Densitometry [Laboratory Procedure]
Processing 00000000.tx.225: Data are representative of a single experiment that has been performed twice with similar results. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of a single experiment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "twice with similar results."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]
   770   C2348205:Similar [Qualitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]
Processing 00000000.tx.226: B, SFM-treated CHO-IR/SOS cells were stimulated with insulin (10 nM) for the indicated times. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "SFM-treated CHO-IR/SOS cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   863   C1183428:Free cell [Cell]
   841   C0085080:Chinese Hamster Ovary Cell [Cell]
   803   C0030281:Insulin Cell [Cell]
   793   C1514760:Receptor Cell [Cell]
   788   C0007634:Cells [Cell]
   788   C3282337:Cells [Cell]
   755 E C1269647:Cell [Cell]
   755 E C1704653:Cell [Medical Device]
   755 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10 nM) for the indicated times."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0312860:NM [Cell Function]
Processing 00000000.tx.227: Cell lysates were analyzed for both phospho-IB and total IB by Western blot technique using specific antibodies. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "analyzed for both phospho-IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0936012:Analyzed [Research Activity]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "total IB by Western blot technique"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.228: This blot is representative of three experiments.  

Phrase: "This blot"

Phrase: "is"

Phrase: "representative of three experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]
Processing 00000000.tx.229: Role of the PI3K/Akt pathway in IB phosphorylation Considering the newly described role of Akt (PKB) in NFB activation (19, 20), we used molecular and pharmacological approaches to evaluate the importance of Akt in insulin-dependent IB phosphorylation. 

Phrase: "Role of the PI3K/Akt pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the newly described role of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(PKB"

Phrase: ")"

Phrase: "in NFB activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "(19,"

Phrase: "20"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "pharmacological approaches to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the importance of Akt"

Phrase: "in insulin-dependent IB phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.230: To this purpose, transient expression of myc-tagged Akt1 constructs in CHO-IR cells was carried out. 

Phrase: "To this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "transient expression of myc-tagged Akt1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "constructs in CHO-IR cells"
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   822   C0085080:cells chinese hamster ovary [Cell]
   770   C0018555:Chinese Hamster [Mammal]
   770   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   770   C1334133:INSULIN RECEPTOR [Gene or Genome]
   754   C1514760:Receptor Cell [Cell]
   750   C0030281:Insulin Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0008120:chinese [Language]
   744   C0018557:Hamster [Mammal]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0029939:Ovary [Body Part, Organ, or Organ Component]
   744   C0152035:Chinese [Population Group]
   744   C0227898:ovary [Body Part, Organ, or Organ Component]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1278992:Ovary [Body Part, Organ, or Organ Component]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C2827421:Construct [Classification]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.231: In the first set of experiments, marked phosphorylation of glycogen synthase kinase-3 (GSK-3) was observed in vitro in anti-myc immunoprecipitates from insulin-treated cells expressing wild-type (WT)-Akt1 construct (Fig. 7A). 

Phrase: "In the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "set of experiments,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C0681814:Experiments [Research Activity]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "marked phosphorylation of glycogen synthase kinase-3 (GSK-3)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in vitro in anti-myc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]

Phrase: "immunoprecipitates from insulin-treated cells"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   781   C0030281:Insulin Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0301871:Immunoprecipitate [Immunologic Factor]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")-"

Phrase: "Akt1 construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.232: As anticipated, the dominant negative (DN) Akt1 (Lys179->Met) was unable to promote insulin-stimulated phosphorylation of GSK-3 (Fig. 7A). 

Phrase: "As"

Phrase: "anticipated"

Phrase: ","

Phrase: "the dominant negative (DN) Akt1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0285558:AKT1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT1 [Gene or Genome]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: "(Lys179-"

Phrase: ">Met)"

Phrase: "was"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "insulin-stimulated phosphorylation of GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.233: The levels of expression of WT- and DN-Akt1 constructs were comparable. 

Phrase: "The levels of expression of WT-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C3244092:expression level [Idea or Concept]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "DN-Akt1 constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "comparable."
Processing 00000000.tx.234: In a second set of experiments, the consequences for insulin-induced Flag-tagged IB phosphorylation of coexpressing myc-tagged Akt1 constructs was investigated. 

Phrase: "In a second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "set of experiments,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C0681814:Experiments [Research Activity]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "the consequences for insulin-induced Flag-tagged IB phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0686907:consequences [Functional Concept]

Phrase: "of coexpressing myc-tagged Akt1 constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.235: Treatment of cells with insulin resulted in the accumulation of phosphorylated Flag-tagged IB, even in cells transfected with DN-Akt1 mutant (Fig. 7B), which indicates that this response is likely because of an Akt1-independent event. 

Phrase: "Treatment of cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "resulted in the accumulation of phosphorylated Flag-tagged IB,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   739   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   739   C1708067:Flag [Functional Concept]
   739   C1708632:Tagged [Qualitative Concept]
   739   C1999216:Inhibitor [Qualitative Concept]
   706 E C0037293:Tag [Neoplastic Process]
   706 E C0181496:Tag [Manufactured Object]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706 E C1710492:TAG [Gene or Genome]
   706   C2825142:Result [Finding]

Phrase: "even in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with DN-Akt1 mutant"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   820   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
           Dominant Negative
   753   C0205160:Negative [Qualitative Concept]
   753   C0285558:AKT1 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C0812228:AKT1 [Gene or Genome]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "(Fig. 7B"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "indicates"

Phrase: "that"

Phrase: "this response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "likely because of an Akt1-independent event."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0332291:Independent of [Functional Concept]
   748   C0085862:Independent [Idea or Concept]
   748   C0285558:AKT1 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332148:Likely [Qualitative Concept]
   748   C0441471:Event [Event]
   748   C0750492:Likely [Idea or Concept]
   748   C0812228:AKT1 [Gene or Genome]
   748   C1299583:Independent [Finding]
Processing 00000000.tx.236: View larger version (41K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.237: Analysis of Akt1 constructs in CHO-IR cells. 

Phrase: "Analysis of Akt1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "constructs in CHO-IR cells."
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   822   C0085080:cells chinese hamster ovary [Cell]
   770   C0018555:Chinese Hamster [Mammal]
   770   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   770   C1334133:INSULIN RECEPTOR [Gene or Genome]
   754   C1514760:Receptor Cell [Cell]
   750   C0030281:Insulin Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0008120:chinese [Language]
   744   C0018557:Hamster [Mammal]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0029939:Ovary [Body Part, Organ, or Organ Component]
   744   C0152035:Chinese [Population Group]
   744   C0227898:ovary [Body Part, Organ, or Organ Component]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1278992:Ovary [Body Part, Organ, or Organ Component]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C2827421:Construct [Classification]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.238: Cells were transiently transfected with a control plasmid (pUSEamp+) or expression vectors for WT or DN mutant Akt1 construct. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with a control plasmid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(pUSEamp+"

Phrase: ")"

Phrase: "or"

Phrase: "expression vectors for WT"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vectors [Spatial Concept]
   726 E C1705099:Vector [Idea or Concept]

Phrase: "or"

Phrase: "DN mutant Akt1 construct."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2827421:Construct [Classification]
   717   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.239: A, Transfected cells were left untreated or incubated with insulin (10 nM) for 2 h. c-Myc immunoprecipitates were resuspended in kinase reaction buffer containing 200 M ATP and 1 g GSK3-fusion protein as the substrate. 

Phrase: "A,"

Phrase: "Transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "or"

Phrase: "incubated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10 nM) for 2 h. c-Myc immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0312860:NM [Cell Function]

Phrase: "were"

Phrase: "resuspended in kinase reaction buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "200 M ATP"

Phrase: "and"

Phrase: "1 g GSK3-fusion protein as the substrate."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   789   C1333582:Fusion 1 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   767   C0060916:protein g [Amino Acid, Peptide, or Protein]
   767   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332466:Fusion [Functional Concept]
   744   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.240: The samples were resolved by SDS-PAGE and immunoblotted with antiphospho-GSK3 antibody (upper panel) and anti c-myc antibody (lower panel). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "resolved by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "immunoblotted with antiphospho-GSK3 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "anti c-myc antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0051967:anti-c antibody [Immunologic Factor]
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.241: B, CHO-IR cells were cotransfected with Flag-tagged IB and plasmid DNA expressing Akt1 constructs. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cotransfected with Flag-tagged IB"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1708067:Flag [Functional Concept]
   753   C1708632:Tagged [Qualitative Concept]
   753   C1999216:Inhibitor [Qualitative Concept]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "plasmid DNA expressing Akt1 constructs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0012931:DNA Construct [Nucleic Acid, Nucleoside, or Nucleotide]
   771   C2827421:Construct [Classification]
Processing 00000000.tx.242: Serum-starved cells were stimulated with insulin for 2 h, and the anti-Flag immunoprecipitates were immunoblotted with phospho-specific IB antibody (upper panel) and then with anti-IB (lower panel). 

Phrase: "Serum-starved cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 2 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "the anti-Flag immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "immunoblotted with phospho-specific IB antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0178481:antibody inhibitor [Immunologic Factor]
   774   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1999216:Inhibitor [Qualitative Concept]
   714   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "then with anti-IB (lower panel"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0432618:Anti-B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441833:Panel [Idea or Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C1883708:Then [Temporal Concept]
   748   C1999216:Inhibitor [Qualitative Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C2003888:Lower [Activity]
   748   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.243: The experiments shown in A and B were repeated independently three to four times.  

Phrase: "The experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "shown in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "independently three to four times."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.244: Class I PI3K is known for its sensitivity to low concentrations of the unrelated pharmacological inhibitors, wortmannin and LY294002 (21). 

Phrase: "Class I PI3K"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2936824:PI-3K [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0441885:Class I [Classification]
   734   C2698967:Class I [Finding]

Phrase: "is"

Phrase: "known for its sensitivity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0205309:Known [Qualitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to low concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of the unrelated pharmacological inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "LY294002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.245: The addition of wortmannin to CHO-IR cells led to a dose-dependent inhibition of insulin-stimulated phosphorylation of Akt at Ser-473, an indicator of its activation (22), with an IC50 of about 14 nM (Fig. 8, A and B). 

Phrase: "The addition of wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "to CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "led to a dose-dependent inhibition of insulin-stimulated phosphorylation of Akt"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
   767   C1519062:inhibition of phosphorylation [Molecular Function]
           Phosphorylation Inhibition
   753   C1512045:Dose-dependent [Quantitative Concept]
   736   C0021467:Inhibition [Mental Process]
   736   C0021469:Inhibition [Molecular Function]
   736   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C0031715:Phosphorylation [Molecular Function]
   736   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0178602:Dose [Quantitative Concept]
   736   C0812228:AKT [Gene or Genome]
   736   C0851827:Dependent [Qualitative Concept]
   736   C0869039:Dose [Quantitative Concept]
   736   C1114758:Dose # [Clinical Attribute]
   736   C1158886:Phosphorylation [Molecular Function]
   736   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C1579433:Insulin [Pharmacologic Substance]
   736   C1628982:% inhibition [Quantitative Concept]
   736   C1701901:Dependent [Qualitative Concept]
   736   C1708698:LED [Manufactured Object]
   736   C1948023:Stimulated [Natural Phenomenon or Process]
   736   C3244310:dependent [Functional Concept]
   736   C3463820:Inhibition [Activity]
   703 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   703 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   703 E C1522538:Lead [Functional Concept]
   703 E C2348269:Lead [Element, Ion, or Isotope]
   703 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "at Ser-473,"

Phrase: "an indicator of its activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   760   C1235732:Indicator [Bird]
   760   C1522602:Indicator [Functional Concept]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "with an IC50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600495:IC50 [Quantitative Concept]

Phrase: "of about 14 nM (Fig. 8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0312860:NM [Cell Function]
   804   C0349966:Fig [Food]
   804   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.246: Similarly, LY294002 strongly inhibited phosphorylation of Akt with an IC50 of about 3 M (data not shown). 

Phrase: "Similarly,"

Phrase: "LY294002 strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "with an IC50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600495:IC50 [Quantitative Concept]

Phrase: "of about 3"

Phrase: "M ("

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.247: On the basis of these results, we next examined the effect of two concentrations of wortmannin (50 nM and 1 M) on insulin-stimulated phosphorylation events. 

Phrase: "On the basis of these results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of two concentrations of wortmannin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(50 nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M) on insulin-stimulated phosphorylation events."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441471:Events [Event]
   753   C0441923:M+ [Intellectual Product]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C3541888:Events [Classification]
Processing 00000000.tx.248: Through activation of PI3K, insulin promotes the Ser/Thr phosphorylation of several downstream protein kinases, which include GSK-3 on Ser-9 and the atypical PKC- on Thr-410 (23). 

Phrase: "Through activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of PI3K,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2936824:PI-3K [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the Ser/Thr phosphorylation of several downstream protein kinases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]

Phrase: "which"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "GSK-3 on Ser-9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the atypical PKC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539645:PKC [Gene or Genome]

Phrase: "on Thr-410"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.249: Immunoblotting total lysates with phospho-specific antibodies demonstrated that insulin was able to transiently phosphorylate GSK-3 and PKC- reaching a maximum after 30 min of stimulation and a subsequent decline by 2 h (Fig. 8C, lanes 35). 

Phrase: "Immunoblotting total lysates with phospho-specific antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1881488:Lysate [Physical Object]

Phrase: "demonstrated"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "able to transiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "phosphorylate"

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "PKC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "a maximum after 30 min of stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0806909:Maximum [Quantitative Concept]
   748   C1552615:maximum [Quantitative Concept]
   748   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "and"

Phrase: "a subsequent decline by 2 h (Fig. 8C,"

Phrase: "lanes 35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.250: Insulin-stimulated phosphorylation of GSK-3 and PKC- was strongly inhibited by 50 nM wortmannin, a pattern similar to that of Akt phosphorylation (Fig. 8C, lanes 6 and 7). 

Phrase: "Insulin-stimulated phosphorylation of GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "PKC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "was"

Phrase: "strongly"

Phrase: "inhibited by 50 nM wortmannin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C0312860:NM [Cell Function]

Phrase: "a pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "similar to that of Akt phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 8C,"

Phrase: "lanes 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.251: In contrast, phosphorylation of IB by insulin showed much lower sensitivity to wortmannin inhibition (Fig. 8C, bottom right panel). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "phosphorylation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "much lower sensitivity to wortmannin inhibition"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   754   C0332324:Sensitive to [Functional Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "(Fig. 8C,"

Phrase: "bottom right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.252: Quantitation of these data demonstrated that the maximum insulin-stimulated phosphorylation of IB was 3.2-fold after a 2-h incubation. 

Phrase: "Quantitation of these data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the maximum insulin-stimulated phosphorylation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "3.2-fold after a 2-h incubation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332462:Fold [Spatial Concept]
   744   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.253: Pretreatment of the cells with 50 nM wortmannin maintained insulins ability to phosphorylate IB by 2.2-fold, whereas addition of 1 M wortmannin caused a small, but not statistically significant, increase in insulin response when compared with the control (Fig. 8C, lane 5 vs. 7 and 9). 

Phrase: "Pretreatment of the cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "with 50 nM wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "insulins ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "phosphorylate"

Phrase: "IB by 2.2-fold,"

Phrase: "whereas"

Phrase: "addition of 1 M wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "but"

Phrase: "not statistically significant, increase in insulin response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0020459:INSULIN INCREASE [Disease or Syndrome]
   748   C0442805:Increase [Functional Concept]

Phrase: "when"

Phrase: "compared with the control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 8C,"

Phrase: "lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "vs. 7"

Phrase: "and"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.254: In parallel, reprobing the membranes with an anti-c-Src antibody showed equal amounts of proteins loaded in each lane. 

Phrase: "In parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "reprobing"

Phrase: "the membranes with an anti-c-Src antibody"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0025255:Membranes [Tissue]
   711 E C0596901:Membrane [Cell Component]
   711 E C1706182:Membrane [Manufactured Object]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "equal amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "loaded in each lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.255: Phosphorylation of IB by insulin was clearly reduced with 30 M LY294002 but not with 3 M of the inhibitor (data not shown). 

Phrase: "Phosphorylation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "clearly"

Phrase: "reduced with 30 M LY294002"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0441923:M+ [Intellectual Product]

Phrase: "but"

Phrase: "not with 3 M of the inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1518422:Not [Functional Concept]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.256: It should be noted that treatment of cells with TNF failed to promote significant phosphorylation of PKC-, Akt, and GSK-3 despite marked increase in phosphorylation of IB (Fig. 8C, lanes 1 and 2). 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that treatment of cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with TNF"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "significant phosphorylation of PKC-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "and"

Phrase: "GSK-3 despite marked increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1539922:MARK KINASE [Gene or Genome]

Phrase: "in phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of IB (Fig. 8C,"

Phrase: "lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.257: View larger version (53K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(53K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.258: Insulin-stimulated IB phosphorylation does not require Class I PI3K. 

Phrase: "Insulin-stimulated IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "Class I PI3K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2936824:PI-3K [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0441885:Class I [Classification]
   734   C2698967:Class I [Finding]
Processing 00000000.tx.259: CHO-IR cells were treated with the indicated concentrations of wortmannin for 30 min before stimulation with 10 nM insulin for 2 h. 

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with the indicated concentrations of wortmannin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   748   C0086045:Concentrations [Mental Process]
   748   C1444656:Indicated [Finding]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "before stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with 10 nM insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.260: A, Lysates were analyzed by immunoblotting with antibodies against phosphorylated Akt at Ser-473. 

Phrase: "A,"

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against phosphorylated Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "at Ser-473."
Processing 00000000.tx.261: B, Following band quantitation by densitometry, change in the levels of phosphorylated Akt was calculated and is presented as relative phosphorylation signal of the insulin-stimulated cells without wortmannin (set equal to 1). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "band quantitation by densitometry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "change in the levels of phosphorylated Akt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "and"

Phrase: "is"

Phrase: "presented as relative phosphorylation signal of the insulin-stimulated cells"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   741   C0030281:Insulin Cell [Cell]
   741   C0037083:signal cell [Cell Function]
   739   C0007634:Cells [Cell]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C0449450:Presented [Idea or Concept]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1547039:*Relative [Quantitative Concept]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1710082:Signal [Phenomenon or Process]
   739   C1948023:Stimulated [Natural Phenomenon or Process]
   739   C3282337:Cells [Cell]
   706 E C0150312:Present [Quantitative Concept]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "without wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "(set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "equal to 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0205163:Equal To [Qualitative Concept]
           Equal
   790   C1549782:Equal [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.262: C, CHO-IR cells were treated with vehicle or wortmannin (50 and 1000 nM) for 30 min before stimulation with insulin for 30 and 120 min. 

Phrase: "C,"

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with vehicle"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
   718 E C0445373:Vehicular [Functional Concept]

Phrase: "or"

Phrase: "wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "(50"

Phrase: "and"

Phrase: "1000 nM) for 30 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "before stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 30"

Phrase: "and"

Phrase: "120 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.263: In another set of cells, TNF (10 ng/ml) was added for 5 min. 

Phrase: "In another"

Phrase: "set of cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0007634:Set of cells [Cell]
           Cells set
           Cells
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "TNF (10 ng/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "added for 5 min."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.264: Immunoblotting of cell lysates was performed using phospho-specific antibodies against PKC- (pThr-410), Akt (pSer-473), GSK-3 (pSer-9), and IB (pSer-32). 

Phrase: "Immunoblotting of cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "phospho-specific antibodies against PKC-"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   862   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(pThr-410"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1335272:PTHR [Gene or Genome]
   861   C1419073:PTHR [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "(pSer-473"

Phrase: ")"

Phrase: ","

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(pSer-9"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "IB (pSer-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.265: Comparable aliquots were probed with anti-c-Src to show comparable protein load in each lane. 

Phrase: "Comparable aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "probed with anti-c-Src to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0432624:Anti C [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0432626:Anti c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "comparable protein load in each lane."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1550025:Load [Idea or Concept]
   753   C1704782:Load [Manufactured Object]
   753   C1708715:Load [Activity]
Processing 00000000.tx.266: The levels of phosphorylated IB were quantitated and expressed as fold stimulation over control cells (time = 0). 

Phrase: "The levels of phosphorylated IB"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "quantitated"

Phrase: "and"

Phrase: "expressed as fold stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332462:Fold [Spatial Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1880834:FOLD [Phenomenon or Process]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "over control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "= 0"

Phrase: ")."
Processing 00000000.tx.267: Comparable results were obtained in three (A, B) or two (C) independent experiments. 

Phrase: "Comparable results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in three"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205449:Three [Quantitative Concept]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(A,"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "(C) independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.268: D and E, CHO-IR cells were transiently transfected with empty vector DNA or with the indicated plasmid DNAs (2 g of myc-tagged Akt, 2 g Flag-tagged IB with and without 3 g p85-PI3K), serum-starved, and then stimulated with 10 nM insulin for 2 h. 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with empty vector DNA"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1880497:Empty [Qualitative Concept]
   704 E C0333668:Depleted [Functional Concept]

Phrase: "or with the indicated plasmid DNAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1444656:Indicated [Finding]
   719   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(2 g of myc-tagged Akt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "2 g Flag-tagged IB with"

Phrase: "and without 3 g p85-PI3K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0439267:g% [Quantitative Concept]
   753   C1515981:And [Idea or Concept]
   753   C2936824:PI-3K [Amino Acid, Peptide, or Protein,Enzyme]
   753   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C3541313:p85 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "starved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348531:Starve [Activity]

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stimulated with 10 nM insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.269: Phosphorylation of Akt was detected by immunoprecipitation with c-myc antibody, followed by immunoblotting with phospho-specific Akt (D, upper panel) and anti-c-myc (D, lower panel) antibodies. 

Phrase: "Phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "detected by immunoprecipitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with c-myc antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0368815:C ANTIBODY [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C1963095:c Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0086661:c myc [Gene or Genome]

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with phospho-specific Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]

Phrase: "(D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "anti-c-myc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0432624:Anti C [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0432626:Anti c [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.270: E, Phosphorylation of IB was detected in anti-Flag immunoprecipitates as indicated in the legend of Fig. 

Phrase: "E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Phosphorylation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "detected in anti-Flag immunoprecipitates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1708067:Flag [Functional Concept]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "as"

Phrase: "indicated in the legend of Fig."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0349966:Fig [Food]
   753   C1337208:FIG [Food]
   753   C1444656:Indicated [Finding]
   753   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.271: 7B. 

Phrase: "7B."
Processing 00000000.tx.272: The immunoblots shown in D and E are representative of three independent experiments.  

Phrase: "The immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "shown in D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.273: To assess directly whether class I PI3K played a prominent role in mediating insulin-induced IB phosphorylation, a dominant negative construct of the regulatory subunit of PI3K, p85, (p85) was transiently cotransfected with Flag-tagged IB and myc-tagged Akt1 plasmids in CHO-IR cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "whether"

Phrase: "class I PI3K"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2936824:PI-3K [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0441885:Class I [Classification]
   734   C2698967:Class I [Finding]

Phrase: "played"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0600138:played [Finding]
   966 E C0032214:Play [Daily or Recreational Activity]

Phrase: "a prominent role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "insulin-induced IB phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "a dominant negative construct of the regulatory subunit of PI3K,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2827421:Construct [Classification]

Phrase: "p85,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3541313:p85 [Gene or Genome]

Phrase: "(p85"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538308:p85 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3541313:p85 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "transiently"

Phrase: "cotransfected with Flag-tagged IB"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1708067:Flag [Functional Concept]
   753   C1708632:Tagged [Qualitative Concept]
   753   C1999216:Inhibitor [Qualitative Concept]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "myc-tagged Akt1 plasmids in CHO-IR cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.274: The p85 mutant lacks the ability to bind the catalytic 110-kDa subunit of class I PI3K, thus causing the disruption of a subset of insulin-stimulated responses (24). 

Phrase: "The p85 mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the catalytic 110-kDa subunit of class I PI3K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0600499:Catalytic Subunit [Amino Acid Sequence]
   742   C1711351:Subunit [Quantitative Concept]

Phrase: "thus"

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "the disruption of a subset of insulin-stimulated responses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332453:Disruption [Functional Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.275: Immunocomplexes from untreated and insulin-treated cells were prepared with antibodies against c-myc and Flag and immunoblotted (Fig. 8, D and E). 

Phrase: "Immunocomplexes from untreated"

Phrase: "and"

Phrase: "insulin-treated cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "prepared with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C1521827:Prepare [Functional Concept]

Phrase: "against c-myc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:c myc [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Flag"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708067:Flag [Functional Concept]

Phrase: "and"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(Fig. 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.276: p85 Expression clearly reduced insulin-mediated phosphorylation of Akt (Fig. 8D). 

Phrase: "p85 Expression clearly reduced insulin-mediated phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fig. 8D"

Phrase: ")."
Processing 00000000.tx.277: By contrast, expression of p85 did not reduce basal and insulin-stimulated IB phosphorylation (Fig. 8E). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "expression of p85"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reduce"

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-stimulated IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fig. 8E"

Phrase: ")."
Processing 00000000.tx.278: These data support the hypothesis that Class I PI3K is not required for the insulin-stimulated IB phosphorylation.  

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that Class I PI3K"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2936824:PI-3K [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0441885:Class I [Classification]
   734   C2698967:Class I [Finding]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for the insulin-stimulated IB phosphorylation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0021643:insulin inhibitor [Pharmacologic Substance]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]
   744   C1514873:Required [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1948023:Stimulated [Natural Phenomenon or Process]
   744   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.279: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  NFB activity is modulated largely through phosphorylation and proteolytic degradation of the inhibitory protein IB in response to a number of external stimuli, including TNF (25). 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "NFB activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "modulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulated [Spatial Concept]

Phrase: "largely through phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "proteolytic degradation of the inhibitory protein IB"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0597297:Protein Degradation [Molecular Function]
   767   C0597304:Protein Degradation [Molecular Function]
   767   C1623036:Protein Degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of external stimuli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "TNF (25"

Phrase: ")."
Processing 00000000.tx.280: However, the existence of alternative mechanisms for NFB activation has also been described (26, 27, 28). 

Phrase: "However,"

Phrase: "the existence of alternative mechanisms"

Phrase: "for NFB activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(26,"

Phrase: "27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.281: In the present study, we investigated the signaling pathways by which insulin promotes NFB activity through the regulation of IB. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the signaling pathways by which insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   809   C1512804:Insulin Signaling Pathway [Molecular Function]
   809   C2984300:Insulin signaling pathway [Molecular Function]
   783   C0037080:pathways signaling [Molecular Function]
   773 E C0037083:signaling pathway [Cell Function]
   773 E C0086982:Signaling Pathway [Molecular Function]
   767   C2984427:Insulin Pathway [Functional Concept]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "NFB activity through the regulation of IB."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.282: Insulin appears to be involved in the control of NFB in cells from diverse origins, such as rat hepatoma cells, mouse skeletal C2C12 muscle cell line, and the human vascular endothelial cells (29, 30, 31). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the control of NFB"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   770   C1824728:FACTOR B [Gene or Genome]
   767   C0683951:control factor [Quantitative Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0521447:Nuclear [Spatial Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C3274648:Control [Qualitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "from diverse origins,"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
   861   C0079946:origins [Classification]
   861   C0439659:Origins [Temporal Concept]
   827 E C1550512:origin [Intellectual Product]
   789 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   789 E C0314603:Genetic [Functional Concept]
   777 E C0205313:Original [Idea or Concept]
   777 E C2347409:Original [Occupational Activity]
   768 E C0005615:Birth [Organism Function]
   768 E C0035150:Reproduction [Organism Function]
   768 E C1550722:birth [Idea or Concept]
   768 E C3245487:birth [Intellectual Product]
   755 E C0454729:Natal [Geographic Area]
   755 E C0559522:Genital [Body System]
   755 E C0598240:originality [Mental Process]
   755 E C1546649:Genital [Intellectual Product]
   755 E C1550642:Genital [Body Substance]

Phrase: "such as rat hepatoma cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0677626:hepatoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0023903:Hepatoma [Neoplastic Process]
   827   C2239176:Hepatoma [Neoplastic Process]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "mouse skeletal C2C12 muscle cell line,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   904   C1513528:Mouse Cell Line [Cell]
   827   C0007600:Cell Line [Cell]
   799   C0205132:Line [Spatial Concept]
   799   C1550648:Line [Substance]
   799   C1552960:Line [Quantitative Concept]
   700   C1704336:Skeletal muscle cell [Cell]

Phrase: "and"

Phrase: "the human vascular endothelial cells"
Meta Candidates (Total=22; Excluded=11; Pruned=0; Remaining=11)
   923   C1257792:Vascular Endothelial Cells [Cell]
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   825   C0005773:Blood Cells [Cell]
   825   C0014261:Endothelium, Vascular [Tissue]
   816 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "(29,"

Phrase: "30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.283: Our present study is the first to show that insulin triggers NFB signaling through IKK-independent mechanisms, which involves Ser-32 phosphorylation and ubiquitination of IB without its degradation. 

Phrase: "Our present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "NFB signaling through IKK-independent mechanisms,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037083:Signaling [Cell Function]
   744   C3537152:signaling [Biologic Function]

Phrase: "which"

Phrase: "involves"

Phrase: "Ser-32 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "ubiquitination of IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519751:Ubiquitination [Molecular Function]

Phrase: "without its degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.284: Importantly, the resistance of phosphorylated IB to proteolytic degradation was observed in two insulin-responsive cell models, CHO-IR and HepG2 cells. 

Phrase: "Importantly,"

Phrase: "the resistance of phosphorylated IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]

Phrase: "to proteolytic degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "observed in two insulin-responsive cell models,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   774   C0030281:Insulin Cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205342:Responsive [Functional Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1441672:Observed [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3161035:Models [Intellectual Product]

Phrase: "CHO-IR"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   840   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C1334133:INSULIN RECEPTOR [Gene or Genome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "HepG2 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.285: Based on these findings, we hypothesized that a nonclassical IKK complex may account for phosphorylation of IB by insulin. 

Phrase: "Based on these findings,"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C0243095:Finding [Finding]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "a nonclassical IKK complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "may"

Phrase: "account for phosphorylation of IB"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1551359:account [Idea or Concept]
   753   C1999216:Inhibitor [Qualitative Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.286: Indeed, a key observation of this study is that IB phosphorylation and induction of NFB DNA binding activity can be increased by insulin without detectable activation of IKK or IKK. 

Phrase: "Indeed,"

Phrase: "a key observation of this study"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   783   C0552617:Study observation [Functional Concept]
   753   C0302523:Observation [Research Activity]
   753   C0700325:observation [Health Care Activity]
   753   C1964257:Observation [Diagnostic Procedure]
   748 E C1518527:Observational Study [Research Activity]

Phrase: "is"

Phrase: "that IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "induction of NFB DNA binding activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1621983:induction activity [Cell Function]
   744   C0205263:Induction [Functional Concept]
   744   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "be"

Phrase: "increased by insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   858   C0020459:increased insulin [Disease or Syndrome]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   718 E C1517378:Gain [Quantitative Concept]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "without detectable activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "or"

Phrase: "IKK."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]
Processing 00000000.tx.287: The lack of involvement of the IKK complex in this response of insulin contrasts sharply from our observation that cells treated with TNF are able to activate NFB signaling by IKK-dependent mechanisms, as has been shown in a number of cell types by others. 

Phrase: "The lack of involvement of the IKK complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332268:lack [Qualitative Concept]

Phrase: "in this response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "contrasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "sharply from our observation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with TNF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "NFB signaling by IKK-dependent mechanisms,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037083:Signaling [Cell Function]
   744   C3537152:signaling [Biologic Function]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "shown in a number of cell types"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   793   C0449475:Type of cell [Intellectual Product]
           Cell types
   774   C0007584:Cell Number [Laboratory Procedure]
   757   C1882124:Number Type [Conceptual Entity]
   748   C0007634:Cell [Cell]
       E   Cell Type
   748   C0237753:*Number [Quantitative Concept]
   748   C0332307:Types [Qualitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C1547052:*Type [Quantitative Concept]
   714   C1547282:Show [Intellectual Product]

Phrase: "by others."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]
Processing 00000000.tx.288: There is already evidence that the IKK complex is not involved in NFB nuclear translocation and transactivation in response to a transcription coactivator or UV radiation (32, 33, 34). 

Phrase: "There"

Phrase: "is"

Phrase: "already"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the IKK complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in NFB nuclear translocation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   778   C1824728:FACTOR B [Gene or Genome]
   774   C1518440:Nuclear Translocation [Molecular Function]
   748   C0040715:Translocation [Cell or Molecular Dysfunction]
   748   C0521447:Nuclear [Spatial Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "transactivation in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040624:Transactivation [Genetic Function]

Phrase: "to a transcription coactivator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336776:Transcription Coactivator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "UV radiation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0041625:UV Radiation [Natural Phenomenon or Process]
   861   C0034519:Radiation [Natural Phenomenon or Process]
   861   C0560559:Radiation [Quantitative Concept]
   861   C0851346:Radiation [Natural Phenomenon or Process]
   861   C1522449:Radiation [Therapeutic or Preventive Procedure]
   861   C1524020:Radiation [Therapeutic or Preventive Procedure]
   861   C1524021:Radiation [Research Activity]

Phrase: "(32,"

Phrase: "33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.289: This raises the question of which kinase(s) could account for the phosphorylation of IB by insulin. 

Phrase: "This"

Phrase: "raises"

Phrase: "the question of which kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1522634:Question [Intellectual Product]

Phrase: "("

Phrase: "s)"

Phrase: "could"

Phrase: "account for the phosphorylation of IB"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1551359:account [Idea or Concept]
   748   C1999216:Inhibitor [Qualitative Concept]
   748   C2741673:Account # [Clinical Attribute]
   748   C2981730:Account [Classification]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.290: Our immunofluorescence microscopy data showed that both the constitutive and inducible IB phosphorylation occurred preferentially in the nucleus of CHO-IR and HepG2 cells. 

Phrase: "Our immunofluorescence microscopy data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both the constitutive"

Phrase: "and"

Phrase: "inducible IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "preferentially in the nucleus of CHO-IR"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   760   C0018555:Chinese Hamster [Mammal]
   760   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   760   C1334133:INSULIN RECEPTOR [Gene or Genome]
   739   C0007610:Nucleus [Cell Component]
   739   C0008120:chinese [Language]
   739   C0018557:Hamster [Mammal]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0029939:Ovary [Body Part, Organ, or Organ Component]
   739   C0152035:Chinese [Population Group]
   739   C0227898:ovary [Body Part, Organ, or Organ Component]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C1278992:Ovary [Body Part, Organ, or Organ Component]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and"

Phrase: "HepG2 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.291: Implicit in this model is the ability of IB protein to enter the nucleus via its intrinsic nuclear import sequence (35) and be efficiently phosphorylated by a resident nuclear kinase. 

Phrase: "Implicit in this model"

Phrase: "is"

Phrase: "the ability of IB protein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "enter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "the nucleus via its intrinsic nuclear import sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0887839:nucleus import [Cell Function]
   744   C0007610:Nucleus [Cell Component]

Phrase: "(35"

Phrase: ")"

Phrase: "and"

Phrase: "be"

Phrase: "efficiently"

Phrase: "phosphorylated by a resident nuclear kinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1320928:Resident [Professional or Occupational Group]
   753   C1549439:Resident [Intellectual Product]
   753   C2347958:Resident [Human]
Processing 00000000.tx.292: In this regard, IKK and IKK can be found both in the cytoplasm and the nucleus under certain experimental conditions (36). 

Phrase: "In this regard,"

Phrase: "IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "and"

Phrase: "IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "can"

Phrase: "be"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "both in the cytoplasm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010834:Cytoplasm [Cell Component]
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "the nucleus under certain experimental conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0007610:Nucleus [Cell Component]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.293: Recently, a new IB kinase complex has been cloned (37), thus opening the possibility that this or another new kinase could account for phosphorylation of IB in the cell nucleus, either constitutively or upon cell activation. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a new IB kinase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "has"

Phrase: "been"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "thus"

Phrase: "opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175566:Opening [Spatial Concept]
  1000   C1882151:Opening [Spatial Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "this"

Phrase: "or"

Phrase: "another new kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "could"

Phrase: "account for phosphorylation of IB"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1551359:account [Idea or Concept]
   753   C1999216:Inhibitor [Qualitative Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "in the cell nucleus,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007610:Cell Nucleus [Cell Component]
           Nucleus
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "either constitutively"

Phrase: "or upon cell activation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1326120:cell activation [Cell Function]
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1879547:Activation [Activity]
   770   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.294: An interesting observation is that insulin increases the phosphorylation-dependent IB ubiquitination in the absence of proteolytic degradation. 

Phrase: "An interesting observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the phosphorylation-dependent IB ubiquitination in the absence of proteolytic degradation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1519751:Ubiquitination [Molecular Function]
Processing 00000000.tx.295: This result indirectly indicates that the modified IB was recognized by -TrCP protein, the receptor for the SCF E3 ubiquitin ligase (38, 39) but failed to be marked for proteolysis. 

Phrase: "This result indirectly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "indicates"

Phrase: "that"

Phrase: "the modified IB"

Phrase: "was"

Phrase: "recognized by -TrCP protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the receptor for the SCF E3 ubiquitin ligase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0072470:SCF Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(38,"

Phrase: "39"

Phrase: ")"

Phrase: "but"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "marked for proteolysis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0522501:Marked [Qualitative Concept]
   790   C0597304:Proteolysis [Molecular Function]
   790   C1706089:Marked [Qualitative Concept]
   718 E C1947941:proteolytic [Enzyme]
Processing 00000000.tx.296: A recent study shows that ubiquitin-dependent degradation by the 26S proteasome is strongly inhibited by insulin in HepG2 cells (40). 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that ubiquitin-dependent degradation by the 26S proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "strongly"

Phrase: "inhibited by insulin"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.297: Therefore, insulin-stimulated block of the multicatalytic activity of nuclear 26 S proteasome (41) may promote sustained level of phosphorylated IB in the cell nucleus. 

Phrase: "Therefore,"

Phrase: "insulin-stimulated block of the multicatalytic activity of nuclear 26 S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   736   C0028778:Block [Pathologic Function]
   736   C0332206:Block [Functional Concept]
   736   C1533157:Block [Substance]
   736   C1706084:Block [Geographic Area]
   736   C2828370:Block [Quantitative Concept]

Phrase: "(41"

Phrase: ")"

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "sustained level of phosphorylated IB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "in the cell nucleus."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007610:Cell Nucleus [Cell Component]
           Nucleus
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.298: By contrast, the marked depletion in the nuclear content in IB in response to TNF (He, H.-J., and M. Bernier, unpublished results) may be because of its inability to inhibit proteosomal activity. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the marked depletion in the nuclear content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333668:Depletion [Functional Concept]

Phrase: "in IB"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to TNF ("

Phrase: "He,"

Phrase: "H.-J.,"

Phrase: "and"

Phrase: "M. Bernier,"

Phrase: "unpublished results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: ")"

Phrase: "may"

Phrase: "be because of its inability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2987476:Be [Conceptual Entity]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "proteosomal activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.299: The mechanism by which insulin stimulates NFB despite lack of IB degradation is not known. 

Phrase: "The mechanism by which insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "stimulates"

Phrase: "NFB despite lack of IB degradation"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.300: Because IB ubiquitination per se does not permit dissociation of the inhibitor present in the NFBIkB complex (25), two mechanisms capable of releasing NFB must be considered: phosphorylation of IB at new sites and/or interaction of IB with signaling molecules. 

Phrase: "Because"

Phrase: "IB ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519751:Ubiquitination [Molecular Function]

Phrase: "per se"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "dissociation of the inhibitor present"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "in the NFBIkB complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "two mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "capable of releasing NFB"

Phrase: "must"

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: ":"

Phrase: "phosphorylation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "at new sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "and/or"

Phrase: "interaction of IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with signaling molecules."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1519315:Signaling Molecule [Biologically Active Substance]
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.301: For example, activation of the Ras/Raf-1/MEK/ERK cascade stimulates the activity of the family of 90-kDa ribosomal S6 kinases whose cellular functions include phosphorylation of the N-terminal regulatory domain of IB (42). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "activation of the Ras/Raf-1/MEK/ERK cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1879547:Activation [Activity]

Phrase: "stimulates"

Phrase: "the activity of the family of 90-kDa ribosomal S6 kinases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]
   737   C1150423:kinase activity [Molecular Function]

Phrase: "whose cellular functions"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   983   C0007613:Cellular Function [Cell Function]
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "phosphorylation of the N-terminal regulatory domain of IB (42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0031715:Phosphorylation [Molecular Function]
   738   C1158886:Phosphorylation [Molecular Function]

Phrase: ")."
Processing 00000000.tx.302: However, the data presented here show the ability of insulin to increase phosphorylation of IB on Ser-32 (without its degradation) in CHO-IR/SOS cells despite impaired Ras signaling (12), consistent with the notion that this pathway is not likely to play a major role. 

Phrase: "However,"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "phosphorylation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "on Ser-32"

Phrase: "("

Phrase: "without its degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: ")"

Phrase: "in CHO-IR/SOS cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   894   C0085080:Chinese Hamster Ovary Cell [Cell]
   829   C0030281:Insulin Cell [Cell]
   813   C1514760:Receptor Cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "despite impaired Ras signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "consistent with the notion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "this pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "not likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a major role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.303: In a number of cell lines, insulin stimulates casein kinase II (43) and the atypical PKC- ( 44, 45), two kinases known to phosphorylate IB protein on sites located in the Ankyrin repeat 6 and C-terminal PEST domain, respectively (46). 

Phrase: "In a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "casein kinase II"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0108555:Casein Kinase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0054846:casein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(43"

Phrase: ")"

Phrase: "and"

Phrase: "the atypical PKC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539645:PKC [Gene or Genome]

Phrase: "( 44,"

Phrase: "45"

Phrase: ")"

Phrase: ","

Phrase: "two kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "phosphorylate"

Phrase: "IB protein on sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "located in the Ankyrin repeat 6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0162527:Ankyrin Repeat [Molecular Function]
   753   C0051926:Ankyrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205341:Repeat [Functional Concept]
   753   C1547730:Repeat [Temporal Concept]
   753   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "C-terminal PEST domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "respectively"

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.304: Moreover, a subclass of Ras proteins has been recently shown to regulate the degradation of IB protein (47). 

Phrase: "Moreover,"

Phrase: "a subclass of Ras proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0445604:Subclass [Classification]

Phrase: "has"

Phrase: "been"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "the degradation of IB protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0597297:Protein Degradation [Molecular Function]
   783   C0597304:Protein Degradation [Molecular Function]
   783   C1623036:Protein Degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.305: Our data do not support the possibility that the atypical PKC-, may function as the protein kinase responsible for phosphorylation of IB by insulin because of the ability of low concentrations of wortmannin and LY294002 to block insulin-stimulated phosphorylation of PKC- on Thr-410 without inhibitory effect on IB phosphorylation. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the atypical PKC-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539645:PKC [Gene or Genome]

Phrase: "may"

Phrase: "function as the protein kinase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0815043:function protein [Amino Acid, Peptide, or Protein]
   797   C1527118:Protein Function [Molecular Function]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031843:function [Physiologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "responsible for phosphorylation of IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "because of the ability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085732:Ability [Organism Attribute]
   928 E C1299581:Able [Finding]

Phrase: "of low concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "LY294002 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "insulin-stimulated phosphorylation of PKC-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "on Thr-410"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "without inhibitory effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "on IB phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.306: Although GSK-3 can function as an inducer of NFB-dependent expression of a subset of survival genes (48), the ability of insulin to decrease GSK-3 activity through phosphorylation on Ser-9 (49, 50) is consistent with a model wherein this protein-serine kinase has no significant effect on insulin-stimulated IB phosphorylation. 

Phrase: "Although"

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "function as an inducer of NFB-dependent expression of a subset"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   750   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   750   C1824728:FACTOR B [Gene or Genome]
   749   C0960756:factor A [Organic Chemical]
   735   C0031843:function [Physiologic Function]
   735   C0185117:Expression [Therapeutic or Preventive Procedure]
   735   C0521447:Nuclear [Spatial Concept]
   735   C0542341:Function [Functional Concept]
   735   C0700205:FUNCTION [Classification]
   735   C0851827:Dependent [Qualitative Concept]
   735   C1515021:Subset [Classification]
   735   C1521761:Factor [Functional Concept]
   735   C1701901:Dependent [Qualitative Concept]
   735   C1705273:Function [Intellectual Product]
   735   C2827422:Factor [Conceptual Entity]
   735   C3244310:dependent [Functional Concept]

Phrase: "of survival genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "(48"

Phrase: ")"

Phrase: ","

Phrase: "the ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "GSK-3 activity through phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   840   C2261482:glycogen synthase kinase activity [Molecular Function]
   804   C1152133:glycogen synthase activity [Molecular Function]
   774   C1150423:kinase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "on Ser-9"

Phrase: "(49,"

Phrase: "50"

Phrase: ")"

Phrase: "is"

Phrase: "consistent with a model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "wherein"

Phrase: "this protein-serine kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0072402:Protein-Serine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
   913   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "no significant effect on insulin-stimulated IB phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.307: Others have reported that the tyrosine phosphatase inhibitor pervanadate can activate NFB transcriptional activity through tyrosine phosphorylation of IB without its proteolytic degradation, thus coupling NFB to cellular tyrosine kinase (10). 

Phrase: "Others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the tyrosine phosphatase inhibitor pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "NFB transcriptional activity through tyrosine phosphorylation of IB"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   746   C1148759:transcription factor activity [Genetic Function]
   746   C3537021:Transcription Factor Activity [Molecular Function]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "without its proteolytic degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "thus"

Phrase: "coupling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupling [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "NFB to cellular tyrosine kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   778   C1824728:FACTOR B [Gene or Genome]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.308: A recent study has also established that tyrosine phosphorylation events provide a key determinant for the binding of PI3K on IB that may underlie the release of NFB to the nucleus in response to pervanadate (26). 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "also"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that tyrosine phosphorylation events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]
   734   C1519726:Tyrosine Phosphorylation [Molecular Function]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a key determinant for the binding of PI3K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1521761:Determinant [Functional Concept]

Phrase: "on IB"

Phrase: "that"

Phrase: "may"

Phrase: "underlie"

Phrase: "the release of NFB"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "in response to pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.309: Nevertheless, the physiological significance of these observations is not clear. 

Phrase: "Nevertheless,"

Phrase: "the physiological significance of these observations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.310: Whether tyrosine phosphorylation of IB is induced as part of an insulin-stimulated response toward NFB-activity is unknown. 

Phrase: "Whether"

Phrase: "tyrosine phosphorylation of IB is"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "induced as part of an insulin-stimulated response"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C1292711:Part of [Spatial Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0205263:Induced [Functional Concept]
   744   C0449719:Part [Spatial Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C1709471:Part [Quantitative Concept]
   744   C1948023:Stimulated [Natural Phenomenon or Process]
   744   C2911692:Response [Mental Process]

Phrase: "toward NFB-activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.311: Conflicting results have begun to emerge regarding the role of Akt as a regulator of IKK catalytic activity. 

Phrase: "Conflicting results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "have"

Phrase: "begun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "emerge"

Phrase: "regarding"

Phrase: "the role of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "as a regulator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182953:REGULATOR [Medical Device]
  1000   C1704734:Regulator [Medical Device]
  1000   C1704735:Regulator [Conceptual Entity]

Phrase: "of IKK catalytic activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0243102:catalytic activity [Molecular Function]
   901   C1264638:Catalytic activity [Functional Concept]
   901   C1547012:*Catalytic Activity [Quantitative Concept]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.312: The apparent discrepancy is certainly linked to the fact that the involvement of Akt in NFB signaling is cell type and stimulus specific. 

Phrase: "The apparent discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1290905:Discrepancy [Finding]

Phrase: "is"

Phrase: "certainly"

Phrase: "linked to the fact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "that"

Phrase: "the involvement of Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "in NFB signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "is"

Phrase: "cell type"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007634:Cell Type [Cell]
           Cell
  1000   C0449475:cell type [Intellectual Product]
   861   C0332307:Type [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1547052:*Type [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "stimulus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234402:Stimulus [Phenomenon or Process]

Phrase: "specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]
Processing 00000000.tx.313: Consistent with this idea, activation of NFB by TNF is mediated by a PI3K/Akt pathway in some cell types (19, 51) but not others (20, 52). 

Phrase: "Consistent with this idea,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "activation of NFB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "by TNF"

Phrase: "is"

Phrase: "mediated by a PI3K/Akt pathway"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0812228:AKT [Gene or Genome]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C2936824:PI-3K [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in some cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "(19,"

Phrase: "51"

Phrase: ")"

Phrase: "but"

Phrase: "not others"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1955473:Others [Finding]

Phrase: "(20,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.314: Our data clearly demonstrate the inability of TNF to induce Akt despite marked IKK activation, IB phosphorylation and degradation, and induction of NFB binding activity in CHO-IR cells. 

Phrase: "Our data clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "the inability of TNF to"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Akt despite marked IKK activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0812228:AKT [Gene or Genome]

Phrase: "IB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "induction of NFB binding activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1621983:induction activity [Cell Function]
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in CHO-IR cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   903   C0085080:Chinese Hamster Ovary Cell [Cell]
   822   C0030281:Insulin Cell [Cell]
   810   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.315: Moreover, we have done experiments in HepG2 cells and found efficient regulation of IB by this cytokine without induction of Akt. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "have"

Phrase: "done"

Phrase: "experiments in HepG2 cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "found efficient regulation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by this cytokine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "without induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of Akt."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]
Processing 00000000.tx.316: Another observation of this study is that pharmacological inhibition of Class I PI3K with low concentrations of wortmannin or LY294002 blocked insulin-stimulated Akt phosphorylation and activity but did not translate into reduction in phosphorylation of IB by insulin. 

Phrase: "Another observation of this study"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C0552617:Study observation [Functional Concept]
   762 E C1518527:Observational Study [Research Activity]
   760   C0302523:Observation [Research Activity]
   760   C0700325:observation [Health Care Activity]
   760   C1964257:Observation [Diagnostic Procedure]

Phrase: "is"

Phrase: "that pharmacological inhibition of Class I PI3K"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "with low concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "or"

Phrase: "LY294002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0251991:LY294002 [Organic Chemical,Pharmacologic Substance]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "insulin-stimulated Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "translate into reduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0040710:translate [Occupational Activity]
   790   C0301630:Reduction [Natural Phenomenon or Process]
   790   C0392756:Reduction [Qualitative Concept]
   790   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of IB"

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.317: Furthermore, the dominant negative p85 PI3K mutant also prevented insulin-dependent phosphorylation of Akt but not that of IB. 

Phrase: "Furthermore,"

Phrase: "the dominant negative p85 PI3K mutant also prevented insulin-dependent phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0031715:Phosphorylation [Molecular Function]
   735   C1158886:Phosphorylation [Molecular Function]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "that of IB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.318: Our observation that a kinase-negative mutant of Akt1 failed to disrupt phosphorylation of IB in response to insulin stimulation suggests that endogenous Akt1 activity was not necessary for this reaction to proceed. 

Phrase: "Our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that a kinase-negative mutant of Akt1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "phosphorylation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that endogenous Akt1 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "not necessary for this reaction to"

Phrase: "proceed."
Processing 00000000.tx.319: Thus, it would appear that Class I PI3K and Akt1 are unlikely players in linking activated insulin receptors with the phosphorylation of IB. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "would"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that Class I PI3K"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2936824:PI-3K [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0441885:Class I [Classification]
   734   C2698967:Class I [Finding]

Phrase: "and"

Phrase: "Akt1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0285558:AKT1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT1 [Gene or Genome]

Phrase: "are"

Phrase: "unlikely players in linking activated insulin receptors"

Phrase: "with the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of IB."
Processing 00000000.tx.320: As alluded earlier, low nanomolar concentrations of wortmannin inhibit Class I PI3K activity, whereas high concentrations of this drug can block the function of different classes of PI3K, including Class II PI3K, DNA-dependent protein kinase, and ataxia telangiectasia mutation (53, 54). 

Phrase: "As"

Phrase: "alluded"

Phrase: "earlier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "low nanomolar concentrations of wortmannin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Class I PI3K activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "whereas"

Phrase: "high concentrations of this drug"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0678756:concentrations drug [Quantitative Concept]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "can"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the function of different classes of PI3K,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Class II PI3K,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2936824:PI-3K [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0441886:Class II [Intellectual Product]
   734   C2698968:Class II [Finding]

Phrase: "DNA-dependent protein kinase,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0212694:DNA-dependent protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335262:DNA-DEPENDENT PROTEIN KINASE [Gene or Genome]
   902   C0032545:DNA Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1418707:DNA KINASE [Gene or Genome]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ataxia telangiectasia mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0004135:Ataxia Telangiectasia [Congenital Abnormality,Disease or Syndrome]

Phrase: "(53,"

Phrase: "54"

Phrase: ")."
Processing 00000000.tx.321: A recent study reported that ataxia telangiectasia mutation participates in insulin signaling (55); 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that ataxia telangiectasia mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0004135:Ataxia Telangiectasia [Congenital Abnormality,Disease or Syndrome]

Phrase: "participates in insulin signaling"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0037083:Signaling [Cell Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3537152:signaling [Biologic Function]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.322: hence, this multifunctional protein kinase may trigger activation of IKK-like enzymes with subsequent phosphorylation of IB by insulin. 

Phrase: "hence,"

Phrase: "this multifunctional protein kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "activation of IKK-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "like enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "with subsequent phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "of IB"

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.323: Together, our results show that insulin promotes IB phosphorylation on Ser-32 in an atypical way: the phosphorylation of IB is mediated through a nonclassical IKK complex and is accompanied by ubiquitination without proteolytic degradation. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "IB phosphorylation on Ser-32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "in an atypical way"

Phrase: ":"

Phrase: "the phosphorylation of IB is"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "mediated through a nonclassical IKK complex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0439855:Complex [Qualitative Concept]
   753   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1150571:IKK [Molecular Function]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "is"

Phrase: "accompanied by ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1519751:Ubiquitination [Molecular Function]

Phrase: "without proteolytic degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.324: The mechanisms underlying these events are unclear. 

Phrase: "The mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "these events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "are"

Phrase: "unclear."
Processing 00000000.tx.325: Can the enzymes of the ubiquitination pathway promote different fates for IB in response to insulin and TNF? 

Phrase: "Can"

Phrase: "the enzymes of the ubiquitination pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0598390:enzyme pathway [Molecular Function]
   753   C0014442:Enzymes [Enzyme,Organic Chemical]
   753   C0014445:enzymes [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "different fates for IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1539479:FATE [Gene or Genome]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "TNF?"
Processing 00000000.tx.326: Several ubiquitin-like proteins have recently been discovered that form conjugates with a number of cellular proteins but do not target them to the proteasome for degradation (56). 

Phrase: "Several ubiquitin-like proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0949455:Ubiquitin-Like Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "discovered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880355:Discover [Activity]

Phrase: "that form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "conjugates with a number of cellular proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0007634:Cellular [Cell]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0178539:Cellular [Functional Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0301869:Conjugate [Immunologic Factor]
   748   C0449788:Number [Quantitative Concept]

Phrase: "but"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "them to the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "for degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.327: Possibly, these relatives of ubiquitin may regulate the activity of NFB through selective modification of IB in response to insulin. 

Phrase: "Possibly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "these relatives of ubiquitin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0080103:Relatives [Family Group]
   737 E C0205345:Relative [Qualitative Concept]
   737 E C1547039:*Relative [Quantitative Concept]

Phrase: "may"

Phrase: "regulate"

Phrase: "the activity of NFB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "through selective modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "of IB"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.328: This function of insulin is independent of Ras- and Akt1-stimulated pathways but appears to require a class of PI3K enzymes that has low sensitivity toward wortmannin.  

Phrase: "This function of insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "is independent of Ras-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332291:Independent of [Functional Concept]
   770   C0034678:RAS [Gene or Genome]
   770   C0085862:Independent [Idea or Concept]
   770   C1299583:Independent [Finding]

Phrase: "and"

Phrase: "Akt1-stimulated pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "but"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "require"

Phrase: "a class of PI3K enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456387:Class [Intellectual Product]
   760   C1705943:Class [Classification]

Phrase: "that"

Phrase: "has"

Phrase: "low sensitivity toward wortmannin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.329: Acknowledgments  We thank Drs. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.330: Albert S. 

Phrase: "Albert S."
Processing 00000000.tx.331: Baldwin, Jr., Masato Kasuga, and Motoyoshi Sakaue for the plasmids and a cell line used in this study and Sutapa Kole for excellent technical assistance.  

Phrase: "Baldwin,"

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Masato Kasuga,"

Phrase: "and"

Phrase: "Motoyoshi Sakaue for the plasmids"

Phrase: "and"

Phrase: "a cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "Sutapa Kole for excellent technical assistance."
Processing 00000000.tx.332: Footnotes  Abbreviations: CHO, Chinese hamster ovary; 

Phrase: "Footnotes  Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "CHO,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "Chinese hamster ovary"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.333: CHO-IR, CHO cells expressing the wild-type human IR; 

Phrase: "CHO-IR,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   840   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C1334133:INSULIN RECEPTOR [Gene or Genome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "CHO cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the wild-type human IR"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   884   C1448132:insulin receptor, human [Amino Acid, Peptide, or Protein,Receptor]
   840   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C1334133:INSULIN RECEPTOR [Gene or Genome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0086418:Human [Human]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.334: DN, dominant negative; 

Phrase: "DN, dominant negative"

Phrase: ";"
Processing 00000000.tx.335: GSK, glycogen synthase kinase; 

Phrase: "GSK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1325174:GSK [Molecular Function]

Phrase: "glycogen synthase kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.336: GST, glutathione S-transferase; 

Phrase: "GST,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glutathione S-transferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.337: IB, inhibitor B; 

Phrase: "IB,"

Phrase: "inhibitor B"

Phrase: ";"
Processing 00000000.tx.338: IKK, IB kinase; 

Phrase: "IKK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "IB kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.339: IR, insulin receptor; 

Phrase: "IR,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.340: MBP, myelin basic protein; 

Phrase: "MBP,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   913   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1527178:Basic [Functional Concept]
   755 E C0920750:basicity [Quantitative Concept]

Phrase: "myelin basic protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   913   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1527178:Basic [Functional Concept]
   755 E C0920750:basicity [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.341: MEK, ERK kinase; 

Phrase: "MEK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752313:mek [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ERK kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.342: NFB, nuclear factor B; 

Phrase: "NFB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   901   C1824728:FACTOR B [Gene or Genome]

Phrase: "nuclear factor B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   901   C1824728:FACTOR B [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.343: PSI, proteasomal inhibitor; 

Phrase: "PSI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   865   C2266856:Proteasome Inhibitor [Molecular Function]
   865   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "proteasomal inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   964   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   964   C2266856:Proteasome Inhibitor [Molecular Function]
   964   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.344: PVDF, polyvinylidene difluoride; 

Phrase: "PVDF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071710:polyvinylidene difluoride [Organic Chemical]

Phrase: "polyvinylidene difluoride"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071710:polyvinylidene difluoride [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.345: SFM, serum-free medium; 

Phrase: "SFM,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0009458:Medium [Intellectual Product]
   827   C0229671:Serum [Body Substance]
   827   C0332296:free [Functional Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1705217:Medium [Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   827   C3244283:medium [Intellectual Product]

Phrase: "serum-free medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0009458:Medium [Intellectual Product]
   827   C0229671:Serum [Body Substance]
   827   C0332296:free [Functional Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1705217:Medium [Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   827   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.346: WT, wild-type. 

Phrase: "WT, wild-type."
Processing 00000000.tx.347: Received August 1, 2001. 

Phrase: "Received August 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2001."
Processing 00000000.tx.348: Accepted for publication October 12, 2001.  

Phrase: "Accepted for publication October 12,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2001."
Processing 00000000.tx.349: References Top Abstract Introduction Materials and Methods Results Discussion References  Hetts SW 1998 To die or not to die: an overview of apoptosis and its role in disease. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hetts SW 1998 To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1420193:SW [Gene or Genome]
   812   C1832169:SW [Body System]
   812   C3538902:SW [Gene or Genome]

Phrase: "die"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   944   C0011065:Expired [Organism Function]
   944   C0231800:Expired [Organ or Tissue Function]
   944   C1704631:Expire [Idea or Concept]
   916 E C0184532:dying [Organism Function]
   916 E C1546956:Died [Finding]
   916 E C1553404:terminated [Idea or Concept]
   916 E C2348570:Terminated [Functional Concept]

Phrase: "or"

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "die"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   944   C0011065:Expired [Organism Function]
   944   C0231800:Expired [Organ or Tissue Function]
   944   C1704631:Expire [Idea or Concept]
   916 E C0184532:dying [Organism Function]
   916 E C1546956:Died [Finding]
   916 E C1553404:terminated [Idea or Concept]
   916 E C2348570:Terminated [Functional Concept]

Phrase: ":"

Phrase: "an overview of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0814812:overview [Intellectual Product]

Phrase: "and"

Phrase: "its role in disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.350: JAMA 279:300307[Abstract/Free FullText] Lee-Kwon W, Park D, Baskar PV, Kole S, Bernier M 1998 Antiapoptotic signaling by the insulin receptor in Chinese hamster ovary cells. 

Phrase: "JAMA 279"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ":"

Phrase: "300307"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee-Kwon W,"

Phrase: "Park D,"

Phrase: "Baskar PV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032463:PV [Neoplastic Process]

Phrase: "Kole S,"

Phrase: "Bernier M 1998 Antiapoptotic signaling by the insulin receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1514762:Receptor Signaling [Molecular Function]
   742   C0037083:Signaling [Cell Function]
   742   C3537152:signaling [Biologic Function]

Phrase: "in Chinese hamster ovary cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.351: Biochemistry 37:1574715757[CrossRef][Medline] Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME 1997 Regulation of neuronal survival by the serine-threonine protein kinase Akt. 

Phrase: "Biochemistry 37"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: ":"

Phrase: "1574715757"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dudek H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Datta SR,"

Phrase: "Franke TF,"

Phrase: "Birnbaum MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Yao R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Cooper GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Segal RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Kaplan DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Greenberg"

Phrase: "ME 1997 Regulation of neuronal survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by the serine-threonine protein kinase Akt."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0812228:AKT [Gene or Genome]
   771   C0072402:Serine-Threonine Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Serine-Threonine Kinase
           Serine Kinase
   771   C1335197:serine/threonine-protein kinase [Gene or Genome]
   771   C1367673:serine/threonine protein-kinase [Gene or Genome]
   722   C1414387:serine/threonine kinase [Gene or Genome]
Processing 00000000.tx.352: Science 275:661665[Abstract/Free FullText] Yenush L, Zanella C, Uchida T, Bernal D, White MF 1998 The pleckstrin homology and phosphotyrosine binding domains of insulin receptor substrate 1 mediate inhibition of apoptosis by insulin. 

Phrase: "Science 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "661665"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yenush L,"

Phrase: "Zanella C,"

Phrase: "Uchida T,"

Phrase: "Bernal D,"

Phrase: "White MF 1998"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0007457:White [Population Group]
   827   C0043157:White [Population Group]
   827   C0220938:White [Qualitative Concept]

Phrase: "The pleckstrin homology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1334043:Homology [Gene or Genome]
   861   C2697616:Homology [Qualitative Concept]

Phrase: "and"

Phrase: "phosphotyrosine binding domains of insulin receptor substrate 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   789   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   750   C1515032:Substrate Domain [Amino Acid Sequence]
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "inhibition of apoptosis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1512772:Inhibition of Apoptosis [Cell Function]
           Apoptosis Inhibition
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.353: Mol Cell Biol 18:67846794[Abstract/Free FullText] Diaz B, Serna J, De Pablo F, de la Rosa EJ 2000 In vivo regulation of cell death by embryonic (pro)insulin and the insulin receptor during early retinal neurogenesis. 

Phrase: "Mol Cell Biol 18"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "67846794"

Phrase: "[Abstract/Free FullText"

Phrase: "] Diaz B,"

Phrase: "Serna J,"

Phrase: "De Pablo F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "de la Rosa EJ 2000 In vivo regulation of cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1711228:Regulation of Cell Death [Cell Function]
   738   C0851285:Regulation [Governmental or Regulatory Activity]
   738   C1327622:Regulation [Biologic Function]

Phrase: "by embryonic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013935:Embryonic [Embryonic Structure]

Phrase: "(pro)insulin"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2987124:PRO [Intellectual Product]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the insulin receptor during early retinal neurogenesis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   778   C1334133:INSULIN RECEPTOR [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.354: Development 127:16411649[Abstract/Free FullText] Bertrand F, Atfi A, Cadoret A, LAllemain G, Robin H, Lascols O, Capeau J, Cherqui G 1998 A role for nuclear factor B in the antiapoptotic function of insulin. 

Phrase: "Development 127"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: ":"

Phrase: "16411649"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bertrand F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Atfi A,"

Phrase: "Cadoret A,"

Phrase: "LAllemain G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Robin H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lascols O,"

Phrase: "Capeau J,"

Phrase: "Cherqui G 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "A role for nuclear factor B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the antiapoptotic function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   861   C2986514:antiapoptotic [Chemical Viewed Functionally]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "of insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.355: J Biol Chem 273:29312938[Abstract/Free FullText] Baldwin Jr AS 1996 The NF-B and IB proteins: new discoveries and insights. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "29312938"

Phrase: "[Abstract/Free FullText"

Phrase: "] Baldwin Jr AS 1996"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1708595:Jr [Idea or Concept]
   770   C3280986:JR [Disease or Syndrome]

Phrase: "The NF-B"

Phrase: "and"

Phrase: "IB proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "new discoveries"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1880355:Discovery [Activity]

Phrase: "and"

Phrase: "insights."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233820:insights [Mental Process]
Processing 00000000.tx.356: Annu Rev Immunol 14:649683[CrossRef][Medline] Johnson C, Van Antwerp D, Hope TJ 1999 An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IB. 

Phrase: "Annu Rev Immunol 14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "649683"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnson C,"

Phrase: "Van Antwerp D,"

Phrase: "Hope TJ 1999"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0039247:TJ [Geographic Area]
   827   C0392347:Hope [Mental Process]
   727 E C3540843:Hopefulness [Mental Process]

Phrase: "An N-terminal nuclear export signal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C1563691:Nuclear Export Signal [Amino Acid Sequence]
   840   C0887840:Nuclear Export [Cell Function]
   804   C0521447:Nuclear [Spatial Concept]
   804   C0699789:Export [Phenomenon or Process]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "required for the nucleocytoplasmic shuttling of IB."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0872070:Nucleocytoplasmic Shuttling [Cell Function]
   744   C1514873:Required [Functional Concept]
   744   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.357: EMBO J 18:66826693[Abstract/Free FullText] May MJ, Ghosh S 1998 Signal transduction through NF-B. 

Phrase: "EMBO J 18"

Phrase: ":"

Phrase: "66826693"

Phrase: "[Abstract/Free FullText"

Phrase: "] May MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Ghosh S 1998 Signal transduction through NF-B."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037083:Signal Transduction [Cell Function]
   744   C1160185:transduction [Organism Function]
   744   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.358: Immunol Today 19:8088[CrossRef][Medline] Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JF 1996 Tyrosine phosphorylation of IB- activates NF-B without proteolytic degradation of IB-. 

Phrase: "Immunol Today 19"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0310367:Today [Antibiotic,Organic Chemical]
   827   C0750526:Today [Temporal Concept]
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "8088"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imbert V,"

Phrase: "Rupec RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Livolsi A,"

Phrase: "Pahl HL,"

Phrase: "Traenckner EB,"

Phrase: "Mueller-Dieckmann C,"

Phrase: "Farahifar D,"

Phrase: "Rossi B,"

Phrase: "Auberger P,"

Phrase: "Baeuerle PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Peyron JF 1996 Tyrosine phosphorylation of IB-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1519726:Tyrosine Phosphorylation [Molecular Function]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C1158886:Phosphorylation [Molecular Function]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "NF-B without proteolytic degradation of IB-."
Processing 00000000.tx.359: Cell 86:787798[Medline] Renard P, Percherancier Y, Kroll M, Thomas D, Virelizier JL, Arenzana-Seisdedos F, Bachelerie F 2000 Inducible NF-B activation is permitted by simultaneous degradation of nuclear IB. 

Phrase: "Cell 86"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "787798"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Renard P,"

Phrase: "Percherancier Y,"

Phrase: "Kroll M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Thomas D,"

Phrase: "Virelizier JL,"

Phrase: "Arenzana-Seisdedos F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Bachelerie F 2000 Inducible NF-B activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "permitted by simultaneous degradation of nuclear IB."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0243125:degradation [Functional Concept]
   744   C0329040:permitted [Fish]
   744   C0521115:Simultaneous [Temporal Concept]
   744   C0521447:Nuclear [Spatial Concept]
   744   C0699900:Degradation [Organism Function]
   744   C1548968:Simultaneous [Idea or Concept]
   744   C1999216:Inhibitor [Qualitative Concept]
   711 E C0023636:Permit [Regulation or Law]
Processing 00000000.tx.360: J Biol Chem 275:1519315215[Abstract/Free FullText] Park D, Pandey S, Maksimova E, Kole S, Bernier M 2000 Akt-dependent antiapoptotic action of insulin is sensitive to farnesyltransferase inhibitor. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1519315215"

Phrase: "[Abstract/Free FullText"

Phrase: "] Park D,"

Phrase: "Pandey S,"

Phrase: "Maksimova E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Kole S,"

Phrase: "Bernier M 2000 Akt-dependent antiapoptotic action of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441472:Action [Functional Concept]
   742   C3266814:Action [Activity]

Phrase: "is"

Phrase: "sensitive to farnesyltransferase inhibitor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.361: Biochemistry 39:1251312521[CrossRef][Medline] Pessara U, Koch N 1990 Tumor necrosis factor alpha regulates expression of the major histocompatibility complex class II-associated invariant chain by binding of an NF-B-like factor to a promoter element. 

Phrase: "Biochemistry 39"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: ":"

Phrase: "1251312521"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pessara U,"

Phrase: "Koch N 1990 Tumor necrosis factor alpha"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   877   C0041368:tumor necrosis factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           tumor necrosis factor
   877   C1168005:Tumor Necrosis Factor alpha [Laboratory Procedure]
   877   C1456820:Tumor Necrosis Factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumour necrosis factor
   845   C1323304:tumor necrosis factor [Molecular Function]
   818   C0333516:Tumor necrosis [Neoplastic Process]
   795   C0027540:Necrosis [Organ or Tissue Function]
   795   C0027651:Tumor [Neoplastic Process]
   795   C0439095:Alpha [Intellectual Product]
   795   C1334928:Necrosis [Finding]
   795   C1521761:Factor [Functional Concept]
   795   C1578706:Tumor [Intellectual Product]
   795   C2003941:Alpha [Intellectual Product]
   795   C2350010:Alpha [Qualitative Concept]
   795   C2827422:Factor [Conceptual Entity]
   795   C3273930:Tumor [Finding]

Phrase: "regulates"

Phrase: "expression of the major histocompatibility complex class II-associated invariant chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "of an NF-B-"

Phrase: "like factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "to a promoter element."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]
Processing 00000000.tx.362: Mol Cell Biol 10:41464154[Medline] Bertrand F, Philippe C, Antoine PJ, Baud L, Groyer A, Capeau J, Cherqui G 1995 Insulin activates nuclear factor B in mammalian cells through a Raf-1-mediated pathway. 

Phrase: "Mol Cell Biol 10"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "41464154"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bertrand F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Philippe C,"

Phrase: "Antoine PJ,"

Phrase: "Baud L,"

Phrase: "Groyer A,"

Phrase: "Capeau J,"

Phrase: "Cherqui G 1995 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "nuclear factor B in mammalian cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   790   C1824728:FACTOR B [Gene or Genome]

Phrase: "through a Raf-1-mediated pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.363: J Biol Chem 270:2443524441[Abstract/Free FullText] Muller MM, Schreiber E, Schaffner W, Matthias P 1989 Rapid test for in vivo stability and DNA binding of mutated octamer binding proteins with "mini-extract" prepared from transfected cells. 

Phrase: "J Biol Chem 270"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2443524441"

Phrase: "[Abstract/Free FullText"

Phrase: "] Muller MM,"

Phrase: "Schreiber E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Schaffner W,"

Phrase: "Matthias P 1989 Rapid test for in vivo stability"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   784   C1511124:in vivo test [Laboratory Procedure]
   742   C0022885:Test [Laboratory Procedure]
   742   C0039593:Test [Functional Concept]
   742   C0392366:test [Intellectual Product]
   742   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "DNA binding of mutated octamer binding proteins"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   804   C0012940:DNA-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788 E C0812382:DNA-binding protein [Gene or Genome]
   778   C1148673:DNA Binding [Genetic Function]
   774   C0058610:dna proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0033618:Protein Binding [Molecular Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "with ""mini-extract"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]

Phrase: "prepared from transfected cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.364: Nucleic Acids Res 17:6420[Medline] Uhlik M, Good L, Xiao G, Harhaj EW, Zandi E, Karin M, Sun SC 1998 NF-B-inducing kinase and IB kinase participate in human T-cell leukemia virus I Tax-mediated NF-B activation. 

Phrase: "Nucleic Acids Res 17"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0001128:Acids [Chemical]
   812   C0007610:Nucleic [Cell Component]
   812   C2347379:RES [Finding]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "6420"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Uhlik M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Good L,"

Phrase: "Xiao G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Harhaj EW,"

Phrase: "Zandi E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Karin M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sun SC 1998 NF-B-inducing kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "IB kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "participate"

Phrase: "in human T-cell leukemia virus I Tax-mediated NF-B activation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   883   C1155065:T-Cell Activation [Cell Function]
   870   C1326120:cell activation [Cell Function]
   850   C0042767:Virus Activation [Biologic Function]
   788   C1879547:Activation [Activity]
   704   C0020094:T-Cell Leukemia Virus I, Human [Virus]
Processing 00000000.tx.365: J Biol Chem 273:2113221136[Abstract/Free FullText] Figueiredo-Pereira ME, Berg KA, Wilk S 1994 A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2113221136"

Phrase: "[Abstract/Free FullText"

Phrase: "] Figueiredo-Pereira"

Phrase: "ME,"

Phrase: "Berg KA,"

Phrase: "Wilk S 1994"

Phrase: "A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C1152591:chymotrypsin inhibitor activity [Molecular Function]
   762   C2673177:proteinase inhibitor activity [Molecular Function]
           proteinase inhibitor
   749   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   749   C0596337:chymotrypsin inhibitor [Pharmacologic Substance]
   749   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   735   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: ")"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "accumulation of ubiquitin-protein"

Phrase: "conjugates in a neuronal cell."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C0301869:Conjugate [Immunologic Factor]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.366: J Neurochem 63:15781581[Medline] Griscavage JM, Wilk S, Ignarro LJ 1996 Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-B. 

Phrase: "J Neurochem 63"

Phrase: ":"

Phrase: "15781581"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Griscavage JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Wilk S,"

Phrase: "Ignarro LJ 1996 Inhibitors of the proteasome pathway"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   767   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   767   C2266856:Proteasome Inhibitors [Molecular Function]
   750 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   744   C0243077:inhibitors [Chemical Viewed Functionally]
   711 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "interfere with induction of nitric oxide synthase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0030015:oxide [Inorganic Chemical]
   748   C0205263:Induction [Functional Concept]
   748   C0521102:Interfere [Qualitative Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
   748   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "in macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "by blocking activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of transcription factor NF-B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   875   C1824728:FACTOR B [Gene or Genome]
Processing 00000000.tx.367: Proc Natl Acad Sci USA 93:33083312[Abstract/Free FullText] Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB 1999 NF-B activation by tumour necrosis factor requires the Akt serine-threonine kinase. 

Phrase: "Proc Natl Acad Sci USA 93"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "33083312"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ozes ON,"

Phrase: "Mayo LD,"

Phrase: "Gustin JA,"

Phrase: "Pfeffer SR,"

Phrase: "Pfeffer LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Donner DB 1999 NF-B activation by tumour necrosis factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1519684:Tumor Necrosis Factor Activation [Physiologic Function]
   739   C1879547:Activation [Activity]

Phrase: "requires"

Phrase: "the Akt serine-threonine kinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0072402:Serine-Threonine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
   923   C1414387:serine/threonine kinase [Gene or Genome]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.368: Nature 401:8285[CrossRef][Medline] Romashkova JA, Makarov SS 1999 NF-B is a target of AKT in anti-apoptotic PDGF signalling. 

Phrase: "Nature 401"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "8285"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Romashkova JA,"

Phrase: "Makarov SS 1999 NF-B is"

Phrase: "a target of AKT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in anti-apoptotic PDGF signalling."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C3537152:signalling [Biologic Function]
   779 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.369: Nature 401:8690[CrossRef][Medline] Vanhaesebroeck B, Alessi DR 2000 The PI3K-PDK1 connection: more than just a road to PKB. 

Phrase: "Nature 401"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "8690"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vanhaesebroeck B,"

Phrase: "Alessi DR 2000"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0031831:DR [Professional or Occupational Group]
   827   C1707664:DR [Biomedical or Dental Material]
   827   C2348314:Dr. [Conceptual Entity]
   827   C3540849:DR [Idea or Concept]

Phrase: "The PI3K-PDK1 connection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449379:Connection [Intellectual Product]

Phrase: ":"

Phrase: "more than just"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205172:More [Functional Concept]

Phrase: "a road to PKB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442650:Road [Manufactured Object]
Processing 00000000.tx.370: Biochem J 346:561576[CrossRef][Medline] Hemmings BA 1997 Akt signaling: linking membrane events to life and death decisions. 

Phrase: "Biochem J 346"

Phrase: ":"

Phrase: "561576"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hemmings BA 1997 Akt signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]

Phrase: ":"

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "membrane events to life and death decisions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0557155:Life events [Organism Attribute]
   748   C0441471:Events [Event]
   748   C3541888:Events [Classification]
Processing 00000000.tx.371: Science 275:628630[Free FullText] Pessin JE, Saltiel AR 2000 Signaling pathways in insulin action: molecular targets of insulin resistance. 

Phrase: "Science 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "628630"

Phrase: "[Free FullText"

Phrase: "] Pessin JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Saltiel AR 2000 Signaling pathways in insulin action"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   782   C1512804:Insulin Signaling Pathway [Molecular Function]
   782   C2984300:Insulin signaling pathway [Molecular Function]
   767   C0037080:pathways signaling [Molecular Function]
   754 E C0037083:signaling pathway [Cell Function]
   754 E C0086982:Signaling Pathway [Molecular Function]
   750   C2984427:Insulin Pathway [Functional Concept]
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]

Phrase: ":"

Phrase: "molecular targets of insulin resistance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.372: J Clin Invest 106:165169[Free FullText] Hara K, Yonezawa K, Sakaue H, Ando A, Kotani K, Kitamura T, Kitamura Y, Ueda H, Stephens L, Jackson TR, Hawkins PT, Dhand R, Clark AE, Holman GD, Waterfield MD, Kasuga M 1994 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "106"

Phrase: ":"

Phrase: "165169"

Phrase: "[Free FullText"

Phrase: "] Hara K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yonezawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sakaue H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ando A,"

Phrase: "Kotani K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kitamura T,"

Phrase: "Kitamura Y,"

Phrase: "Ueda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Stephens L,"

Phrase: "Jackson TR,"

Phrase: "Hawkins PT,"

Phrase: "Dhand R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Clark AE,"

Phrase: "Holman GD,"

Phrase: "Waterfield MD,"

Phrase: "Kasuga M 1994 1-Phosphatidylinositol 3-kinase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   842   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   812   C1150423:kinase activity [Molecular Function]
   793   C0205177:Activity [Functional Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "required for insulin-stimulated glucose transport"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0178666:glucose transport [Cell Function]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   753   C0005528:Transport, NOS [Cell Function]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1317949:Transport [Manufactured Object]
   753   C1514873:Required [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C3495449:transport [Medical Device]

Phrase: "but"

Phrase: "not for RAS activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034678:RAS [Gene or Genome]
   770   C1518422:Not [Functional Concept]
   770   C1879547:Activation [Activity]

Phrase: "in CHO cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.373: Proc Natl Acad Sci USA 191:74157419 Karin M, Ben-Neriah Y 2000 Phosphorylation meets ubiquitination: the control of NF-B activity. 

Phrase: "Proc Natl Acad Sci USA 191"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "74157419 Karin M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Ben-Neriah Y 2000 Phosphorylation meets ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1519751:Ubiquitination [Molecular Function]

Phrase: ":"

Phrase: "the control of NF-B activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   748   C1706449:Active Control [Research Activity]
Processing 00000000.tx.374: Annu Rev Immunol 18:621663[CrossRef][Medline] Beraud C, Henzel WJ, Baeuerle PA 1999 Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-B activation. 

Phrase: "Annu Rev Immunol 18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "621663"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Beraud C,"

Phrase: "Henzel WJ,"

Phrase: "Baeuerle PA 1999 Involvement of regulatory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "and"

Phrase: "catalytic subunits of phosphoinositide 3-kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600499:Subunits, Catalytic [Amino Acid Sequence]
   719   C1711351:Subunit [Quantitative Concept]

Phrase: "in NF-B activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]
Processing 00000000.tx.375: Proc Natl Acad Sci USA 96:429434[Abstract/Free FullText] Martin AG, Fresno M 2000 Tumor necrosis factor- activation of NF-B requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel. 

Phrase: "Proc Natl Acad Sci USA 96"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "429434"

Phrase: "[Abstract/Free FullText"

Phrase: "] Martin AG,"

Phrase: "Fresno M 2000 Tumor necrosis factor- activation of NF-B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1519684:Tumor Necrosis Factor Activation [Physiologic Function]
   739   C1879547:Activation [Activity]

Phrase: "requires"

Phrase: "the phosphorylation of Ser-471"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "in the transactivation domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040624:Transactivation [Genetic Function]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "of c-Rel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035018:C-REL [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.376: J Biol Chem 275:2438324391[Abstract/Free FullText] Bergmann M, Hart L, Lindsay M, Barnes PJ, Newton R 1998 IB Degradation and NF-B DNA binding are insufficient for interleukin-1 and tumor necrosis factor--induced B-dependent transcription: requirement for an additional activation pathway. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2438324391"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bergmann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hart L,"

Phrase: "Lindsay M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Barnes PJ,"

Phrase: "Newton R 1998 IB Degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0243125:degradation [Functional Concept]
   799   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "NF-B DNA binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1148673:DNA Binding [Genetic Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "are"

Phrase: "insufficient for interleukin-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205412:Insufficient [Qualitative Concept]
   770   C0231180:Insufficient [Qualitative Concept]

Phrase: "and"

Phrase: "tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "--"

Phrase: "induced B-dependent transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040649:Transcription [Genetic Function]

Phrase: ":"

Phrase: "requirement for an additional activation pathway."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514873:Requirement [Functional Concept]
Processing 00000000.tx.377: J Biol Chem 273:66076610[Abstract/Free FullText] Zhou G, Kuo MT 1997 NF-B-mediated induction of mdr1b expression by insulin in rat hepatoma cells. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "66076610"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhou G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kuo MT 1997 NF-B-mediated induction of mdr1b expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205263:Induction [Functional Concept]
   739   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in rat hepatoma cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0677626:hepatoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0023903:Hepatoma [Neoplastic Process]
   827   C2239176:Hepatoma [Neoplastic Process]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.378: J Biol Chem 272:1517415183[Abstract/Free FullText] Conejo R, Valverde AM, Benito M, Lorenzo M 2001 Insulin produces myogenesis in C2C12 myoblasts by induction of NF-B and downregulation of AP-1 activities. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1517415183"

Phrase: "[Abstract/Free FullText"

Phrase: "] Conejo R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Valverde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0651652:Valverde [Biologically Active Substance,Pharmacologic Substance]

Phrase: "AM"

Phrase: ","

Phrase: "Benito M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lorenzo M 2001 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "produces"

Phrase: "myogenesis in C2C12 myoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596997:Myogenesis [Organ or Tissue Function]

Phrase: "by induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of NF-B"

Phrase: "and"

Phrase: "downregulation of AP-1 activities."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013081:Down-Regulation [Cell Function,Molecular Function]
Processing 00000000.tx.379: J Cell Physiol 186:8294[CrossRef][Medline] De Mattia G, Bravi MC, Costanzo A, Laurenti O, Cassone Faldetta M, Armiento A, De Luca O, Ferri C 1999 Effects of insulin on in vitro vascular cell adhesion molecule-1 expression and in vivo soluble VCAM-1 release. 

Phrase: "J Cell Physiol 186"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "8294"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] De Mattia G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Bravi MC,"

Phrase: "Costanzo A,"

Phrase: "Laurenti O,"

Phrase: "Cassone Faldetta M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Armiento A,"

Phrase: "De Luca O,"

Phrase: "Ferri C 1999 Effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on in vitro vascular cell adhesion molecule-1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0185117:Expression [Therapeutic or Preventive Procedure]
   723   C0078056:Vascular Cell Adhesion Molecule-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   723   C1421435:VASCULAR CELL ADHESION MOLECULE 1 [Gene or Genome]

Phrase: "and"

Phrase: "in vivo soluble VCAM-1 release."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0030685:Release [Health Care Activity]
   799   C0391871:Release [Functional Concept]
   799   C0439180:% release [Quantitative Concept]
   799   C0680255:release [Health Care Activity]
   799   C1283071:Release [Functional Concept]
   799   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.380: Diabetologia 42:12351239[CrossRef][Medline] Purcell NH, Yu C, He D, Xiang J, Paran N, DiDonato JA, Yamaoka S, Shaul Y, Lin A 2001 Activation of NF-B by hepatitis B virus X protein through an IB kinase-independent mechanism. 

Phrase: "Diabetologia 42"

Phrase: ":"

Phrase: "12351239"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Purcell NH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0268059:NH [Disease or Syndrome]

Phrase: "Yu C,"

Phrase: "He D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Xiang J,"

Phrase: "Paran N,"

Phrase: "DiDonato JA,"

Phrase: "Yamaoka S,"

Phrase: "Shaul Y,"

Phrase: "Lin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "A 2001 Activation of NF-B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "by hepatitis B virus X protein"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
  1000   C0062529:hepatitis B virus X protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Hepatitis B Virus-X
           Hepatitis B X-Protein
   884   C0019169:Hepatitis B Virus [Virus]
   853   C0019186:Hepatitis virus [Virus]
   853   C0042736:Virus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0019163:Hepatitis B [Disease or Syndrome]
   840   C0019378:B Virus [Virus]
   804   C0019158:Hepatitis [Disease or Syndrome]
   804   C0019159:hepatitis [Disease or Syndrome]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0042776:Virus [Virus]
   804   C0319157:virus [Virus]
   804   C0795623:hepatitis [Immunologic Factor,Pharmacologic Substance]

Phrase: "through an IB kinase-independent mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441712:Mechanism [Functional Concept]
   804   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.381: Am J Physiol Gastrointest Liver Physiol 280:G669G677 Bender K, Gottlicher M, Whiteside S, Rahmsdorf HJ, Herrlich P 1998 Sequential DNA damage-independent and -dependent activation of NF-B by UV. 

Phrase: "Am"

Phrase: "J Physiol Gastrointest Liver Physiol 280"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   799   C0023884:Liver [Body Part, Organ, or Organ Component]
   799   C0736268:LIVER [Body Part, Organ, or Organ Component]
   799   C1278929:Liver [Body Part, Organ, or Organ Component]
   799   C2346688:LIVER [Food]
   743 E C0205054:Hepatic [Body Location or Region]

Phrase: ":"

Phrase: "G669G677 Bender K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Gottlicher M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Whiteside S,"

Phrase: "Rahmsdorf HJ,"

Phrase: "Herrlich P 1998 Sequential DNA damage-independent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0085862:Independent [Idea or Concept]
   795   C1299583:Independent [Finding]

Phrase: "and -"

Phrase: "dependent activation of NF-B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "by UV."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041625:UV [Natural Phenomenon or Process]
  1000   C1961129:uV [Quantitative Concept]
Processing 00000000.tx.382: EMBO J 17:51705181[Abstract/Free FullText] Li N, Karin M 1998 Ionizing radiation and short wavelength UV activate NF-B through two distinct mechanisms. 

Phrase: "EMBO J 17"

Phrase: ":"

Phrase: "51705181"

Phrase: "[Abstract/Free FullText"

Phrase: "] Li N,"

Phrase: "Karin M 1998 Ionizing radiation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0034538:Ionising radiation [Natural Phenomenon or Process]
   804   C0034519:Radiation [Natural Phenomenon or Process]
   804   C0560559:Radiation [Quantitative Concept]
   804   C0851346:Radiation [Natural Phenomenon or Process]
   804   C1522449:Radiation [Therapeutic or Preventive Procedure]
   804   C1524020:Radiation [Therapeutic or Preventive Procedure]
   804   C1524021:Radiation [Research Activity]

Phrase: "and"

Phrase: "short wavelength UV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041625:UV [Natural Phenomenon or Process]
   827   C1961129:uV [Quantitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "NF-B through two distinct mechanisms."
Processing 00000000.tx.383: Proc Natl Acad Sci USA 95:1301213017[Abstract/Free FullText] Sachdev S, Hoffmann A, Hannink M 1998 Nuclear localization of IB is mediated by the second ankyrin repeat: the IB ankyrin repeats define a novel class of cis-acting nuclear import sequences. 

Phrase: "Proc Natl Acad Sci USA 95"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1301213017"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sachdev S,"

Phrase: "Hoffmann A,"

Phrase: "Hannink M 1998 Nuclear localization of IB is"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]

Phrase: "mediated by the second ankyrin repeat"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0162527:Ankyrin Repeat [Molecular Function]
   753   C0051926:Ankyrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0205341:Repeat [Functional Concept]
   753   C0205436:Second [Quantitative Concept]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C1547730:Repeat [Temporal Concept]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]
   753   C1705914:Repeat [Conceptual Entity]

Phrase: ":"

Phrase: "the IB ankyrin repeats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0162527:Ankyrin Repeats [Molecular Function]
   812   C0205341:repeats [Functional Concept]
   812   C1705914:Repeats [Conceptual Entity]
   779 E C1547730:Repeat [Temporal Concept]

Phrase: "define"

Phrase: "a novel class of cis-acting nuclear import sequences."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0456387:Class [Intellectual Product]
   742   C1705943:Class [Classification]
Processing 00000000.tx.384: Mol Cell Biol 18:25242534[Abstract/Free FullText] Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M 1997 The IB kinase complex (IKK) contains two kinase subunits, IKK and IKK, necessary for IB phosphorylation and NF-B activation. 

Phrase: "Mol Cell Biol 18"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "25242534"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zandi E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Rothwarf DM,"

Phrase: "Delhase M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hayakawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Karin M 1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "The IB kinase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: ")"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "two kinase subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "and"

Phrase: "IKK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "necessary for IB phosphorylation"

Phrase: "and"

Phrase: "NF-B activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]
Processing 00000000.tx.385: Cell 91:243252[Medline] Shimada T, Kawai T, Takeda K, Matsumoto M, Inoue J, Tatsumi Y, Kanamaru A, Akira S 1999 IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IB kinases. 

Phrase: "Cell 91"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "243252"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimada T,"

Phrase: "Kawai T,"

Phrase: "Takeda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Matsumoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Inoue J,"

Phrase: "Tatsumi Y,"

Phrase: "Kanamaru A,"

Phrase: "Akira S 1999 IKK-i,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1422750:IKK-i [Gene or Genome]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "a novel lipopolysaccharide-inducible kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "is"

Phrase: "related to IB kinases."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   781   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   781   C3537023:kinase inhibitor [Molecular Function]
   781   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1999216:Inhibitor [Qualitative Concept]
   726 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.386: Int Immunol 11:13571362[Abstract/Free FullText] Spencer E, Jiang J, Chen ZJ 1999 Signal-induced ubiquitination of IB by the F-box protein Slimb/-TrCP. 

Phrase: "Int Immunol 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0063789:INT [Organic Chemical]
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
   827   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "13571362"

Phrase: "[Abstract/Free FullText"

Phrase: "] Spencer E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Jiang J,"

Phrase: "Chen ZJ 1999 Signal-induced ubiquitination of IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1519751:Ubiquitination [Molecular Function]

Phrase: "by the F-box protein Slimb/-TrCP."
Processing 00000000.tx.387: Genes Dev 13:284294[Abstract/Free FullText] Kroll M, Margottin F, Kohl A, Renard P, Durand H, Concordet JP, Bachelerie F, Arenzana-Seisdedos F, Benarous R 1999 Inducible degradation of IB by the proteasome requires interaction with the F-box protein h-TrCP. 

Phrase: "Genes Dev 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "284294"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kroll M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Margottin F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Kohl A,"

Phrase: "Renard P,"

Phrase: "Durand H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Concordet JP,"

Phrase: "Bachelerie F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Arenzana-Seisdedos F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Benarous R 1999 Inducible degradation of IB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "by the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "requires"

Phrase: "interaction with the F-box protein h-TrCP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0872079:interaction protein [Molecular Function]
   744   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.388: J Biol Chem 274:79417945[Abstract/Free FullText] Bennett RG, Hamel FG, Duckworth WC 2000 Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "79417945"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Duckworth WC 2000 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the ubiquitin-dependent degrading activity of the 26S proteasome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1325411:ubiquitin activity [Molecular Function]
   762   C1622946:proteasome activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.389: Endocrinology 141:25082517[Abstract/Free FullText] Reits EA, Benham AM, Plougastel B, Neefjes J, Trowsdale J 1997 Dynamics of proteasome distribution in living cells. 

Phrase: "Endocrinology 141"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "25082517"

Phrase: "[Abstract/Free FullText"

Phrase: "] Reits EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Benham"

Phrase: "AM"

Phrase: ","

Phrase: "Plougastel B,"

Phrase: "Neefjes J,"

Phrase: "Trowsdale J 1997 Dynamics of proteasome distribution"

Phrase: "in living cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.390: EMBO J 16:60876094[Abstract/Free FullText] Ghoda L, Lin X, Greene WC 1997 The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IB and stimulates its degradation in vitro. 

Phrase: "EMBO J 16"

Phrase: ":"

Phrase: "60876094"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ghoda L,"

Phrase: "Lin X,"

Phrase: "Greene WC 1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013123:WC [Organism Function]
   827   C2825512:WC [Quantitative Concept]

Phrase: "The 90-kDa ribosomal S6 kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(pp90rsk"

Phrase: ")"

Phrase: "phosphorylates"

Phrase: "the N-terminal regulatory domain of IB"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0220905:regulatory [Regulation or Law]
   744   C1704735:Regulatory [Conceptual Entity]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "stimulates"

Phrase: "its degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.391: J Biol Chem 272:2128121288[Abstract/Free FullText] Kim SJ, Kahn CR 1997 Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2128121288"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kim SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Kahn CR 1997 Insulin regulation of mitogen-activated protein kinase kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0851285:Regulation [Governmental or Regulatory Activity]
   738   C1327622:Regulation [Biologic Function]

Phrase: "(MEK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752313:mek [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "casein kinase in the cell nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0054846:casein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "a possible role in the regulation of gene expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.392: Biochem J 323:621627[Medline] Mendez R, Kollmorgen G, White MF, Rhoads RE 1997 Requirement of protein kinase C for stimulation of protein synthesis by insulin. 

Phrase: "Biochem J 323"

Phrase: ":"

Phrase: "621627"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mendez R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kollmorgen G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "White MF,"

Phrase: "Rhoads RE 1997 Requirement of protein kinase C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0556043:Protein requirement [Finding]
   744   C1514873:Requirement [Functional Concept]

Phrase: "for stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.393: Mol Cell Biol 17:51845192[Abstract] Bandyopadhyay G, Standaert ML, Sajan MP, Karnitz LM, Cong L, Quon MJ, Farese RV 1999 Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-. 

Phrase: "Mol Cell Biol 17"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "51845192"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bandyopadhyay G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Standaert ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Sajan MP,"

Phrase: "Karnitz LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Cong L,"

Phrase: "Quon MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Farese RV 1999 Dependence of insulin-stimulated glucose transporter 4 translocation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0011546:Dependence [Mental Process]
   738   C0439857:Dependence [Mental or Behavioral Dysfunction]
   738   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "on 3-phosphoinositide-dependent protein kinase-1"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
  1000   C0541150:3-Phosphoinositide Dependent Protein Kinase-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335204:3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 [Gene or Genome]
   947   C0538677:3-phosphoinositide-dependent protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0089793:Phosphoinositide Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031621:phosphoinositide [Biologically Active Substance,Lipid]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439086:<3 [Quantitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C2827736:3+ [Quantitative Concept]
   799   C2981702:3+ [Classification]
   799   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "its target threonine-410 in the activation loop"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0419518:Loop [Medical Device]
   744   C0445022:Loop [Spatial Concept]
   744   C1521840:Target [Functional Concept]
   744   C1879547:Activation [Activity]
   744   C2986546:TARGET [Diagnostic Procedure]

Phrase: "of protein kinase C-."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.394: Mol Endocrinol 13:17661772[Abstract/Free FullText] Pando MP, Verma IM 2000 Signal-dependent and -independent degradation of free and NF-B-bound IB. 

Phrase: "Mol Endocrinol 13"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "17661772"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pando MP,"

Phrase: "Verma IM 2000 Signal-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0851827:Dependent [Qualitative Concept]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]

Phrase: "and -"

Phrase: "independent degradation of free"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "NF-B-bound IB."
Processing 00000000.tx.395: J Biol Chem 275:212781286[Abstract/Free FullText] Fenwick C, Na SY, Voll RE, Zhong H, Im SY, Lee JW, Ghosh S 2000 A subclass of Ras proteins that regulate the degradation of IB. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "212781286"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fenwick C,"

Phrase: "Na SY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039138:SY [Geographic Area]
   861   C1706466:SY [Intellectual Product]

Phrase: "Voll RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Zhong H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Im SY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039138:SY [Geographic Area]
   861   C1706466:SY [Intellectual Product]

Phrase: "Lee JW,"

Phrase: "Ghosh S 2000"

Phrase: "A subclass of Ras proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0445604:Subclass [Classification]

Phrase: "that"

Phrase: "regulate"

Phrase: "the degradation of IB."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.396: Science 287:869873[Abstract/Free FullText] Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR 2000 Requirement for glycogen synthase kinase-3 in cell survival and NF-B activation. 

Phrase: "Science 287"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "869873"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoeflich KP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022772:KP [Geographic Area]
   861   C1881334:kp [Quantitative Concept]

Phrase: "Luo J,"

Phrase: "Rubie EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Tsao MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Jin O,"

Phrase: "Woodgett JR 2000 Requirement for glycogen synthase kinase-3 in cell survival"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1514873:Requirement [Functional Concept]

Phrase: "and"

Phrase: "NF-B activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]
Processing 00000000.tx.397: Nature 406:8690[CrossRef][Medline] Summers SA, Kao AW, Kohn AD, Backus GS, Roth RA, Pessin JE, Birnbaum MJ 1999 The role of glycogen synthase kinase 3 in insulin-stimulated glucose metabolism. 

Phrase: "Nature 406"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "8690"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Summers SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Kao AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Kohn AD,"

Phrase: "Backus GS,"

Phrase: "Roth RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Pessin JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Birnbaum MJ 1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0733411:MJ-1999 [Organic Chemical,Pharmacologic Substance]
   827   C0439254:MJ [Medical Device]

Phrase: "The role of glycogen synthase kinase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in insulin-stimulated glucose metabolism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C3547575:insulin metabolism [Molecular Function]
   861   C0596620:glucose metabolism [Molecular Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.398: J Biol Chem 274:1793417940[Abstract/Free FullText] Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Cherqui G, Perret C, Capeau J 2001 Insulin and IGF-1 stimulate the -catenin pathway through two signalling cascades involving GSK-3 inhibition and Ras activation. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1793417940"

Phrase: "[Abstract/Free FullText"

Phrase: "] Desbois-Mouthon C,"

Phrase: "Cadoret A,"

Phrase: "Blivet-Van Eggelpoel MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439254:MJ [Medical Device]

Phrase: "Bertrand F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Cherqui G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Perret C,"

Phrase: "Capeau J 2001 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "stimulate"

Phrase: "the -catenin pathway through two signalling cascades"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   774   C0037083:signalling pathway [Cell Function]
   757 E C0037080:Signal Pathway [Molecular Function]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "GSK-3 inhibition"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0021467:Inhibition [Mental Process]
   804   C0021469:Inhibition [Molecular Function]
   804   C1628982:% inhibition [Quantitative Concept]
   804   C3463820:Inhibition [Activity]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   733 E C0311403:Inhibited [Qualitative Concept]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Ras activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]
Processing 00000000.tx.399: Oncogene 20:252259[CrossRef][Medline] Reddy SA, Huang JH, Liao WS 2000 Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-B activation. 

Phrase: "Oncogene 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: ":"

Phrase: "252259"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reddy SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Huang JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Liao WS 2000 Phosphatidylinositol 3-kinase as a mediator"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   762 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "of TNF-induced NF-B activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1879547:Activation [Activity]
   708   C0024320:TNF-b [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.400: J Immunol 164:13551363[Abstract/Free FullText] Madge LA, Pober JS 2000 A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFB in human endothelial cells. 

Phrase: "J Immunol 164"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "13551363"

Phrase: "[Abstract/Free FullText"

Phrase: "] Madge LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Pober JS 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "A phosphatidylinositol 3-kinase/Akt pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   717   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "activated by tumor necrosis factor"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   862   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   862   C1323304:tumor necrosis factor [Molecular Function]
   862   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C0333516:Tumor necrosis [Neoplastic Process]
   762 E C1300818:Necrotic tumor [Neoplastic Process]
   760   C0027540:Necrosis [Organ or Tissue Function]
   760   C0027651:Tumor [Neoplastic Process]
   760   C1334928:Necrosis [Finding]
   760   C1521761:Factor [Functional Concept]
   760   C1578706:Tumor [Intellectual Product]
   760   C1879547:Activated [Activity]
   760   C2827422:Factor [Conceptual Entity]
   760   C3273930:Tumor [Finding]
   726 E C1515877:Activate [Functional Concept]

Phrase: "or"

Phrase: "interleukin-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "NFB in human endothelial cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   778   C1824728:FACTOR B [Gene or Genome]
Processing 00000000.tx.401: J Biol Chem 275:1545815465[Abstract/Free FullText] Virbasius JV, Guilherme A, Czech MP 1996 Mouse p170 is a novel phosphatidylinositol 3-kinase containing a C2 domain. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1545815465"

Phrase: "[Abstract/Free FullText"

Phrase: "] Virbasius JV,"

Phrase: "Guilherme A,"

Phrase: "Czech MP 1996 Mouse p170"

Phrase: "is"

Phrase: "a novel phosphatidylinositol 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   895 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a C2 domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511359:C2 Domain [Amino Acid Sequence]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.402: J Biol Chem 271:1330413307[Abstract/Free FullText] Sarkaria JN, Tibbetts RS, Busby EC, Kennedy AP, Hill DE, Abraham RT 1998 Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. 

Phrase: "J Biol Chem 271"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1330413307"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sarkaria JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Tibbetts RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Busby EC,"

Phrase: "Kennedy AP,"

Phrase: "Hill DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Abraham RT 1998 Inhibition of phosphoinositide 3-kinase related kinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]

Phrase: "by the radiosensitizing agent wortmannin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   734   C0034541:Radiosensitizing Agent [Pharmacologic Substance]
Processing 00000000.tx.403: Cancer Res 58:43754382[Abstract] Yang DQ, Kastan MB 2000 Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. 

Phrase: "Cancer Res 58"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "43754382"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yang DQ,"

Phrase: "Kastan MB 2000 Participation of ATM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679823:Participation [Functional Concept]

Phrase: "in insulin signalling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C3537152:signalling [Biologic Function]
   827 E C1710082:Signal [Phenomenon or Process]

Phrase: "through phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of eIF-4E-binding protein 1."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   897   C0013728:EIF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1414323:EIF-1 [Gene or Genome]
   840   C0058988:EIF-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C3539642:eIF-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C0450378:4e [Intellectual Product]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
Processing 00000000.tx.404: Nat Cell Biol 2:893898[CrossRef][Medline] Jentsch S, Pyrowolakis G 2000 Ubiquitin and its kin: how close are the family ties? 

Phrase: "Nat Cell Biol 2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C0796518:NAT-2 [Gene or Genome]
   902   C1261253:NAT-2 [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1705514:NAT-2 [Gene or Genome]
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "893898"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jentsch S,"

Phrase: "Pyrowolakis G 2000 Ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "its kin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416642:KIN [Gene or Genome]

Phrase: ":"

Phrase: "how close"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0587267:Close [Functional Concept]

Phrase: "are"

Phrase: "the family ties?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0453920:Tie [Manufactured Object]
   827   C3472712:Tie [Manufactured Object]
Processing 00000000.tx.405: Trends Cell Biol 10:335342[CrossRef][Medline]

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol 10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "335342"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

